No., subject, TM-score, RMSD, Sequence Identity, Subject length, Aligned length, Description
1, d4qv5E_, 1.0000, 0.00, 1.000, 231, 231, YCP BETA5-M45I MUTANT
2, d4qv5S_, 0.9999, 0.00, 1.000, 231, 231, YCP BETA5-M45I MUTANT
3, d4qv4S_, 0.9999, 0.04, 1.000, 231, 231, YCP BETA5-M45T MUTANT
4, d4qv4E_, 0.9999, 0.04, 1.000, 231, 231, YCP BETA5-M45T MUTANT
5, d4qv3S_, 0.9999, 0.05, 1.000, 231, 231, YCP BETA5-M45V MUTANT
6, d4qv3E_, 0.9999, 0.05, 1.000, 231, 231, YCP BETA5-M45V MUTANT
7, d4qv1S_, 0.9999, 0.06, 1.000, 231, 231, YCP BETA5-M45A MUTANT
8, d4qv1E_, 0.9999, 0.06, 1.000, 231, 231, YCP BETA5-M45A MUTANT
9, d4qvnS_, 0.9998, 0.07, 1.000, 231, 231, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
10, d4qvnE_, 0.9998, 0.07, 1.000, 231, 231, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
11, d4qv8S_, 0.9998, 0.06, 1.000, 231, 231, YCP BETA5-C52F MUTANT
12, d4qv8E_, 0.9998, 0.06, 1.000, 231, 231, YCP BETA5-C52F MUTANT
13, d4qv7S_, 0.9998, 0.06, 1.000, 231, 231, YCP BETA5-A50V MUTANT
14, d4qv7E_, 0.9998, 0.06, 1.000, 231, 231, YCP BETA5-A50V MUTANT
15, d4qv0S_, 0.9998, 0.07, 1.000, 231, 231, YCP BETA5-A49T-A50V-DOUBLE MUTANT
16, d4qv0E_, 0.9998, 0.07, 1.000, 231, 231, YCP BETA5-A49T-A50V-DOUBLE MUTANT
17, d5l6bS_, 0.9997, 0.09, 1.000, 231, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
18, d5l6bE_, 0.9997, 0.09, 1.000, 231, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
19, d5l6aS_, 0.9997, 0.09, 1.000, 231, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
20, d5l6aE_, 0.9997, 0.09, 1.000, 231, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
21, d5l63S_, 0.9997, 0.10, 1.000, 231, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
22, d5l63E_, 0.9997, 0.10, 1.000, 231, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
23, d5l5wS_, 0.9997, 0.10, 1.000, 231, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
24, d5l5wE_, 0.9997, 0.10, 1.000, 231, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
25, d5l5uS_, 0.9997, 0.10, 1.000, 231, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
26, d5l5uE_, 0.9997, 0.10, 1.000, 231, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
27, d5l5hS_, 0.9997, 0.10, 1.000, 231, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
28, d5l5hE_, 0.9997, 0.10, 1.000, 231, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
29, d5l5bS_, 0.9997, 0.09, 1.000, 231, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
30, d5l5bE_, 0.9997, 0.09, 1.000, 231, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
31, d5czaS_, 0.9997, 0.09, 1.000, 231, 231, YEAST 20S PROTEASOME BETA5-D166N MUTANT
32, d5czaE_, 0.9997, 0.09, 1.000, 231, 231, YEAST 20S PROTEASOME BETA5-D166N MUTANT
33, d5bxnS_, 0.9997, 0.08, 1.000, 231, 231, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
34, d5bxnE_, 0.9997, 0.08, 1.000, 231, 231, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
35, d5bxlS_, 0.9997, 0.10, 1.000, 231, 231, YEAST 20S PROTEASOME BETA2-G170A MUTANT
36, d4qzzS_, 0.9997, 0.08, 1.000, 231, 231, YCP IN COMPLEX WITH OMURALIDE
37, d4qzzE_, 0.9997, 0.08, 1.000, 231, 231, YCP IN COMPLEX WITH OMURALIDE
38, d4qwuS_, 0.9997, 0.09, 1.000, 231, 231, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
39, d4qwuE_, 0.9997, 0.09, 1.000, 231, 231, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
40, d4qw1S_, 0.9997, 0.08, 1.000, 231, 231, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
41, d4qw1E_, 0.9997, 0.09, 1.000, 231, 231, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
42, d4qvlS_, 0.9997, 0.09, 1.000, 231, 231, YCP IN COMPLEX WITH BORTEZOMIB
43, d4qvlE_, 0.9997, 0.09, 1.000, 231, 231, YCP IN COMPLEX WITH BORTEZOMIB
44, d4qv9S_, 0.9997, 0.09, 1.000, 231, 231, YCP BETA5-C63F MUTANT
45, d4qv9E_, 0.9997, 0.09, 1.000, 231, 231, YCP BETA5-C63F MUTANT
46, d4quyS_, 0.9997, 0.08, 1.000, 231, 231, YCP BETA5-A49S-MUTANT
47, d4quyE_, 0.9997, 0.08, 1.000, 231, 231, YCP BETA5-A49S-MUTANT
48, p6gopS_, 0.9996, 0.11, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
49, p6gopE_, 0.9996, 0.11, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
50, d5m2bS_, 0.9996, 0.11, 1.000, 231, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
51, d5m2bE_, 0.9996, 0.11, 1.000, 231, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
52, d5l6cS_, 0.9996, 0.11, 1.000, 231, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
53, d5l6cE_, 0.9996, 0.11, 1.000, 231, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
54, d5l67S_, 0.9996, 0.11, 1.000, 231, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
55, d5l67E_, 0.9996, 0.11, 1.000, 231, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
56, d5l66S_, 0.9996, 0.11, 1.000, 231, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
57, d5l66E_, 0.9996, 0.11, 1.000, 231, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
58, d5l65S_, 0.9996, 0.10, 1.000, 231, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
59, d5l65E_, 0.9996, 0.10, 1.000, 231, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
60, d5l64S_, 0.9996, 0.11, 1.000, 231, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
61, d5l64E_, 0.9996, 0.11, 1.000, 231, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
62, d5l62S_, 0.9996, 0.11, 1.000, 231, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
63, d5l62E_, 0.9996, 0.11, 1.000, 231, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
64, d5l61S_, 0.9996, 0.10, 1.000, 231, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
65, d5l61E_, 0.9996, 0.10, 1.000, 231, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
66, d5l5xS_, 0.9996, 0.11, 1.000, 231, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
67, d5l5xE_, 0.9996, 0.11, 1.000, 231, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
68, d5l5rS_, 0.9996, 0.10, 1.000, 231, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
69, d5l5rE_, 0.9996, 0.10, 1.000, 231, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
70, d5l5pS_, 0.9996, 0.11, 1.000, 231, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
71, d5l5pE_, 0.9996, 0.11, 1.000, 231, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
72, d5l5oS_, 0.9996, 0.11, 1.000, 231, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
73, d5l5oE_, 0.9996, 0.11, 1.000, 231, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
74, d5l5fS_, 0.9996, 0.11, 1.000, 231, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
75, d5l5fE_, 0.9996, 0.11, 1.000, 231, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
76, d5l5dS_, 0.9996, 0.10, 1.000, 231, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
77, d5l5dE_, 0.9996, 0.10, 1.000, 231, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
78, d5l5aS_, 0.9996, 0.11, 1.000, 231, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
79, d5l5aE_, 0.9996, 0.11, 1.000, 231, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
80, d5fgaS_, 0.9996, 0.11, 1.000, 231, 231, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
81, d5fgaE_, 0.9996, 0.11, 1.000, 231, 231, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
82, d5fg7S_, 0.9996, 0.11, 1.000, 231, 231, YEAST 20S PROTEASOME BETA2-T1A MUTANT
83, d5fg7E_, 0.9996, 0.11, 1.000, 231, 231, YEAST 20S PROTEASOME BETA2-T1A MUTANT
84, d5d0wS_, 0.9996, 0.10, 1.000, 231, 231, YEAST 20S PROTEASOME BETA5-T1S MUTANT
85, d5d0wE_, 0.9996, 0.10, 1.000, 231, 231, YEAST 20S PROTEASOME BETA5-T1S MUTANT
86, d5bxlE_, 0.9996, 0.10, 1.000, 231, 231, YEAST 20S PROTEASOME BETA2-G170A MUTANT
87, d4ya4S_, 0.9996, 0.10, 1.000, 231, 231, YEAST 20S PROTEASOME BETA2-H114D MUTANT
88, d4ya4E_, 0.9996, 0.10, 1.000, 231, 231, YEAST 20S PROTEASOME BETA2-H114D MUTANT
89, d4ya1S_, 0.9996, 0.10, 1.000, 231, 231, YEAST 20S PROTEASOME BETA2-H116N MUTANT
90, d4ya1E_, 0.9996, 0.10, 1.000, 231, 231, YEAST 20S PROTEASOME BETA2-H116N MUTANT
91, d4y9yS_, 0.9996, 0.10, 1.000, 231, 231, YEAST 20S PROTEASOME BETA2-H116E MUTANT
92, d4y9yE_, 0.9996, 0.10, 1.000, 231, 231, YEAST 20S PROTEASOME BETA2-H116E MUTANT
93, d4y8rS_, 0.9996, 0.11, 1.000, 231, 231, YEAST 20S PROTEASOME BETA2-H116D MUTANT
94, d4y8rE_, 0.9996, 0.11, 1.000, 231, 231, YEAST 20S PROTEASOME BETA2-H116D MUTANT
95, d4qvpS_, 0.9996, 0.11, 1.000, 231, 231, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
96, d4qvpE_, 0.9996, 0.11, 1.000, 231, 231, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
97, d5lttS_, 0.9995, 0.11, 1.000, 231, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
98, d5lttE_, 0.9995, 0.11, 1.000, 231, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
99, d5l5zS_, 0.9995, 0.12, 1.000, 231, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
100, d5l5zE_, 0.9995, 0.12, 1.000, 231, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
101, d5l5tS_, 0.9995, 0.12, 1.000, 231, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
102, d5l5tE_, 0.9995, 0.12, 1.000, 231, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
103, d5l5sS_, 0.9995, 0.11, 1.000, 231, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
104, d5l5sE_, 0.9995, 0.11, 1.000, 231, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
105, d5l5qS_, 0.9995, 0.12, 1.000, 231, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
106, d5l5qE_, 0.9995, 0.12, 1.000, 231, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
107, d5l5jS_, 0.9995, 0.12, 1.000, 231, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
108, d5l5jE_, 0.9995, 0.12, 1.000, 231, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
109, d5l5iS_, 0.9995, 0.12, 1.000, 231, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
110, d5l5iE_, 0.9995, 0.12, 1.000, 231, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
111, d5l55S_, 0.9995, 0.12, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
112, d5l55E_, 0.9995, 0.12, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
113, d5l52S_, 0.9995, 0.12, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
114, d5l52E_, 0.9995, 0.12, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
115, d5cz7E_, 0.9995, 0.13, 1.000, 231, 231, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
116, d5cz6S_, 0.9995, 0.11, 1.000, 231, 231, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
117, d5cz6E_, 0.9995, 0.11, 1.000, 231, 231, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
118, p5cghS_, 0.9995, 0.12, 1.000, 231, 231, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
119, p5cghE_, 0.9995, 0.12, 1.000, 231, 231, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
120, p5cggS_, 0.9995, 0.12, 1.000, 231, 231, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
121, p5cggE_, 0.9995, 0.12, 1.000, 231, 231, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
122, d5cgfS_, 0.9995, 0.12, 1.000, 231, 231, YEAST 20S PROTEASOME BETA5-G48C MUTANT
123, d5cgfE_, 0.9995, 0.12, 1.000, 231, 231, YEAST 20S PROTEASOME BETA5-G48C MUTANT
124, d5ahjS_, 0.9995, 0.12, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
125, d5ahjE_, 0.9995, 0.12, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
126, d4y8mS_, 0.9995, 0.13, 1.000, 231, 231, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
127, d4y8mE_, 0.9995, 0.13, 1.000, 231, 231, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
128, d4r00S_, 0.9995, 0.11, 1.000, 231, 231, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
129, d4r00E_, 0.9995, 0.11, 1.000, 231, 231, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
130, d4qz0S_, 0.9995, 0.12, 1.000, 231, 231, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
131, d4qz0E_, 0.9995, 0.12, 1.000, 231, 231, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
132, d4qw6S_, 0.9995, 0.13, 1.000, 231, 231, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
133, d4qw6E_, 0.9995, 0.13, 1.000, 231, 231, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
134, d4qvyS_, 0.9995, 0.12, 1.000, 231, 231, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
135, d4qvyE_, 0.9995, 0.12, 1.000, 231, 231, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
136, d4qvwS_, 0.9995, 0.12, 1.000, 231, 231, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
137, d4qvwE_, 0.9995, 0.12, 1.000, 231, 231, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
138, d4quxS_, 0.9995, 0.12, 1.000, 231, 231, YCP BETA5-A49T-MUTANT
139, d4quxE_, 0.9995, 0.12, 1.000, 231, 231, YCP BETA5-A49T-MUTANT
140, d5l68S_, 0.9994, 0.13, 1.000, 231, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
141, d5l68E_, 0.9994, 0.13, 1.000, 231, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
142, d5l5yS_, 0.9994, 0.13, 1.000, 231, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
143, d5l5yE_, 0.9994, 0.13, 1.000, 231, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
144, d5l5eS_, 0.9994, 0.14, 1.000, 231, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
145, d5l5eE_, 0.9994, 0.14, 1.000, 231, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
146, d5fggS_, 0.9994, 0.13, 1.000, 231, 231, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
147, d5fggE_, 0.9994, 0.13, 1.000, 231, 231, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
148, d5fg9S_, 0.9994, 0.13, 1.000, 231, 231, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
149, d5fg9E_, 0.9994, 0.13, 1.000, 231, 231, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
150, d5d0zS_, 0.9994, 0.14, 1.000, 231, 231, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
151, d5d0zE_, 0.9994, 0.14, 1.000, 231, 231, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
152, d5d0vS_, 0.9994, 0.13, 1.000, 231, 231, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
153, d5d0vE_, 0.9994, 0.13, 1.000, 231, 231, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
154, d5d0sS_, 0.9994, 0.13, 1.000, 231, 231, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
155, d5d0sE_, 0.9994, 0.13, 1.000, 231, 231, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
156, d5cz7S_, 0.9994, 0.13, 1.000, 231, 231, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
157, d4z1lS_, 0.9994, 0.14, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
158, d4z1lE_, 0.9994, 0.14, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
159, d4qz4S_, 0.9994, 0.13, 1.000, 231, 231, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
160, d4qz4E_, 0.9994, 0.14, 1.000, 231, 231, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
161, d4qwxS_, 0.9994, 0.13, 1.000, 231, 231, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
162, d4qwxE_, 0.9994, 0.13, 1.000, 231, 231, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
163, d4qwlS_, 0.9994, 0.13, 1.000, 231, 231, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
164, d4qwlE_, 0.9994, 0.13, 1.000, 231, 231, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
165, d4qwfS_, 0.9994, 0.14, 1.000, 231, 231, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
166, d4qwfE_, 0.9994, 0.14, 1.000, 231, 231, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
167, d4qw5S_, 0.9994, 0.14, 1.000, 231, 231, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
168, d4qw5E_, 0.9994, 0.14, 1.000, 231, 231, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
169, d5l69S_, 0.9993, 0.14, 1.000, 231, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
170, d5l69E_, 0.9993, 0.14, 1.000, 231, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
171, d5l60S_, 0.9993, 0.15, 1.000, 231, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
172, d5l60E_, 0.9993, 0.15, 1.000, 231, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
173, d5l5vS_, 0.9993, 0.14, 1.000, 231, 231,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
174, d5l5vE_, 0.9993, 0.14, 1.000, 231, 231,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
175, d5jhrS_, 0.9993, 0.14, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
176, d5jhrE_, 0.9993, 0.14, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
177, p4ya9S_, 0.9993, 0.15, 1.000, 231, 231, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
178, p4ya9E_, 0.9993, 0.15, 1.000, 231, 231, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
179, p4y8pS_, 0.9993, 0.14, 1.000, 231, 231, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
180, p4y8pE_, 0.9993, 0.14, 1.000, 231, 231, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
181, p4y77S_, 0.9993, 0.15, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
182, p4y77E_, 0.9993, 0.15, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
183, d4qz6S_, 0.9993, 0.14, 1.000, 231, 231, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
184, d4qz6E_, 0.9993, 0.14, 1.000, 231, 231, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
185, d4qz3S_, 0.9993, 0.15, 1.000, 231, 231, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
186, d4qz3E_, 0.9993, 0.15, 1.000, 231, 231, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
187, d4qw7S_, 0.9993, 0.14, 1.000, 231, 231, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
188, d4qw7E_, 0.9993, 0.14, 1.000, 231, 231, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
189, d4qvqS_, 0.9993, 0.14, 1.000, 231, 231, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
190, d4qvqE_, 0.9993, 0.14, 1.000, 231, 231, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
191, d4qv6S_, 0.9993, 0.14, 1.000, 231, 231, YCP BETA5-A49V MUTANT
192, d4qv6E_, 0.9993, 0.15, 1.000, 231, 231, YCP BETA5-A49V MUTANT
193, d5jhsS_, 0.9992, 0.16, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
194, d5jhsE_, 0.9992, 0.16, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
195, d5cz9S_, 0.9992, 0.15, 1.000, 231, 231, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
196, d5cz9E_, 0.9992, 0.15, 1.000, 231, 231, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
197, p5cgiS_, 0.9992, 0.15, 1.000, 231, 231, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
198, p5cgiE_, 0.9992, 0.15, 1.000, 231, 231, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
199, d5bouS_, 0.9992, 0.15, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
200, d5bouE_, 0.9992, 0.15, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
201, p4ya7S_, 0.9992, 0.15, 1.000, 231, 231, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
202, p4ya7E_, 0.9992, 0.15, 1.000, 231, 231, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
203, p4y75S_, 0.9992, 0.15, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
204, p4y75E_, 0.9992, 0.15, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
205, d4qz7S_, 0.9992, 0.16, 1.000, 231, 231, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
206, d4qz7E_, 0.9992, 0.16, 1.000, 231, 231, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
207, d4qz5S_, 0.9992, 0.16, 1.000, 231, 231, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
208, d4qz2S_, 0.9992, 0.16, 1.000, 231, 231, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
209, d4qz2E_, 0.9992, 0.16, 1.000, 231, 231, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
210, d5fgfS_, 0.9991, 0.16, 1.000, 231, 231, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
211, d5fgfE_, 0.9991, 0.16, 1.000, 231, 231, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
212, d5dkjS_, 0.9991, 0.16, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
213, d5dkjE_, 0.9991, 0.16, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
214, d5d0tS_, 0.9991, 0.16, 1.000, 231, 231, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
215, d5d0tE_, 0.9991, 0.16, 1.000, 231, 231, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
216, p4y9zS_, 0.9991, 0.16, 1.000, 231, 231, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
217, p4y9zE_, 0.9991, 0.16, 1.000, 231, 231, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
218, p4y8tS_, 0.9991, 0.16, 1.000, 231, 231, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
219, p4y8tE_, 0.9991, 0.16, 1.000, 231, 231, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
220, p4y8kS_, 0.9991, 0.16, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
221, p4y8kE_, 0.9991, 0.16, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
222, p4y6vS_, 0.9991, 0.16, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
223, p4y6vE_, 0.9991, 0.16, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
224, d4rurS_, 0.9991, 0.16, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
225, d4rurE_, 0.9991, 0.16, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
226, d4r17S_, 0.9991, 0.17, 1.000, 231, 231, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
227, d4qzwS_, 0.9991, 0.16, 1.000, 231, 231, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
228, d4qzwE_, 0.9991, 0.16, 1.000, 231, 231, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
229, d4qz5E_, 0.9991, 0.16, 1.000, 231, 231, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
230, d5fgeS_, 0.9990, 0.18, 1.000, 231, 231, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
231, d5fgeE_, 0.9990, 0.18, 1.000, 231, 231, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
232, d5cz8S_, 0.9990, 0.18, 1.000, 231, 231, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
233, d5cz8E_, 0.9990, 0.18, 1.000, 231, 231, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
234, p4y8sS_, 0.9990, 0.17, 1.000, 231, 231, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
235, p4y8sE_, 0.9990, 0.17, 1.000, 231, 231, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
236, p4y82S_, 0.9990, 0.18, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
237, p4y82E_, 0.9990, 0.18, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
238, d4r18S_, 0.9990, 0.17, 1.000, 231, 231, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
239, d4r18E_, 0.9990, 0.17, 1.000, 231, 231, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
240, d4r17E_, 0.9990, 0.17, 1.000, 231, 231, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
241, d4qwrS_, 0.9990, 0.17, 1.000, 231, 231, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
242, d4qwrE_, 0.9990, 0.17, 1.000, 231, 231, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
243, d4qw4S_, 0.9990, 0.17, 1.000, 231, 231, YCP IN COMPLEX WITH CARFILZOMIB
244, d4qw4E_, 0.9990, 0.17, 1.000, 231, 231, YCP IN COMPLEX WITH CARFILZOMIB
245, d4qvmS_, 0.9990, 0.18, 1.000, 231, 231, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
246, d4qvmE_, 0.9990, 0.18, 1.000, 231, 231, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
247, d4no8S_, 0.9990, 0.18, 1.000, 231, 231, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
248, d4no8E_, 0.9990, 0.18, 1.000, 231, 231, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
249, d4no1S_, 0.9990, 0.17, 1.000, 231, 231, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
250, d4no1E_, 0.9990, 0.17, 1.000, 231, 231, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
251, d4nnnS_, 0.9990, 0.17, 1.000, 231, 231, YCP IN COMPLEX WITH MG132
252, d4nnnE_, 0.9990, 0.17, 1.000, 231, 231, YCP IN COMPLEX WITH MG132
253, d5lajS_, 0.9989, 0.18, 1.000, 231, 231, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
254, d5lajE_, 0.9989, 0.18, 1.000, 231, 231, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
255, d5l54S_, 0.9989, 0.18, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
256, d5l54E_, 0.9989, 0.18, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
257, d5d0xS_, 0.9989, 0.19, 1.000, 231, 231, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
258, d5d0xE_, 0.9989, 0.19, 1.000, 231, 231, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
259, p4ya2S_, 0.9989, 0.18, 1.000, 231, 231, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
260, p4ya2E_, 0.9989, 0.18, 1.000, 231, 231, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
261, p4y8uS_, 0.9989, 0.18, 1.000, 231, 231, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
262, p4y8uE_, 0.9989, 0.18, 1.000, 231, 231, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
263, p4y8nS_, 0.9989, 0.18, 1.000, 231, 231, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
264, p4y8nE_, 0.9989, 0.18, 1.000, 231, 231, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
265, p4y8lS_, 0.9989, 0.18, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
266, p4y8lE_, 0.9989, 0.18, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
267, p4y8jS_, 0.9989, 0.19, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
268, p4y8jE_, 0.9989, 0.19, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
269, p4y8hS_, 0.9989, 0.19, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
270, p4y8hE_, 0.9989, 0.19, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
271, p4y8gS_, 0.9989, 0.19, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
272, p4y8gE_, 0.9989, 0.19, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
273, p4y74S_, 0.9989, 0.18, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
274, p4y74E_, 0.9989, 0.18, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
275, p4y6aS_, 0.9989, 0.18, 1.000, 231, 231, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
276, p4y6aE_, 0.9989, 0.18, 1.000, 231, 231, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
277, p4y69S_, 0.9989, 0.18, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
278, p4y69E_, 0.9989, 0.18, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
279, d4qltS_, 0.9989, 0.19, 1.000, 231, 231, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
280, d4qltE_, 0.9989, 0.19, 1.000, 231, 231, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
281, d5fhsS_, 0.9988, 0.19, 1.000, 231, 231, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
282, d5fhsE_, 0.9988, 0.19, 1.000, 231, 231, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
283, p4y8qS_, 0.9988, 0.19, 1.000, 231, 231, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
284, p4y8qE_, 0.9988, 0.19, 1.000, 231, 231, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
285, p4y81S_, 0.9988, 0.20, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
286, p4y81E_, 0.9988, 0.20, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
287, p4y70S_, 0.9988, 0.19, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
288, p4y70E_, 0.9988, 0.19, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
289, d4qz1S_, 0.9988, 0.19, 1.000, 231, 231, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
290, d4qz1E_, 0.9988, 0.19, 1.000, 231, 231, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
291, d4qw0S_, 0.9988, 0.19, 1.000, 231, 231, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
292, d4qw0E_, 0.9988, 0.19, 1.000, 231, 231, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
293, d4qlsS_, 0.9988, 0.19, 1.000, 231, 231, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
294, d4qlsE_, 0.9988, 0.19, 1.000, 231, 231, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
295, d4qlqS_, 0.9988, 0.19, 1.000, 231, 231, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
296, d4qlqE_, 0.9988, 0.19, 1.000, 231, 231, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
297, d5laiS_, 0.9987, 0.20, 1.000, 231, 231, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
298, d5laiE_, 0.9987, 0.20, 1.000, 231, 231, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
299, d5fgiS_, 0.9987, 0.20, 1.000, 231, 231, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
300, d5fgiE_, 0.9987, 0.20, 1.000, 231, 231, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
301, p5fghS_, 0.9987, 0.20, 1.000, 231, 231, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
302, p5fghE_, 0.9987, 0.20, 1.000, 231, 231, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
303, p4ya5S_, 0.9987, 0.20, 1.000, 231, 231, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
304, p4ya5E_, 0.9987, 0.20, 1.000, 231, 231, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
305, p4y8oS_, 0.9987, 0.20, 1.000, 231, 231, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
306, p4y8oE_, 0.9987, 0.20, 1.000, 231, 231, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
307, p4y8iS_, 0.9987, 0.20, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
308, p4y8iE_, 0.9987, 0.20, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
309, p4y84S_, 0.9987, 0.20, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
310, p4y84E_, 0.9987, 0.20, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
311, p4y7xS_, 0.9987, 0.20, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
312, p4y7xE_, 0.9987, 0.20, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
313, p4y7wS_, 0.9987, 0.20, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
314, p4y7wE_, 0.9987, 0.20, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
315, d4r02S_, 0.9987, 0.20, 1.000, 231, 231, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
316, d4r02E_, 0.9987, 0.20, 1.000, 231, 231, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
317, d4qzxS_, 0.9987, 0.20, 1.000, 231, 231, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
318, d4qzxE_, 0.9987, 0.20, 1.000, 231, 231, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
319, d4no9S_, 0.9987, 0.20, 1.000, 231, 231, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
320, d4no9E_, 0.9987, 0.20, 1.000, 231, 231, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
321, d5fgdS_, 0.9986, 0.21, 1.000, 231, 231, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
322, d5fgdE_, 0.9986, 0.21, 1.000, 231, 231, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
323, d5cz5S_, 0.9986, 0.21, 1.000, 231, 231, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
324, d5cz5E_, 0.9986, 0.21, 1.000, 231, 231, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
325, p4y80S_, 0.9986, 0.21, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
326, p4y80E_, 0.9986, 0.21, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
327, p4y7yS_, 0.9986, 0.21, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
328, p4y7yE_, 0.9986, 0.21, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
329, d4qwiS_, 0.9986, 0.21, 1.000, 231, 231, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
330, d4qwiE_, 0.9986, 0.21, 1.000, 231, 231, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
331, d4nnwS_, 0.9986, 0.21, 1.000, 231, 231, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
332, d4nnwE_, 0.9986, 0.21, 1.000, 231, 231, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
333, p4y6zS_, 0.9985, 0.21, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
334, p4y6zE_, 0.9985, 0.21, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
335, d4qxjS_, 0.9985, 0.22, 1.000, 231, 231, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
336, d4qxjE_, 0.9985, 0.21, 1.000, 231, 231, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
337, d5dkiS_, 0.9984, 0.23, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
338, d5dkiE_, 0.9984, 0.22, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
339, d4qluS_, 0.9984, 0.22, 1.000, 231, 231, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
340, d4qluE_, 0.9984, 0.22, 1.000, 231, 231, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
341, p4qbyS_, 0.9984, 0.22, 1.000, 231, 231, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
342, p4qbyE_, 0.9984, 0.22, 1.000, 231, 231, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
343, d4no6S_, 0.9984, 0.22, 1.000, 231, 231, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
344, d4no6E_, 0.9984, 0.22, 1.000, 231, 231, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
345, d4qwkS_, 0.9983, 0.23, 1.000, 231, 231, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
346, d4qwkE_, 0.9983, 0.23, 1.000, 231, 231, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
347, d4qlvS_, 0.9983, 0.23, 1.000, 231, 231, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
348, d4qlvE_, 0.9983, 0.23, 1.000, 231, 231, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
349, d5cz4S_, 0.9982, 0.23, 1.000, 231, 231, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
350, d5cz4E_, 0.9982, 0.23, 1.000, 231, 231, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
351, p4y78S_, 0.9982, 0.24, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
352, p4y78E_, 0.9982, 0.24, 1.000, 231, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
353, d4ltcS_, 0.9982, 0.25, 1.000, 233, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
354, d4ltcE_, 0.9982, 0.25, 1.000, 233, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
355, d4qw3S_, 0.9980, 0.25, 1.000, 231, 231, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
356, d4qw3E_, 0.9980, 0.25, 1.000, 231, 231, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
357, d4qvvS_, 0.9980, 0.25, 1.000, 231, 231, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
358, d4qvvE_, 0.9980, 0.25, 1.000, 231, 231, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
359, p4ya3S_, 0.9979, 0.26, 1.000, 231, 231, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
360, p4ya3E_, 0.9979, 0.26, 1.000, 231, 231, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
361, d4qwsE_, 0.9979, 0.26, 1.000, 231, 231, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
362, d4qwjE_, 0.9979, 0.26, 1.000, 231, 231, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
363, p4ya0E_, 0.9978, 0.26, 1.000, 231, 231, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
364, d4qwsS_, 0.9978, 0.26, 1.000, 231, 231, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
365, d4qwjS_, 0.9978, 0.26, 1.000, 231, 231, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
366, d4jsqS_, 0.9978, 0.28, 1.000, 233, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
367, d4jsqE_, 0.9978, 0.28, 1.000, 233, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
368, p4ya0S_, 0.9977, 0.27, 1.000, 231, 231, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
369, d4jsuS_, 0.9977, 0.28, 1.000, 233, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
370, d4jsuE_, 0.9977, 0.28, 1.000, 233, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
371, p3un4S_, 0.9977, 0.28, 1.000, 233, 231, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
372, p3un4E_, 0.9977, 0.28, 1.000, 233, 231, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
373, d4inrE_, 0.9976, 0.29, 1.000, 233, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
374, d4hnpS_, 0.9976, 0.28, 0.996, 233, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
375, d4eu2F_, 0.9976, 0.27, 1.000, 232, 231, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
376, d4jt0S_, 0.9975, 0.29, 1.000, 233, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
377, d4jt0E_, 0.9975, 0.29, 1.000, 233, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
378, d4intS_, 0.9975, 0.29, 1.000, 233, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
379, d4intE_, 0.9975, 0.29, 1.000, 233, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
380, d4inrS_, 0.9975, 0.29, 1.000, 233, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
381, d3nzjS_, 0.9975, 0.29, 1.000, 233, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
382, d3nzjE_, 0.9975, 0.29, 1.000, 233, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
383, d3gpwS_, 0.9975, 0.29, 1.000, 233, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
384, d3gpwE_, 0.9975, 0.29, 1.000, 233, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
385, d3gptS_, 0.9975, 0.29, 1.000, 233, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
386, d3gptE_, 0.9975, 0.29, 1.000, 233, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
387, d3nzxS_, 0.9974, 0.30, 1.000, 233, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
388, d3nzxE_, 0.9974, 0.30, 1.000, 233, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
389, d3hyeS_, 0.9974, 0.30, 1.000, 233, 231, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
390, d3hyeE_, 0.9974, 0.30, 1.000, 233, 231, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
391, d4qwgS_, 0.9973, 0.29, 1.000, 231, 231, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
392, d4qwgE_, 0.9973, 0.29, 1.000, 231, 231, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
393, d4j70S_, 0.9973, 0.30, 1.000, 233, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
394, d4inuE_, 0.9973, 0.31, 1.000, 233, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
395, d3un8S_, 0.9973, 0.30, 1.000, 233, 231, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
396, d3un8E_, 0.9973, 0.30, 1.000, 233, 231, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
397, d3nzwS_, 0.9973, 0.30, 1.000, 233, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
398, d3nzwE_, 0.9973, 0.30, 1.000, 233, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
399, d4q1sS_, 0.9972, 0.31, 1.000, 233, 231, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
400, d4j70E_, 0.9972, 0.31, 1.000, 233, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
401, d4hnpE_, 0.9972, 0.30, 0.996, 233, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
402, d3tddS_, 0.9972, 0.31, 1.000, 233, 231, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
403, d3tddE_, 0.9972, 0.31, 1.000, 233, 231, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
404, d3mg0S_, 0.9972, 0.31, 1.000, 233, 231, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
405, d4inuS_, 0.9971, 0.32, 1.000, 233, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
406, d2fakS_, 0.9971, 0.31, 1.000, 233, 231, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
407, d2fakE_, 0.9971, 0.31, 1.000, 233, 231, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
408, p4x6zT_, 0.9970, 0.31, 0.996, 232, 231, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
409, d4lqiS_, 0.9970, 0.32, 1.000, 233, 231, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
410, d4lqiE_, 0.9970, 0.32, 1.000, 233, 231, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
411, p4gk7S_, 0.9970, 0.32, 1.000, 233, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
412, p4gk7E_, 0.9970, 0.32, 1.000, 233, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
413, d4fzcS_, 0.9970, 0.32, 1.000, 233, 231, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
414, d4fzcE_, 0.9970, 0.32, 1.000, 233, 231, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
415, d3mg0E_, 0.9970, 0.32, 1.000, 233, 231, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
416, d3shjS_, 0.9969, 0.32, 1.000, 233, 231, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
417, d3shjE_, 0.9969, 0.32, 1.000, 233, 231, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
418, d2gplS_, 0.9969, 0.32, 1.000, 233, 231, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
419, d2gplE_, 0.9969, 0.32, 1.000, 233, 231, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
420, p4x6zF_, 0.9968, 0.32, 1.000, 232, 231, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
421, d3okjS_, 0.9968, 0.33, 1.000, 233, 231, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
422, d3okjE_, 0.9968, 0.32, 1.000, 233, 231, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
423, d3d29S_, 0.9968, 0.33, 1.000, 233, 231, PROTEASOME INHIBITION BY FELLUTAMIDE B
424, d3d29E_, 0.9968, 0.33, 1.000, 233, 231, PROTEASOME INHIBITION BY FELLUTAMIDE B
425, d2f16S_, 0.9968, 0.33, 1.000, 233, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
426, d2f16E_, 0.9968, 0.33, 1.000, 233, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
427, d4hrdS_, 0.9967, 0.33, 0.996, 233, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
428, d4hrdE_, 0.9967, 0.33, 0.996, 233, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
429, d4fzgS_, 0.9967, 0.33, 1.000, 233, 231, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
430, d4fzgE_, 0.9967, 0.33, 1.000, 233, 231, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
431, d4eu2T_, 0.9967, 0.33, 1.000, 232, 231, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
432, d4q1sE_, 0.9966, 0.34, 1.000, 233, 231, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
433, d4hrcE_, 0.9965, 0.33, 0.996, 233, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
434, d3dy3S_, 0.9965, 0.34, 1.000, 233, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
435, d2zcyS_, 0.9965, 0.34, 1.000, 233, 231, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
436, d2zcyE_, 0.9965, 0.34, 1.000, 233, 231, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
437, d3dy4S_, 0.9964, 0.35, 1.000, 233, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
438, d3dy4E_, 0.9964, 0.35, 1.000, 233, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
439, d3dy3E_, 0.9964, 0.34, 1.000, 233, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
440, d2fnyS_, 0.9964, 0.35, 1.000, 233, 231,  
441, d2fnyE_, 0.9964, 0.35, 1.000, 233, 231,  
442, d3gpjS_, 0.9963, 0.35, 1.000, 233, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
443, d3gpjE_, 0.9963, 0.35, 1.000, 233, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
444, d3e47S_, 0.9963, 0.35, 1.000, 233, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
445, d3e47E_, 0.9963, 0.35, 1.000, 233, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
446, d3bdmS_, 0.9963, 0.35, 1.000, 233, 231, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
447, d3bdmE_, 0.9963, 0.35, 1.000, 233, 231, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
448, d4hrcS_, 0.9961, 0.36, 0.996, 233, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
449, d3mg4E_, 0.9961, 0.37, 1.000, 233, 231, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
450, p5nifF_, 0.9960, 0.36, 1.000, 232, 231, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
451, p4zzgF_, 0.9960, 0.35, 1.000, 232, 231, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
452, d1rypT_, 0.9960, 0.36, 0.996, 233, 231, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
453, d1rypF_, 0.9960, 0.37, 0.996, 233, 231, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
454, p5nifT_, 0.9956, 0.38, 1.000, 232, 231, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
455, d3wxrT_, 0.9956, 0.38, 0.996, 232, 231, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
456, p4zzgT_, 0.9955, 0.38, 1.000, 232, 231, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
457, d3mg4S_, 0.9954, 0.40, 1.000, 233, 231, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
458, d1g65E_, 0.9953, 0.40, 0.996, 233, 231, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
459, d1g65S_, 0.9951, 0.40, 0.996, 233, 231, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
460, d3wxrF_, 0.9950, 0.41, 0.996, 232, 231, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
461, d3oeuE_, 0.9949, 0.43, 1.000, 233, 231, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
462, d3oevE_, 0.9947, 0.43, 1.000, 233, 231, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
463, d3sdkS_, 0.9946, 0.43, 0.996, 233, 231, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
464, d3mg8S_, 0.9946, 0.44, 1.000, 233, 231, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
465, d3mg8E_, 0.9946, 0.44, 1.000, 233, 231, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
466, d3sdkE_, 0.9944, 0.44, 1.000, 233, 231, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
467, d3oevS_, 0.9944, 0.44, 1.000, 233, 231, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
468, d3mg6E_, 0.9944, 0.45, 1.000, 233, 231, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
469, d3mg7E_, 0.9943, 0.45, 1.000, 233, 231, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
470, d3oeuS_, 0.9942, 0.45, 1.000, 233, 231, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
471, d3mg7S_, 0.9942, 0.45, 1.000, 233, 231, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
472, d3mg6S_, 0.9940, 0.46, 1.000, 233, 231, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
473, d1jd2E_, 0.9939, 0.45, 0.996, 233, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
474, d1jd2Z_, 0.9933, 0.47, 0.996, 233, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
475, d4g4sF_, 0.9923, 0.50, 1.000, 234, 231, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
476, d3sdiE_, 0.9918, 0.37, 0.996, 230, 230, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
477, d1z7qT1, 0.9918, 0.52, 1.000, 233, 231, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
478, d1z7qF1, 0.9918, 0.52, 1.000, 233, 231, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
479, d3sdiS_, 0.9908, 0.40, 0.996, 230, 230, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
480, d1g0uE_, 0.9906, 0.41, 0.996, 230, 230, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
481, d1g0uS_, 0.9901, 0.43, 0.996, 230, 230, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
482, p1fntT_, 0.9900, 0.57, 1.000, 233, 231, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
483, p1fntF_, 0.9900, 0.57, 1.000, 233, 231, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
484, p4v7oT_, 0.9893, 0.60, 1.000, 234, 231, 
485, p4v7oNA_, 0.9893, 0.60, 1.000, 234, 231, 
486, p4v7oF_, 0.9893, 0.59, 1.000, 234, 231, 
487, p4v7oBB_, 0.9893, 0.60, 1.000, 234, 231, 
488, d3l5qW_, 0.9893, 0.60, 1.000, 234, 231,  
489, d3l5qK_, 0.9893, 0.59, 1.000, 234, 231,  
490, d1vsyT_, 0.9893, 0.60, 1.000, 234, 231,  
491, d1vsyF_, 0.9893, 0.60, 1.000, 234, 231,  
492, p5mp9f_, 0.9867, 0.66, 1.000, 231, 231, 26S PROTEASOME IN PRESENCE OF ATP (S1)
493, p5mp9F_, 0.9866, 0.66, 1.000, 233, 231, 26S PROTEASOME IN PRESENCE OF ATP (S1)
494, p3jcpOA_, 0.9856, 0.69, 0.996, 233, 231, 
495, p3jcpO_, 0.9856, 0.69, 0.996, 233, 231, 
496, p5mpaf_, 0.9818, 0.77, 1.000, 231, 231, 26S PROTEASOME IN PRESENCE OF ATP (S2)
497, p3jcoOA_, 0.9777, 0.86, 0.996, 233, 231, 
498, p3jcoO_, 0.9777, 0.86, 0.996, 233, 231, 
499, p3unhS_, 0.9727, 0.81, 0.533, 238, 229, MOUSE 20S IMMUNOPROTEASOME
500, p3unhE_, 0.9727, 0.81, 0.533, 238, 229, MOUSE 20S IMMUNOPROTEASOME
501, d3unfS_, 0.9725, 0.81, 0.533, 238, 229, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
502, d3unfE_, 0.9725, 0.81, 0.533, 238, 229, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
503, p5mpaF_, 0.9718, 0.98, 0.996, 233, 231, 26S PROTEASOME IN PRESENCE OF ATP (S2)
504, d3unbS_, 0.9715, 0.83, 0.533, 238, 229, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
505, d1iruT_, 0.9714, 0.84, 0.528, 238, 229, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
506, d1iruF_, 0.9714, 0.84, 0.528, 238, 229, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
507, d4r67T_, 0.9713, 0.83, 0.528, 238, 229, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
508, p4r67h_, 0.9713, 0.83, 0.528, 238, 229, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
509, d4r67F_, 0.9713, 0.83, 0.528, 238, 229, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
510, p5gjqG_, 0.9711, 0.83, 0.528, 238, 229, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
511, p5gjqm_, 0.9710, 0.83, 0.528, 238, 229, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
512, p3unbu_, 0.9709, 0.84, 0.533, 238, 229, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
513, d4r3oT_, 0.9708, 0.84, 0.528, 238, 229, HUMAN CONSTITUTIVE 20S PROTEASOME
514, d4r3oF_, 0.9707, 0.85, 0.528, 238, 229, HUMAN CONSTITUTIVE 20S PROTEASOME
515, d3unbE_, 0.9704, 0.86, 0.533, 238, 229, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
516, p3unbg_, 0.9703, 0.87, 0.533, 238, 229, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
517, p5gjrX_, 0.9702, 0.85, 0.528, 238, 229, 
518, p5gjrLA_, 0.9702, 0.85, 0.528, 238, 229, 
519, p3uneE_, 0.9698, 0.86, 0.533, 238, 229, MOUSE CONSTITUTIVE 20S PROTEASOME
520, p3uneS_, 0.9690, 0.89, 0.533, 238, 229, MOUSE CONSTITUTIVE 20S PROTEASOME
521, d5lf4E_, 0.9689, 0.79, 0.531, 233, 228, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
522, d5lf3E_, 0.9689, 0.79, 0.531, 233, 228, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
523, p5lf0E_, 0.9689, 0.79, 0.531, 233, 228, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
524, p3uneu_, 0.9689, 0.89, 0.533, 238, 229, MOUSE CONSTITUTIVE 20S PROTEASOME
525, p5wvkT_, 0.9688, 1.04, 0.996, 233, 231, 
526, d5lf7E_, 0.9687, 0.80, 0.531, 233, 228, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
527, p5lf6E_, 0.9687, 0.80, 0.531, 233, 228, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
528, p5lezE_, 0.9686, 0.80, 0.531, 233, 228, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
529, p3uneg_, 0.9686, 0.89, 0.533, 238, 229, MOUSE CONSTITUTIVE 20S PROTEASOME
530, d5lf7S_, 0.9685, 0.80, 0.531, 237, 228, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
531, d5lf1E_, 0.9685, 0.80, 0.531, 233, 228, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
532, p5leyE_, 0.9685, 0.81, 0.531, 233, 228, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
533, d5lexE_, 0.9685, 0.80, 0.531, 233, 228, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
534, d5le5S_, 0.9684, 0.80, 0.531, 237, 228, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
535, p5lf6S_, 0.9683, 0.80, 0.531, 237, 228, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
536, d5lf4S_, 0.9683, 0.80, 0.531, 237, 228, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
537, p5lf0S_, 0.9683, 0.80, 0.531, 237, 228, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
538, d5le5E_, 0.9683, 0.81, 0.531, 233, 228, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
539, d5lf3S_, 0.9682, 0.80, 0.531, 237, 228, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
540, p5leyS_, 0.9681, 0.81, 0.531, 235, 228, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
541, d5lf1S_, 0.9680, 0.81, 0.531, 237, 228, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
542, p5l4gT_, 0.9674, 0.91, 0.528, 238, 229, 
543, p5lezS_, 0.9673, 0.83, 0.531, 237, 228, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
544, p6avoL_, 0.9671, 0.92, 0.528, 234, 229, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
545, d5lexS_, 0.9671, 0.83, 0.531, 235, 228, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
546, p6avoG_, 0.9670, 0.92, 0.528, 234, 229, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
547, p5l4gF_, 0.9630, 1.03, 0.528, 238, 229, 
548, p5vfsF_, 0.9591, 1.06, 0.528, 238, 229, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
549, p5vfsEA_, 0.9586, 1.07, 0.528, 238, 229, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
550, p5mpbF_, 0.9581, 1.21, 1.000, 231, 231, 
551, p5vfuW_, 0.9576, 1.09, 0.528, 238, 229, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
552, p5vftL_, 0.9576, 1.09, 0.528, 238, 229, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
553, p5t0cX_, 0.9571, 1.09, 0.528, 238, 229, 
554, p5t0cDB_, 0.9571, 1.09, 0.528, 238, 229, 
555, p5a5bF_, 0.9570, 1.22, 0.996, 233, 231, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
556, p4cr3F_, 0.9570, 1.22, 0.996, 233, 231, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
557, p5vfoL_, 0.9566, 1.10, 0.528, 238, 229, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
558, p5vfqF_, 0.9563, 1.11, 0.528, 238, 229, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
559, d4cr2F_, 0.9560, 1.25, 0.996, 233, 231, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
560, p5vfol_, 0.9553, 1.13, 0.528, 238, 229, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
561, p5vfrl_, 0.9549, 1.13, 0.528, 238, 229, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
562, p5vfrL_, 0.9541, 1.14, 0.528, 238, 229, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
563, p5vfqEA_, 0.9541, 1.14, 0.528, 238, 229, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
564, p5vfpDA_, 0.9541, 1.15, 0.528, 238, 229, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
565, p5vfpF_, 0.9538, 1.15, 0.528, 238, 229, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
566, p5mpbT_, 0.9531, 1.29, 1.000, 233, 231, 
567, p5vftl_, 0.9518, 1.19, 0.528, 238, 229, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
568, p5vfuKA_, 0.9517, 1.19, 0.528, 238, 229, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
569, p5t0gL_, 0.9511, 1.19, 0.528, 238, 229, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
570, p5mpcF_, 0.9510, 1.33, 1.000, 231, 231, 
571, p5m32E_, 0.9500, 1.24, 0.537, 234, 229, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
572, p5t0jL_, 0.9433, 1.30, 0.528, 238, 229, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
573, p5wviG_, 0.9423, 1.43, 0.996, 233, 231, 
574, p5t0hL_, 0.9422, 1.31, 0.528, 238, 229, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
575, p6epcF_, 0.9390, 1.42, 0.533, 238, 229, GROUND STATE 26S PROTEASOME (GS2)
576, p5wviZ_, 0.9377, 1.49, 0.996, 233, 231, 
577, p6epeF_, 0.9354, 1.49, 0.533, 238, 229, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS2)
578, p4cr4F_, 0.9328, 1.62, 0.970, 233, 231, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
579, p6epfF_, 0.9298, 1.59, 0.533, 238, 229, GROUND STATE 26S PROTEASOME (GS1)
580, d1z7qQ1, 0.9174, 1.64, 0.308, 243, 227, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
581, d1z7qC1, 0.9174, 1.64, 0.308, 243, 227, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
582, p6epdF_, 0.9167, 1.76, 0.533, 238, 229, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS1)
583, p1fntC_, 0.9111, 1.66, 0.310, 241, 226, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
584, p1fntQ_, 0.9110, 1.66, 0.310, 241, 226, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
585, d4g4sE_, 0.9108, 1.75, 0.345, 249, 226, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
586, p5gjqn_, 0.9101, 1.99, 0.270, 243, 226, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
587, d5lexT_, 0.9097, 1.96, 0.265, 240, 226, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
588, d5lf7T_, 0.9094, 1.97, 0.265, 240, 226, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
589, p5gjrMA_, 0.9093, 1.99, 0.270, 243, 226, 
590, d5le5T_, 0.9092, 1.97, 0.265, 240, 226, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
591, p5lezT_, 0.9089, 1.97, 0.265, 240, 226, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
592, d5lf1T_, 0.9088, 1.98, 0.265, 240, 226, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
593, p5gjqX_, 0.9087, 2.00, 0.270, 243, 226, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
594, d4eu2O_, 0.9087, 1.95, 0.223, 241, 229, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
595, p5leyT_, 0.9086, 1.98, 0.265, 240, 226, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
596, p5gjrY_, 0.9085, 2.00, 0.270, 243, 226, 
597, d5lf4T_, 0.9084, 1.98, 0.265, 240, 226, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
598, d3wxrO_, 0.9083, 1.92, 0.223, 243, 229, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
599, d3unbT_, 0.9083, 2.00, 0.265, 244, 226, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
600, d5lf3T_, 0.9080, 1.98, 0.265, 240, 226, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
601, d4eu2A_, 0.9080, 1.92, 0.223, 241, 229, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
602, d3mg6U_, 0.9080, 1.94, 0.223, 243, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
603, p5lf6T_, 0.9079, 1.99, 0.265, 240, 226, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
604, p5lf0T_, 0.9079, 1.99, 0.265, 240, 226, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
605, d3sdkU_, 0.9079, 1.94, 0.223, 243, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
606, p3unbv_, 0.9078, 2.01, 0.265, 244, 226, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
607, d3oevU_, 0.9077, 1.95, 0.223, 243, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
608, d3mg7U_, 0.9077, 1.95, 0.227, 243, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
609, d3oeuU_, 0.9076, 1.94, 0.223, 243, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
610, d3mg8U_, 0.9076, 1.95, 0.223, 243, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
611, d4hnpU_, 0.9075, 1.91, 0.219, 243, 228, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
612, d4r3oU_, 0.9074, 2.03, 0.270, 245, 226, HUMAN CONSTITUTIVE 20S PROTEASOME
613, d3un8U_, 0.9074, 1.95, 0.219, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
614, d4r3oG_, 0.9073, 2.03, 0.270, 245, 226, HUMAN CONSTITUTIVE 20S PROTEASOME
615, p3uneh_, 0.9068, 2.05, 0.265, 244, 226, MOUSE CONSTITUTIVE 20S PROTEASOME
616, d3oevG_, 0.9068, 1.96, 0.223, 243, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
617, d3mg6G_, 0.9068, 1.96, 0.223, 243, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
618, d1ya7G_, 0.9068, 1.62, 0.335, 227, 224, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
619, d3mg7G_, 0.9067, 1.95, 0.223, 243, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
620, d4hrcU_, 0.9066, 1.91, 0.219, 243, 228, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
621, p3uneT_, 0.9066, 2.06, 0.265, 244, 226, MOUSE CONSTITUTIVE 20S PROTEASOME
622, d4qv9U_, 0.9065, 1.91, 0.219, 241, 228, YCP BETA5-C63F MUTANT
623, d4qv9G_, 0.9065, 1.91, 0.219, 241, 228, YCP BETA5-C63F MUTANT
624, d4inrU_, 0.9065, 1.96, 0.219, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
625, d5fggU_, 0.9064, 1.90, 0.219, 241, 228, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
626, d4qv3U_, 0.9064, 1.91, 0.219, 241, 228, YCP BETA5-M45V MUTANT
627, d4qv3G_, 0.9064, 1.91, 0.219, 241, 228, YCP BETA5-M45V MUTANT
628, d3oeuG_, 0.9064, 1.95, 0.223, 243, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
629, d5fggG_, 0.9063, 1.90, 0.219, 241, 228, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
630, d5d0sU_, 0.9063, 1.91, 0.219, 241, 228, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
631, d5l55U_, 0.9062, 1.91, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
632, d5d0sG_, 0.9062, 1.91, 0.219, 241, 228, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
633, d4ltcU_, 0.9062, 1.97, 0.223, 243, 229, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
634, d4intU_, 0.9062, 1.96, 0.219, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
635, d3mg4U_, 0.9062, 2.00, 0.223, 243, 229, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
636, d1ya7F_, 0.9062, 1.61, 0.335, 227, 224, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
637, d5l55G_, 0.9061, 1.91, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
638, d5ahjU_, 0.9061, 1.91, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
639, d5ahjG_, 0.9061, 1.91, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
640, d4qwlU_, 0.9061, 1.91, 0.219, 241, 228, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
641, d4qwlG_, 0.9061, 1.91, 0.219, 241, 228, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
642, d4jsqG_, 0.9061, 1.97, 0.219, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
643, d4g4sA_, 0.9061, 1.84, 0.220, 241, 227, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
644, d3un8G_, 0.9061, 1.97, 0.219, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
645, d3mg8G_, 0.9061, 1.96, 0.223, 243, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
646, p5nifA_, 0.9060, 1.96, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
647, d5l52U_, 0.9060, 1.91, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
648, p4x6zO_, 0.9060, 1.90, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
649, d3wxrA_, 0.9060, 1.97, 0.223, 243, 229, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
650, p3uneF_, 0.9060, 2.06, 0.265, 244, 226, MOUSE CONSTITUTIVE 20S PROTEASOME
651, d5l52G_, 0.9059, 1.91, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
652, d5fgfU_, 0.9059, 1.91, 0.219, 241, 228, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
653, p5cggU_, 0.9059, 1.91, 0.219, 241, 228, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
654, p4zzgA_, 0.9059, 1.96, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
655, d4r67U_, 0.9059, 2.05, 0.270, 245, 226, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
656, d4r02T_, 0.9059, 2.01, 0.300, 243, 227, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
657, d4hrcF_, 0.9059, 2.03, 0.295, 244, 227, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
658, p3un4U_, 0.9059, 2.02, 0.223, 243, 229, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
659, p5l4gG_, 0.9058, 2.21, 0.264, 242, 227, 
660, d5fgfG_, 0.9058, 1.92, 0.219, 241, 228, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
661, p5cggG_, 0.9058, 1.91, 0.219, 241, 228, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
662, p4zzgO_, 0.9058, 1.96, 0.223, 242, 229, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
663, p4r67w_, 0.9058, 2.05, 0.270, 245, 226, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
664, p4r67i_, 0.9058, 2.05, 0.270, 245, 226, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
665, d4r67G_, 0.9058, 2.06, 0.270, 245, 226, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
666, p3un4G_, 0.9058, 2.02, 0.223, 243, 229, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
667, d3sdkG_, 0.9058, 1.96, 0.223, 243, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
668, d5jhrU_, 0.9057, 1.91, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
669, d5jhrG_, 0.9057, 1.91, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
670, d5czaU_, 0.9057, 1.92, 0.219, 241, 228, YEAST 20S PROTEASOME BETA5-D166N MUTANT
671, d5czaG_, 0.9057, 1.92, 0.219, 241, 228, YEAST 20S PROTEASOME BETA5-D166N MUTANT
672, d5cgfU_, 0.9057, 1.93, 0.219, 241, 228, YEAST 20S PROTEASOME BETA5-G48C MUTANT
673, d5cgfG_, 0.9057, 1.93, 0.219, 241, 228, YEAST 20S PROTEASOME BETA5-G48C MUTANT
674, p4y8hU_, 0.9057, 1.91, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
675, p4y8hG_, 0.9057, 1.91, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
676, d4qv7U_, 0.9057, 1.92, 0.219, 241, 228, YCP BETA5-A50V MUTANT
677, d4qv7G_, 0.9057, 1.92, 0.219, 241, 228, YCP BETA5-A50V MUTANT
678, d4jsuU_, 0.9057, 2.03, 0.223, 243, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
679, d4jsuG_, 0.9057, 2.03, 0.223, 243, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
680, d4fzcU_, 0.9057, 2.01, 0.223, 243, 229, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
681, d5fhsU_, 0.9056, 1.92, 0.219, 241, 228, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
682, d5fhsG_, 0.9056, 1.92, 0.219, 241, 228, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
683, d5fg7U_, 0.9056, 1.93, 0.219, 241, 228, YEAST 20S PROTEASOME BETA2-T1A MUTANT
684, d5fg7G_, 0.9056, 1.93, 0.219, 241, 228, YEAST 20S PROTEASOME BETA2-T1A MUTANT
685, d5d0zU_, 0.9056, 1.92, 0.219, 241, 228, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
686, d5d0zG_, 0.9056, 1.92, 0.219, 241, 228, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
687, d5d0wU_, 0.9056, 1.92, 0.219, 241, 228, YEAST 20S PROTEASOME BETA5-T1S MUTANT
688, d5d0wG_, 0.9056, 1.92, 0.219, 241, 228, YEAST 20S PROTEASOME BETA5-T1S MUTANT
689, d5cz8U_, 0.9056, 1.92, 0.219, 241, 228, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
690, d5cz8G_, 0.9056, 1.92, 0.219, 241, 228, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
691, d4qz6U_, 0.9056, 1.92, 0.219, 241, 228, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
692, d4nnnU_, 0.9056, 1.91, 0.219, 241, 228, YCP IN COMPLEX WITH MG132
693, d4lqiU_, 0.9056, 2.02, 0.223, 243, 229, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
694, d4inrG_, 0.9056, 1.97, 0.219, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
695, d4fzcG_, 0.9056, 2.01, 0.223, 243, 229, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
696, d5cz9U_, 0.9055, 1.92, 0.219, 241, 228, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
697, d4qz6G_, 0.9055, 1.92, 0.219, 241, 228, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
698, d4quyU_, 0.9055, 1.92, 0.219, 241, 228, YCP BETA5-A49S-MUTANT
699, d4quyG_, 0.9055, 1.92, 0.219, 241, 228, YCP BETA5-A49S-MUTANT
700, d4nnnG_, 0.9055, 1.91, 0.219, 241, 228, YCP IN COMPLEX WITH MG132
701, d4j70U_, 0.9055, 2.03, 0.223, 243, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
702, d4j70G_, 0.9055, 2.03, 0.223, 243, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
703, d4fzgU_, 0.9055, 2.01, 0.223, 243, 229, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
704, d4fzgG_, 0.9055, 2.01, 0.223, 243, 229, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
705, d3tddU_, 0.9055, 2.02, 0.223, 243, 229, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
706, d3shjU_, 0.9055, 2.02, 0.223, 243, 229, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
707, d5m2bT_, 0.9054, 2.03, 0.300, 243, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
708, d5l5bU_, 0.9054, 1.92, 0.219, 241, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
709, d5l5bG_, 0.9054, 1.92, 0.219, 241, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
710, d5cz9G_, 0.9054, 1.92, 0.219, 241, 228, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
711, d4z1lU_, 0.9054, 1.93, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
712, d4y8rU_, 0.9054, 1.93, 0.219, 241, 228, YEAST 20S PROTEASOME BETA2-H116D MUTANT
713, d4y8rG_, 0.9054, 1.93, 0.219, 241, 228, YEAST 20S PROTEASOME BETA2-H116D MUTANT
714, p4y8kG_, 0.9054, 1.92, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
715, d4r00U_, 0.9054, 1.93, 0.219, 241, 228, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
716, d4r00G_, 0.9054, 1.93, 0.219, 241, 228, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
717, d4lqiG_, 0.9054, 2.02, 0.223, 243, 229, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
718, d3tddG_, 0.9054, 2.02, 0.223, 243, 229, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
719, d3shjG_, 0.9054, 2.02, 0.223, 243, 229, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
720, d2f16U_, 0.9054, 2.02, 0.223, 243, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
721, d5l63T_, 0.9053, 2.04, 0.300, 243, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
722, d5l63F_, 0.9053, 2.04, 0.300, 243, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
723, d5l5hT_, 0.9053, 2.03, 0.300, 243, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
724, d5l5hF_, 0.9053, 2.03, 0.300, 243, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
725, d5fgaU_, 0.9053, 1.93, 0.219, 241, 228, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
726, d4z1lG_, 0.9053, 1.93, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
727, p4ya7U_, 0.9053, 1.92, 0.219, 241, 228, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
728, d4ya4U_, 0.9053, 1.93, 0.219, 241, 228, YEAST 20S PROTEASOME BETA2-H114D MUTANT
729, d4ya4G_, 0.9053, 1.93, 0.219, 241, 228, YEAST 20S PROTEASOME BETA2-H114D MUTANT
730, p4y8kU_, 0.9053, 1.92, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
731, d4qv5U_, 0.9053, 1.92, 0.219, 241, 228, YCP BETA5-M45I MUTANT
732, d4no9U_, 0.9053, 1.91, 0.219, 241, 228, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
733, d4no9G_, 0.9053, 1.91, 0.219, 241, 228, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
734, d4no1U_, 0.9053, 1.92, 0.219, 241, 228, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
735, d4no1G_, 0.9053, 1.92, 0.219, 241, 228, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
736, d4jsqU_, 0.9053, 2.03, 0.223, 243, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
737, d2fakU_, 0.9053, 2.03, 0.223, 243, 229, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
738, d2f16G_, 0.9053, 2.03, 0.223, 243, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
739, d5fgaG_, 0.9052, 1.93, 0.219, 241, 228, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
740, p4zzgU_, 0.9052, 2.01, 0.300, 244, 227, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
741, p4ya7G_, 0.9052, 1.92, 0.219, 241, 228, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
742, d4ya1U_, 0.9052, 1.93, 0.219, 241, 228, YEAST 20S PROTEASOME BETA2-H116N MUTANT
743, d4ya1G_, 0.9052, 1.93, 0.219, 241, 228, YEAST 20S PROTEASOME BETA2-H116N MUTANT
744, p4y8pU_, 0.9052, 1.92, 0.219, 241, 228, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
745, p4x6zG_, 0.9052, 2.18, 0.294, 244, 228, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
746, d4r18T_, 0.9052, 2.04, 0.300, 243, 227, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
747, d4r18F_, 0.9052, 2.04, 0.300, 243, 227, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
748, d4qv5G_, 0.9052, 1.92, 0.219, 241, 228, YCP BETA5-M45I MUTANT
749, d4q1sU_, 0.9052, 1.98, 0.223, 243, 229, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
750, d4jt0U_, 0.9052, 2.03, 0.223, 243, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
751, d4jt0G_, 0.9052, 2.03, 0.223, 243, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
752, d4hrdU_, 0.9052, 1.95, 0.219, 243, 228, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
753, p3unbh_, 0.9052, 2.06, 0.270, 244, 226, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
754, d2fakG_, 0.9052, 2.03, 0.223, 243, 229, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
755, d5l64T_, 0.9051, 2.04, 0.300, 243, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
756, d5l64F_, 0.9051, 2.04, 0.300, 243, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
757, d5l61T_, 0.9051, 2.04, 0.300, 243, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
758, d5l61F_, 0.9051, 2.04, 0.300, 243, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
759, d5l5rT_, 0.9051, 2.06, 0.298, 243, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
760, d5l5rF_, 0.9051, 2.06, 0.298, 243, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
761, d5l5pT_, 0.9051, 2.04, 0.300, 243, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
762, d5l5pF_, 0.9051, 2.04, 0.300, 243, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
763, d5l5oT_, 0.9051, 2.04, 0.300, 243, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
764, d5l5oF_, 0.9051, 2.04, 0.300, 243, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
765, d5jhsU_, 0.9051, 1.92, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
766, d5jhsG_, 0.9051, 1.92, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
767, p4y8sU_, 0.9051, 1.92, 0.219, 241, 228, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
768, p4y8sG_, 0.9051, 1.92, 0.219, 241, 228, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
769, p4y8pG_, 0.9051, 1.92, 0.219, 241, 228, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
770, d4qzxU_, 0.9051, 1.93, 0.219, 241, 228, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
771, d4qzxG_, 0.9051, 1.93, 0.219, 241, 228, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
772, d4qz3U_, 0.9051, 1.92, 0.219, 241, 228, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
773, d4qwrU_, 0.9051, 1.92, 0.219, 241, 228, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
774, d4qwrG_, 0.9051, 1.92, 0.219, 241, 228, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
775, d4qw7U_, 0.9051, 1.92, 0.219, 241, 228, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
776, d4qw7G_, 0.9051, 1.92, 0.219, 241, 228, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
777, d4qw5U_, 0.9051, 1.92, 0.219, 241, 228, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
778, d4qw5G_, 0.9051, 1.92, 0.219, 241, 228, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
779, d4qv8U_, 0.9051, 1.93, 0.219, 241, 228, YCP BETA5-C52F MUTANT
780, d4qv8G_, 0.9051, 1.93, 0.219, 241, 228, YCP BETA5-C52F MUTANT
781, d4qv4U_, 0.9051, 1.93, 0.219, 241, 228, YCP BETA5-M45T MUTANT
782, d4qv4G_, 0.9051, 1.93, 0.219, 241, 228, YCP BETA5-M45T MUTANT
783, d4qv1U_, 0.9051, 1.93, 0.219, 241, 228, YCP BETA5-M45A MUTANT
784, d4no6U_, 0.9051, 1.92, 0.219, 241, 228, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
785, d4inuG_, 0.9051, 1.97, 0.219, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
786, d3nzxU_, 0.9051, 2.03, 0.223, 243, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
787, d3e47U_, 0.9051, 2.02, 0.223, 243, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
788, d1iruU_, 0.9051, 2.05, 0.265, 245, 226, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
789, d1iruG_, 0.9051, 2.05, 0.265, 245, 226, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
790, p5nifU_, 0.9050, 2.01, 0.300, 244, 227, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
791, d5l6cT_, 0.9050, 2.04, 0.300, 243, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
792, d5l6cF_, 0.9050, 2.04, 0.300, 243, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
793, d5l69T_, 0.9050, 2.04, 0.295, 243, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
794, d5l69F_, 0.9050, 2.04, 0.295, 243, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
795, p4ya2U_, 0.9050, 1.92, 0.219, 241, 228, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
796, p4y9zU_, 0.9050, 1.92, 0.219, 241, 228, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
797, p4y9zG_, 0.9050, 1.92, 0.219, 241, 228, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
798, p4y8lU_, 0.9050, 1.93, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
799, p4y8lG_, 0.9050, 1.93, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
800, d4qz5U_, 0.9050, 1.92, 0.219, 241, 228, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
801, d4qz3G_, 0.9050, 1.92, 0.219, 241, 228, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
802, d4qz0U_, 0.9050, 1.92, 0.219, 241, 228, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
803, d4qz0G_, 0.9050, 1.92, 0.219, 241, 228, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
804, d4qwuU_, 0.9050, 1.93, 0.219, 241, 228, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
805, d4qwuG_, 0.9050, 1.93, 0.219, 241, 228, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
806, d4qv5T_, 0.9050, 2.04, 0.300, 243, 227, YCP BETA5-M45I MUTANT
807, d4qv5F_, 0.9050, 2.04, 0.300, 243, 227, YCP BETA5-M45I MUTANT
808, d4qv1G_, 0.9050, 1.93, 0.219, 241, 228, YCP BETA5-M45A MUTANT
809, d4qv0U_, 0.9050, 1.93, 0.219, 241, 228, YCP BETA5-A49T-A50V-DOUBLE MUTANT
810, d4qv0G_, 0.9050, 1.93, 0.219, 241, 228, YCP BETA5-A49T-A50V-DOUBLE MUTANT
811, d4qluU_, 0.9050, 1.92, 0.219, 241, 228, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
812, d4no8U_, 0.9050, 1.92, 0.219, 241, 228, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
813, d4no8G_, 0.9050, 1.92, 0.219, 241, 228, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
814, d4no6G_, 0.9050, 1.92, 0.219, 241, 228, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
815, d3e47G_, 0.9050, 2.02, 0.223, 243, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
816, d2fnyU_, 0.9050, 2.02, 0.223, 243, 229,  
817, p6gopU_, 0.9049, 1.93, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
818, d5l6aT_, 0.9049, 2.06, 0.298, 243, 228, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
819, d5l6aF_, 0.9049, 2.06, 0.298, 243, 228, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
820, d5l67T_, 0.9049, 2.04, 0.300, 243, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
821, d5l67F_, 0.9049, 2.04, 0.300, 243, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
822, d5l62T_, 0.9049, 2.04, 0.300, 243, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
823, d5l62F_, 0.9049, 2.04, 0.300, 243, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
824, d5l5tT_, 0.9049, 2.04, 0.300, 243, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
825, d5l5tF_, 0.9049, 2.04, 0.300, 243, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
826, d5l5sT_, 0.9049, 2.04, 0.300, 243, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
827, d5l5sF_, 0.9049, 2.04, 0.300, 243, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
828, d5l5jT_, 0.9049, 2.04, 0.300, 243, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
829, d5l5jF_, 0.9049, 2.04, 0.300, 243, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
830, d5l5bT_, 0.9049, 2.06, 0.298, 243, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
831, d5l5bF_, 0.9049, 2.06, 0.298, 243, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
832, d5fgeU_, 0.9049, 1.93, 0.219, 241, 228, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
833, d5d0vU_, 0.9049, 1.92, 0.219, 241, 228, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
834, p4ya2G_, 0.9049, 1.93, 0.219, 241, 228, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
835, p4y7yU_, 0.9049, 1.93, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
836, d4qzzU_, 0.9049, 1.93, 0.219, 241, 228, YCP IN COMPLEX WITH OMURALIDE
837, d4qzzG_, 0.9049, 1.93, 0.219, 241, 228, YCP IN COMPLEX WITH OMURALIDE
838, d4qz5G_, 0.9049, 1.93, 0.219, 241, 228, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
839, d4qwjU_, 0.9049, 1.93, 0.219, 241, 228, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
840, d4qwjG_, 0.9049, 1.93, 0.219, 241, 228, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
841, d4qw6U_, 0.9049, 1.92, 0.219, 241, 228, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
842, d4qv6T_, 0.9049, 2.06, 0.298, 243, 228, YCP BETA5-A49V MUTANT
843, d4qv6F_, 0.9049, 2.06, 0.298, 243, 228, YCP BETA5-A49V MUTANT
844, d4qluG_, 0.9049, 1.92, 0.219, 241, 228, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
845, d4ltcG_, 0.9049, 1.99, 0.223, 243, 229, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
846, d4inuU_, 0.9049, 2.03, 0.223, 243, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
847, d3nzxG_, 0.9049, 2.04, 0.223, 243, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
848, d3mg0U_, 0.9049, 2.03, 0.227, 243, 229, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
849, d2gplU_, 0.9049, 2.03, 0.223, 243, 229, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
850, d5l5yT_, 0.9048, 2.04, 0.300, 243, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
851, d5l5yF_, 0.9048, 2.04, 0.300, 243, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
852, d5l5qT_, 0.9048, 2.04, 0.300, 243, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
853, d5l5qF_, 0.9048, 2.04, 0.300, 243, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
854, d5l5iF_, 0.9048, 2.04, 0.300, 243, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
855, d5l5dT_, 0.9048, 2.07, 0.298, 243, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
856, d5l5dF_, 0.9048, 2.07, 0.298, 243, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
857, d5fgeG_, 0.9048, 1.93, 0.219, 241, 228, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
858, d5d0vG_, 0.9048, 1.93, 0.219, 241, 228, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
859, p5cgiU_, 0.9048, 1.93, 0.219, 241, 228, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
860, d5bxnT_, 0.9048, 2.06, 0.298, 243, 228, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
861, d5bxnF_, 0.9048, 2.06, 0.298, 243, 228, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
862, p4ya9F_, 0.9048, 2.04, 0.300, 243, 227, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
863, p4y7yG_, 0.9048, 1.93, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
864, d4qw6G_, 0.9048, 1.92, 0.219, 241, 228, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
865, d3okjU_, 0.9048, 2.03, 0.223, 243, 229, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
866, d3gpwU_, 0.9048, 2.04, 0.223, 243, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
867, d2gplG_, 0.9048, 2.04, 0.223, 243, 229, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
868, d2fnyG_, 0.9048, 2.03, 0.223, 243, 229,  
869, p1fntE_, 0.9048, 1.62, 0.344, 244, 224, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
870, p6gopG_, 0.9047, 1.93, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
871, d5l68T_, 0.9047, 2.04, 0.300, 243, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
872, d5l68F_, 0.9047, 2.04, 0.300, 243, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
873, d5l5uU_, 0.9047, 1.93, 0.219, 241, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
874, d5l5uG_, 0.9047, 1.93, 0.219, 241, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
875, d5d0wT_, 0.9047, 2.06, 0.298, 243, 228, YEAST 20S PROTEASOME BETA5-T1S MUTANT
876, d5cz5U_, 0.9047, 1.93, 0.219, 241, 228, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
877, p5cgiG_, 0.9047, 1.93, 0.219, 241, 228, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
878, d5bxlU_, 0.9047, 1.94, 0.219, 241, 228, YEAST 20S PROTEASOME BETA2-G170A MUTANT
879, d5bxlG_, 0.9047, 1.94, 0.219, 241, 228, YEAST 20S PROTEASOME BETA2-G170A MUTANT
880, d4r02F_, 0.9047, 2.06, 0.298, 243, 228, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
881, d4hrdF_, 0.9047, 2.07, 0.298, 244, 228, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
882, p3unev_, 0.9047, 2.08, 0.270, 244, 226, MOUSE CONSTITUTIVE 20S PROTEASOME
883, d3okjG_, 0.9047, 2.03, 0.223, 243, 229, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
884, d3gpwG_, 0.9047, 2.04, 0.223, 243, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
885, d1rypU_, 0.9047, 2.06, 0.298, 244, 228, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
886, p1fntS_, 0.9047, 1.62, 0.344, 244, 224, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
887, d5m2bF_, 0.9046, 2.07, 0.298, 243, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
888, d5lttU_, 0.9046, 1.94, 0.219, 241, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
889, d5lttG_, 0.9046, 1.94, 0.219, 241, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
890, d5lexF_, 0.9046, 1.98, 0.267, 239, 225, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
891, d5l60T_, 0.9046, 2.05, 0.300, 243, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
892, d5l5wT_, 0.9046, 2.07, 0.298, 243, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
893, d5l5wF_, 0.9046, 2.07, 0.298, 243, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
894, d5l5uT_, 0.9046, 2.06, 0.298, 243, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
895, d5l5uF_, 0.9046, 2.06, 0.298, 243, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
896, d5fg9U_, 0.9046, 1.94, 0.219, 241, 228, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
897, d5fg9G_, 0.9046, 1.94, 0.219, 241, 228, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
898, d5d0wF_, 0.9046, 2.06, 0.298, 243, 228, YEAST 20S PROTEASOME BETA5-T1S MUTANT
899, d5cz5G_, 0.9046, 1.93, 0.219, 241, 228, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
900, d4ya4T_, 0.9046, 2.06, 0.298, 243, 228, YEAST 20S PROTEASOME BETA2-H114D MUTANT
901, d4ya4F_, 0.9046, 2.06, 0.298, 243, 228, YEAST 20S PROTEASOME BETA2-H114D MUTANT
902, d4y9yU_, 0.9046, 1.94, 0.219, 241, 228, YEAST 20S PROTEASOME BETA2-H116E MUTANT
903, p4y8tU_, 0.9046, 1.93, 0.219, 241, 228, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
904, p4y8tT_, 0.9046, 2.03, 0.300, 243, 227, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
905, p4y8tG_, 0.9046, 1.94, 0.219, 241, 228, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
906, p4y8tF_, 0.9046, 2.03, 0.300, 243, 227, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
907, p4y8gT_, 0.9046, 2.21, 0.294, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
908, p4y8gF_, 0.9046, 2.21, 0.294, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
909, p4y7wU_, 0.9046, 1.93, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
910, p4v7oIA_, 0.9046, 2.06, 0.223, 243, 229, 
911, d4qzwU_, 0.9046, 1.93, 0.219, 241, 228, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
912, d4qltU_, 0.9046, 1.93, 0.219, 241, 228, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
913, d4qltG_, 0.9046, 1.93, 0.219, 241, 228, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
914, d4qlsU_, 0.9046, 1.93, 0.219, 241, 228, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
915, d4qlsG_, 0.9046, 1.93, 0.219, 241, 228, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
916, d4ltcF_, 0.9046, 2.20, 0.294, 244, 228, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
917, p3unhT_, 0.9046, 1.93, 0.267, 244, 225, MOUSE 20S IMMUNOPROTEASOME
918, p3unhF_, 0.9046, 1.93, 0.267, 244, 225, MOUSE 20S IMMUNOPROTEASOME
919, d3hyeU_, 0.9046, 2.04, 0.223, 243, 229, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
920, d1vsyA_, 0.9046, 2.06, 0.223, 243, 229,  
921, d5lajT_, 0.9045, 2.05, 0.300, 243, 227, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
922, d5lajF_, 0.9045, 2.05, 0.300, 243, 227, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
923, d5l6bT_, 0.9045, 2.07, 0.298, 243, 228, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
924, d5l6bF_, 0.9045, 2.07, 0.298, 243, 228, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
925, d5l66T_, 0.9045, 2.07, 0.298, 243, 228, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
926, d5l66F_, 0.9045, 2.07, 0.298, 243, 228, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
927, d5l60F_, 0.9045, 2.05, 0.300, 243, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
928, d5l5vT_, 0.9045, 2.05, 0.300, 243, 227,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
929, d5l5vF_, 0.9045, 2.05, 0.300, 243, 227,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
930, d5l5rU_, 0.9045, 1.94, 0.219, 241, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
931, d5l54U_, 0.9045, 1.94, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
932, d5cz7T_, 0.9045, 2.04, 0.300, 243, 227, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
933, d5cz7F_, 0.9045, 2.04, 0.300, 243, 227, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
934, d5bxnG_, 0.9045, 1.94, 0.219, 241, 228, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
935, d5bxlT_, 0.9045, 2.06, 0.298, 243, 228, YEAST 20S PROTEASOME BETA2-G170A MUTANT
936, d4y9yG_, 0.9045, 1.94, 0.219, 241, 228, YEAST 20S PROTEASOME BETA2-H116E MUTANT
937, p4y8qU_, 0.9045, 1.93, 0.219, 241, 228, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
938, p4y8qG_, 0.9045, 1.93, 0.219, 241, 228, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
939, d4y8mU_, 0.9045, 1.94, 0.219, 241, 228, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
940, p4y8jU_, 0.9045, 1.93, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
941, p4y8jG_, 0.9045, 1.93, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
942, p4y8gU_, 0.9045, 1.93, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
943, p4y8gG_, 0.9045, 1.93, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
944, p4y7wG_, 0.9045, 1.93, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
945, p4y70U_, 0.9045, 1.93, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
946, p4y70G_, 0.9045, 1.93, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
947, p4v7oO_, 0.9045, 2.06, 0.223, 243, 229, 
948, p4v7oA_, 0.9045, 2.06, 0.223, 243, 229, 
949, d4qzwG_, 0.9045, 1.93, 0.219, 241, 228, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
950, d4qwiU_, 0.9045, 1.93, 0.219, 241, 228, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
951, d4qwiG_, 0.9045, 1.93, 0.219, 241, 228, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
952, d4qvpU_, 0.9045, 1.94, 0.219, 241, 228, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
953, d4qvpG_, 0.9045, 1.94, 0.219, 241, 228, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
954, d4qvnU_, 0.9045, 1.94, 0.219, 241, 228, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
955, d4qvnT_, 0.9045, 2.07, 0.298, 243, 228, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
956, d4qvnG_, 0.9045, 1.94, 0.219, 241, 228, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
957, d4qvnF_, 0.9045, 2.07, 0.298, 243, 228, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
958, d4qv3F_, 0.9045, 2.04, 0.300, 243, 227, YCP BETA5-M45V MUTANT
959, d4q1sG_, 0.9045, 2.03, 0.223, 243, 229, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
960, d4q1sF_, 0.9045, 2.04, 0.300, 244, 227, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
961, d4ltcT_, 0.9045, 2.20, 0.294, 244, 228, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
962, d4hnpF_, 0.9045, 2.02, 0.300, 244, 227, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
963, d3nzwU_, 0.9045, 2.04, 0.223, 243, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
964, d3nzjU_, 0.9045, 2.04, 0.223, 243, 229, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
965, d3l5qC_, 0.9045, 2.06, 0.223, 243, 229,  
966, d3l5qA_, 0.9045, 2.06, 0.223, 243, 229,  
967, d3hyeG_, 0.9045, 2.04, 0.223, 243, 229, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
968, p6gopT_, 0.9044, 2.06, 0.298, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
969, p5nifO_, 0.9044, 1.94, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
970, p5lezF_, 0.9044, 1.98, 0.267, 239, 225, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
971, d5l5rG_, 0.9044, 1.94, 0.219, 241, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
972, d5l54G_, 0.9044, 1.94, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
973, d5czaT_, 0.9044, 2.06, 0.298, 243, 228, YEAST 20S PROTEASOME BETA5-D166N MUTANT
974, d5czaF_, 0.9044, 2.06, 0.298, 243, 228, YEAST 20S PROTEASOME BETA5-D166N MUTANT
975, d5cz7U_, 0.9044, 1.94, 0.219, 241, 228, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
976, d5cz7G_, 0.9044, 1.94, 0.219, 241, 228, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
977, d5bxnU_, 0.9044, 1.94, 0.219, 241, 228, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
978, d5bxlF_, 0.9044, 2.06, 0.298, 243, 228, YEAST 20S PROTEASOME BETA2-G170A MUTANT
979, d4y8mG_, 0.9044, 1.94, 0.219, 241, 228, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
980, p4y77U_, 0.9044, 1.93, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
981, p4y77G_, 0.9044, 1.93, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
982, p4v7oWA_, 0.9044, 2.06, 0.223, 243, 229, 
983, d4qvlT_, 0.9044, 2.07, 0.298, 243, 228, YCP IN COMPLEX WITH BORTEZOMIB
984, d4qvlF_, 0.9044, 2.07, 0.298, 243, 228, YCP IN COMPLEX WITH BORTEZOMIB
985, d4nnwU_, 0.9044, 1.92, 0.219, 241, 228, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
986, d4nnwG_, 0.9044, 1.92, 0.219, 241, 228, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
987, d4intG_, 0.9044, 2.04, 0.223, 243, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
988, d4hnpT_, 0.9044, 2.06, 0.295, 244, 227, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
989, d4eu2U_, 0.9044, 2.08, 0.294, 244, 228, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
990, d3nzjG_, 0.9044, 2.04, 0.223, 243, 229, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
991, d3gptU_, 0.9044, 2.04, 0.223, 243, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
992, d3gptG_, 0.9044, 2.04, 0.223, 243, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
993, d3bdmU_, 0.9044, 2.05, 0.223, 243, 229, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
994, d1vsyO_, 0.9044, 2.06, 0.223, 243, 229,  
995, p6gopF_, 0.9043, 2.07, 0.298, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
996, d5lajU_, 0.9043, 1.94, 0.219, 241, 228, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
997, d5l6aU_, 0.9043, 1.94, 0.219, 241, 228, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
998, d5l6aG_, 0.9043, 1.94, 0.219, 241, 228, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
999, d5l65T_, 0.9043, 2.07, 0.298, 243, 228, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1000, d5l65F_, 0.9043, 2.07, 0.298, 243, 228, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1001, d5l5fT_, 0.9043, 2.07, 0.298, 243, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1002, d5l5fF_, 0.9043, 2.07, 0.298, 243, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1003, d5l5aT_, 0.9043, 2.07, 0.298, 243, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
1004, d5l5aF_, 0.9043, 2.07, 0.298, 243, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
1005, d5fgiU_, 0.9043, 1.94, 0.219, 241, 228, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1006, d5fgiG_, 0.9043, 1.94, 0.219, 241, 228, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1007, d5fgdU_, 0.9043, 1.93, 0.219, 241, 228, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1008, d5fgdG_, 0.9043, 1.94, 0.219, 241, 228, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1009, d4ya1T_, 0.9043, 2.07, 0.298, 243, 228, YEAST 20S PROTEASOME BETA2-H116N MUTANT
1010, d4ya1F_, 0.9043, 2.07, 0.298, 243, 228, YEAST 20S PROTEASOME BETA2-H116N MUTANT
1011, p4y8uU_, 0.9043, 1.95, 0.219, 241, 228, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
1012, p4y8uG_, 0.9043, 1.95, 0.219, 241, 228, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
1013, d4y8rT_, 0.9043, 2.06, 0.298, 243, 228, YEAST 20S PROTEASOME BETA2-H116D MUTANT
1014, d4y8rF_, 0.9043, 2.06, 0.298, 243, 228, YEAST 20S PROTEASOME BETA2-H116D MUTANT
1015, p4y80U_, 0.9043, 1.93, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
1016, p4y80G_, 0.9043, 1.93, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
1017, d4r02U_, 0.9043, 1.93, 0.219, 241, 228, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
1018, d4qvyT_, 0.9043, 2.07, 0.298, 243, 228, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
1019, d4qvyF_, 0.9043, 2.07, 0.298, 243, 228, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
1020, d4quyT_, 0.9043, 2.06, 0.298, 243, 228, YCP BETA5-A49S-MUTANT
1021, d4quyF_, 0.9043, 2.06, 0.298, 243, 228, YCP BETA5-A49S-MUTANT
1022, d4q1sT_, 0.9043, 2.05, 0.295, 244, 227, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
1023, d3un8T_, 0.9043, 2.23, 0.293, 244, 229, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
1024, d3nzwG_, 0.9043, 2.05, 0.223, 243, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
1025, d3bdmG_, 0.9043, 2.05, 0.223, 243, 229, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
1026, d1rypG_, 0.9043, 2.06, 0.298, 244, 228, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
1027, d5lajG_, 0.9042, 1.94, 0.219, 241, 228, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1028, d5d0tU_, 0.9042, 1.95, 0.219, 241, 228, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
1029, p4zzgG_, 0.9042, 2.03, 0.300, 244, 227, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1030, p4ya9U_, 0.9042, 1.93, 0.219, 241, 228, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
1031, p4ya9G_, 0.9042, 1.93, 0.219, 241, 228, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
1032, p4y82U_, 0.9042, 1.93, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
1033, p4y82G_, 0.9042, 1.93, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
1034, d4qz4U_, 0.9042, 1.93, 0.219, 241, 228, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1035, d4qz2U_, 0.9042, 1.93, 0.219, 241, 228, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1036, d4qwfT_, 0.9042, 2.06, 0.295, 243, 227, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
1037, d4qwfF_, 0.9042, 2.06, 0.295, 243, 227, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
1038, d4qw1U_, 0.9042, 1.94, 0.219, 241, 228, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
1039, d4qw1G_, 0.9042, 1.94, 0.219, 241, 228, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
1040, d4qvlU_, 0.9042, 1.94, 0.219, 241, 228, YCP IN COMPLEX WITH BORTEZOMIB
1041, d4qv4T_, 0.9042, 2.07, 0.298, 243, 228, YCP BETA5-M45T MUTANT
1042, d4qv4F_, 0.9042, 2.07, 0.298, 243, 228, YCP BETA5-M45T MUTANT
1043, d4qv1T_, 0.9042, 2.07, 0.298, 243, 228, YCP BETA5-M45A MUTANT
1044, d4qv1F_, 0.9042, 2.07, 0.298, 243, 228, YCP BETA5-M45A MUTANT
1045, d3un8F_, 0.9042, 2.23, 0.293, 244, 229, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
1046, d1ya7C_, 0.9042, 1.64, 0.335, 227, 224, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
1047, d1rypO_, 0.9042, 2.08, 0.223, 243, 229, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
1048, d5l6bU_, 0.9041, 1.94, 0.219, 241, 228, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1049, d5l6bG_, 0.9041, 1.94, 0.219, 241, 228, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1050, d5l5zT_, 0.9041, 2.08, 0.298, 243, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1051, d5l5zF_, 0.9041, 2.08, 0.298, 243, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1052, d5fg7T_, 0.9041, 2.07, 0.298, 243, 228, YEAST 20S PROTEASOME BETA2-T1A MUTANT
1053, d5fg7F_, 0.9041, 2.07, 0.298, 243, 228, YEAST 20S PROTEASOME BETA2-T1A MUTANT
1054, d5d0tG_, 0.9041, 1.95, 0.219, 241, 228, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
1055, d5cz6T_, 0.9041, 2.07, 0.298, 243, 228, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
1056, d5cz6F_, 0.9041, 2.07, 0.298, 243, 228, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
1057, p5cghU_, 0.9041, 1.94, 0.219, 241, 228, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
1058, p5cghG_, 0.9041, 1.94, 0.219, 241, 228, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
1059, d5ahjT_, 0.9041, 2.08, 0.298, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
1060, d5ahjF_, 0.9041, 2.08, 0.298, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
1061, d4y9yT_, 0.9041, 2.07, 0.298, 243, 228, YEAST 20S PROTEASOME BETA2-H116E MUTANT
1062, p4y7xU_, 0.9041, 1.94, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
1063, p4y75U_, 0.9041, 1.93, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
1064, p4y75T_, 0.9041, 2.07, 0.298, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
1065, p4y75F_, 0.9041, 2.08, 0.298, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
1066, d4r17U_, 0.9041, 1.94, 0.219, 241, 228, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1067, d4r00T_, 0.9041, 2.05, 0.300, 243, 227, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
1068, d4r00F_, 0.9041, 2.05, 0.300, 243, 227, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
1069, d4qzzT_, 0.9041, 2.07, 0.298, 243, 228, YCP IN COMPLEX WITH OMURALIDE
1070, d4qzzF_, 0.9041, 2.07, 0.298, 243, 228, YCP IN COMPLEX WITH OMURALIDE
1071, d4qz4G_, 0.9041, 1.93, 0.219, 241, 228, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1072, d4qz2G_, 0.9041, 1.94, 0.219, 241, 228, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1073, d4qw1T_, 0.9041, 2.07, 0.298, 243, 228, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
1074, d4qw1F_, 0.9041, 2.07, 0.298, 243, 228, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
1075, d4qvqT_, 0.9041, 2.02, 0.300, 243, 227, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
1076, d4qvqF_, 0.9041, 2.02, 0.300, 243, 227, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
1077, d4qvlG_, 0.9041, 1.94, 0.219, 241, 228, YCP IN COMPLEX WITH BORTEZOMIB
1078, d4qv9T_, 0.9041, 2.06, 0.298, 243, 228, YCP BETA5-C63F MUTANT
1079, d4qv9F_, 0.9041, 2.06, 0.298, 243, 228, YCP BETA5-C63F MUTANT
1080, d4qv6U_, 0.9041, 1.94, 0.219, 241, 228, YCP BETA5-A49V MUTANT
1081, p4qbyT_, 0.9041, 2.04, 0.300, 243, 227, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
1082, p4qbyF_, 0.9041, 2.04, 0.300, 243, 227, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
1083, d3nzjT_, 0.9041, 2.07, 0.298, 244, 228, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
1084, d3nzjF_, 0.9041, 2.07, 0.298, 244, 228, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
1085, d1ya7B_, 0.9041, 1.65, 0.335, 227, 224, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
1086, d1rypA_, 0.9041, 2.08, 0.223, 243, 229, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
1087, p5nifG_, 0.9040, 2.04, 0.300, 244, 227, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1088, d5l67U_, 0.9040, 1.94, 0.219, 241, 228, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1089, d5l67G_, 0.9040, 1.95, 0.219, 241, 228, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1090, d5l5xT_, 0.9040, 2.08, 0.298, 243, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1091, d5l5iT_, 0.9040, 2.08, 0.298, 243, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
1092, d5fgaF_, 0.9040, 2.07, 0.298, 243, 228, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
1093, d5fg9F_, 0.9040, 2.07, 0.298, 243, 228, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
1094, p5cghT_, 0.9040, 2.22, 0.294, 243, 228, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
1095, p5cghF_, 0.9040, 2.22, 0.294, 243, 228, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
1096, p4ya9T_, 0.9040, 2.07, 0.298, 243, 228, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
1097, d4y9yF_, 0.9040, 2.07, 0.298, 243, 228, YEAST 20S PROTEASOME BETA2-H116E MUTANT
1098, d4y8mT_, 0.9040, 2.07, 0.298, 243, 228, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
1099, d4y8mF_, 0.9040, 2.07, 0.298, 243, 228, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
1100, p4y8kT_, 0.9040, 2.06, 0.295, 243, 227, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
1101, p4y8kF_, 0.9040, 2.06, 0.295, 243, 227, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
1102, p4y7xG_, 0.9040, 1.94, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
1103, p4y75G_, 0.9040, 1.93, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
1104, p4x6zA_, 0.9040, 1.93, 0.219, 242, 228, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
1105, d4r17T_, 0.9040, 2.23, 0.293, 243, 229, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1106, d4r17G_, 0.9040, 1.94, 0.219, 241, 228, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1107, d4r17F_, 0.9040, 2.23, 0.293, 243, 229, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1108, d4qvwT_, 0.9040, 2.07, 0.298, 243, 228, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
1109, d4qvwF_, 0.9040, 2.07, 0.298, 243, 228, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
1110, d4qv6G_, 0.9040, 1.94, 0.219, 241, 228, YCP BETA5-A49V MUTANT
1111, d4quxT_, 0.9040, 2.07, 0.298, 243, 228, YCP BETA5-A49T-MUTANT
1112, d4quxF_, 0.9040, 2.07, 0.298, 243, 228, YCP BETA5-A49T-MUTANT
1113, d4no6T_, 0.9040, 2.04, 0.300, 243, 227, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
1114, d4no6F_, 0.9040, 2.04, 0.300, 243, 227, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
1115, d4hnpG_, 0.9040, 2.01, 0.223, 243, 229, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
1116, p4gk7U_, 0.9040, 2.03, 0.223, 243, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
1117, d4g4sC_, 0.9040, 1.54, 0.311, 237, 222, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
1118, d3mg8R_, 0.9040, 1.65, 0.341, 242, 223, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
1119, d3mg4G_, 0.9040, 2.04, 0.223, 243, 229, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
1120, d3dy4U_, 0.9040, 2.06, 0.223, 243, 229, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
1121, d5lttT_, 0.9039, 2.08, 0.298, 243, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
1122, d5lttF_, 0.9039, 2.08, 0.298, 243, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
1123, d5l5xF_, 0.9039, 2.08, 0.298, 243, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1124, d5l5hU_, 0.9039, 1.94, 0.219, 241, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1125, d5l5hG_, 0.9039, 1.95, 0.219, 241, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1126, d5l5eU_, 0.9039, 1.95, 0.219, 241, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1127, p5l4gU_, 0.9039, 2.05, 0.265, 241, 226, 
1128, d5fggT_, 0.9039, 2.08, 0.298, 243, 228, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1129, d5fggF_, 0.9039, 2.08, 0.298, 243, 228, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1130, d5fgaT_, 0.9039, 2.07, 0.298, 243, 228, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
1131, d5fg9T_, 0.9039, 2.07, 0.298, 243, 228, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
1132, d5bouT_, 0.9039, 2.08, 0.298, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
1133, d5bouF_, 0.9039, 2.08, 0.298, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
1134, p4ya2T_, 0.9039, 2.22, 0.294, 243, 228, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
1135, p4ya2F_, 0.9039, 2.22, 0.294, 243, 228, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
1136, p4y82F_, 0.9039, 2.05, 0.300, 243, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
1137, p4y81T_, 0.9039, 2.06, 0.295, 243, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
1138, p4y78U_, 0.9039, 1.94, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
1139, p4y78G_, 0.9039, 1.94, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
1140, d4qz7U_, 0.9039, 1.94, 0.219, 241, 228, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1141, d4qw6T_, 0.9039, 2.22, 0.285, 243, 228, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
1142, d4qw6F_, 0.9039, 2.22, 0.285, 243, 228, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
1143, d4qvyU_, 0.9039, 1.95, 0.219, 241, 228, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
1144, d4qvpT_, 0.9039, 2.07, 0.298, 243, 228, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
1145, d4qvpF_, 0.9039, 2.07, 0.298, 243, 228, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
1146, d4qv7T_, 0.9039, 2.07, 0.298, 243, 228, YCP BETA5-A50V MUTANT
1147, d4qv7F_, 0.9039, 2.07, 0.298, 243, 228, YCP BETA5-A50V MUTANT
1148, d4qv0T_, 0.9039, 2.07, 0.298, 243, 228, YCP BETA5-A49T-A50V-DOUBLE MUTANT
1149, d4qv0F_, 0.9039, 2.07, 0.298, 243, 228, YCP BETA5-A49T-A50V-DOUBLE MUTANT
1150, d4quxU_, 0.9039, 1.95, 0.219, 241, 228, YCP BETA5-A49T-MUTANT
1151, d4qlsT_, 0.9039, 2.23, 0.294, 243, 228, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
1152, d4qlsF_, 0.9039, 2.23, 0.294, 243, 228, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
1153, d4lqiT_, 0.9039, 2.08, 0.298, 244, 228, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
1154, d4intT_, 0.9039, 2.23, 0.293, 244, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
1155, d4inrT_, 0.9039, 2.23, 0.293, 244, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
1156, d4hrcT_, 0.9039, 2.06, 0.295, 244, 227, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
1157, p4gk7G_, 0.9039, 2.04, 0.223, 243, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
1158, d3dy4G_, 0.9039, 2.06, 0.223, 243, 229, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
1159, d3d29T_, 0.9039, 2.08, 0.298, 244, 228, PROTEASOME INHIBITION BY FELLUTAMIDE B
1160, d1ya7A_, 0.9039, 1.64, 0.335, 227, 224, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
1161, d1g65T_, 0.9039, 2.06, 0.298, 244, 228, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
1162, d5l5oU_, 0.9038, 1.94, 0.219, 241, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1163, d5l5oG_, 0.9038, 1.94, 0.219, 241, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1164, d5l5eT_, 0.9038, 2.08, 0.298, 243, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1165, d5l5eG_, 0.9038, 1.95, 0.219, 241, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1166, d5l5eF_, 0.9038, 2.08, 0.298, 243, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1167, d5l5aU_, 0.9038, 1.95, 0.219, 241, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
1168, d5l5aG_, 0.9038, 1.95, 0.219, 241, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
1169, p4ya7T_, 0.9038, 2.07, 0.298, 243, 228, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
1170, p4ya7F_, 0.9038, 2.07, 0.298, 243, 228, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
1171, p4y8pT_, 0.9038, 2.08, 0.298, 243, 228, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
1172, p4y8pF_, 0.9038, 2.08, 0.298, 243, 228, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
1173, p4y81F_, 0.9038, 2.06, 0.295, 243, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
1174, p4y77T_, 0.9038, 2.08, 0.298, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
1175, p4y6vF_, 0.9038, 2.08, 0.298, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
1176, d4r18U_, 0.9038, 1.95, 0.219, 241, 228, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1177, d4r18G_, 0.9038, 1.95, 0.219, 241, 228, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1178, d4qz7G_, 0.9038, 1.94, 0.219, 241, 228, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1179, d4qxjU_, 0.9038, 1.94, 0.219, 241, 228, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1180, d4qxjG_, 0.9038, 1.94, 0.219, 241, 228, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1181, d4qwxU_, 0.9038, 1.94, 0.219, 241, 228, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1182, d4qwxG_, 0.9038, 1.94, 0.219, 241, 228, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1183, d4qwlT_, 0.9038, 2.08, 0.298, 243, 228, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
1184, d4qwlF_, 0.9038, 2.08, 0.298, 243, 228, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
1185, d4qwkU_, 0.9038, 1.94, 0.219, 241, 228, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1186, d4qvyG_, 0.9038, 1.95, 0.219, 241, 228, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
1187, d4qvqU_, 0.9038, 1.95, 0.219, 241, 228, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
1188, d4qv8T_, 0.9038, 2.07, 0.298, 243, 228, YCP BETA5-C52F MUTANT
1189, d4qv8F_, 0.9038, 2.07, 0.298, 243, 228, YCP BETA5-C52F MUTANT
1190, d4quxG_, 0.9038, 1.95, 0.219, 241, 228, YCP BETA5-A49T-MUTANT
1191, d4qlvU_, 0.9038, 1.95, 0.219, 241, 228, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
1192, d4qlvG_, 0.9038, 1.95, 0.219, 241, 228, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
1193, d4lqiF_, 0.9038, 2.08, 0.298, 244, 228, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
1194, d4jsqT_, 0.9038, 2.23, 0.293, 244, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
1195, d4jsqF_, 0.9038, 2.23, 0.293, 244, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
1196, d4intF_, 0.9038, 2.23, 0.293, 244, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
1197, d4g4sG_, 0.9038, 2.24, 0.293, 246, 229, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
1198, d3hyeT_, 0.9038, 2.22, 0.293, 244, 229, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
1199, d3hyeF_, 0.9038, 2.22, 0.293, 244, 229, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
1200, d3gptT_, 0.9038, 2.22, 0.293, 244, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
1201, d3gptF_, 0.9038, 2.22, 0.293, 244, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
1202, d3d29F_, 0.9038, 2.08, 0.298, 244, 228, PROTEASOME INHIBITION BY FELLUTAMIDE B
1203, d2zcyF_, 0.9038, 2.08, 0.298, 244, 228, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
1204, d5l65U_, 0.9037, 1.95, 0.219, 241, 228, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1205, d5l64U_, 0.9037, 1.95, 0.219, 241, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1206, d5l64G_, 0.9037, 1.95, 0.219, 241, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1207, d5l61U_, 0.9037, 1.95, 0.219, 241, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1208, d5l61G_, 0.9037, 1.95, 0.219, 241, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1209, d5l5fU_, 0.9037, 1.95, 0.219, 241, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1210, d5l5fG_, 0.9037, 1.95, 0.219, 241, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1211, d5l55T_, 0.9037, 2.08, 0.298, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1212, d5jhrT_, 0.9037, 2.08, 0.298, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
1213, d5jhrF_, 0.9037, 2.08, 0.298, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
1214, d5fgeT_, 0.9037, 2.06, 0.300, 243, 227, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1215, d5cgfT_, 0.9037, 2.07, 0.298, 243, 228, YEAST 20S PROTEASOME BETA5-G48C MUTANT
1216, d5cgfF_, 0.9037, 2.07, 0.298, 243, 228, YEAST 20S PROTEASOME BETA5-G48C MUTANT
1217, p4y84U_, 0.9037, 1.94, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
1218, p4y77F_, 0.9037, 2.08, 0.298, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
1219, p4y74U_, 0.9037, 1.94, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
1220, p4y74G_, 0.9037, 1.94, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
1221, p4y6vT_, 0.9037, 2.08, 0.298, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
1222, d4qwuF_, 0.9037, 2.08, 0.298, 243, 228, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
1223, d4qwkG_, 0.9037, 1.94, 0.219, 241, 228, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1224, d4qw4T_, 0.9037, 2.03, 0.295, 243, 227, YCP IN COMPLEX WITH CARFILZOMIB
1225, d4qw4F_, 0.9037, 2.04, 0.295, 243, 227, YCP IN COMPLEX WITH CARFILZOMIB
1226, d4qvqG_, 0.9037, 1.95, 0.219, 241, 228, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
1227, d4qv3T_, 0.9037, 2.08, 0.298, 243, 228, YCP BETA5-M45V MUTANT
1228, d4qlqU_, 0.9037, 1.94, 0.219, 241, 228, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
1229, d4nnnT_, 0.9037, 2.07, 0.298, 243, 228, YCP IN COMPLEX WITH MG132
1230, d4nnnF_, 0.9037, 2.07, 0.298, 243, 228, YCP IN COMPLEX WITH MG132
1231, d4inrF_, 0.9037, 2.23, 0.293, 244, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
1232, p4gk7T_, 0.9037, 2.08, 0.298, 244, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
1233, p4gk7F_, 0.9037, 2.08, 0.298, 244, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
1234, d4eu2G_, 0.9037, 2.24, 0.293, 244, 229, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
1235, d3unfT_, 0.9037, 1.92, 0.271, 244, 225, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
1236, d3unfF_, 0.9037, 1.92, 0.271, 244, 225, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
1237, d3gpjU_, 0.9037, 2.06, 0.227, 243, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
1238, d3gpjG_, 0.9037, 2.06, 0.223, 243, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
1239, d3dy3T_, 0.9037, 2.09, 0.298, 244, 228, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
1240, d3dy3F_, 0.9037, 2.09, 0.298, 244, 228, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
1241, d2fakT_, 0.9037, 2.22, 0.293, 244, 229, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
1242, d1g65F_, 0.9037, 2.06, 0.298, 244, 228, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
1243, p5lf0F_, 0.9036, 2.08, 0.271, 239, 225, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
1244, d5l6cU_, 0.9036, 1.95, 0.219, 241, 228, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1245, d5l65G_, 0.9036, 1.95, 0.219, 241, 228, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1246, d5l63U_, 0.9036, 1.95, 0.219, 241, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1247, d5l62U_, 0.9036, 1.95, 0.219, 241, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1248, d5l62G_, 0.9036, 1.95, 0.219, 241, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1249, d5l5xU_, 0.9036, 1.95, 0.219, 241, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1250, d5l5xG_, 0.9036, 1.95, 0.219, 241, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1251, d5l5pU_, 0.9036, 1.95, 0.219, 241, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1252, d5l5pG_, 0.9036, 1.95, 0.219, 241, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1253, d5l55F_, 0.9036, 2.08, 0.298, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1254, d5fgeF_, 0.9036, 2.06, 0.300, 243, 227, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1255, d5cz6U_, 0.9036, 1.95, 0.219, 241, 228, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
1256, d5cz6G_, 0.9036, 1.95, 0.219, 241, 228, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
1257, p5cggT_, 0.9036, 2.08, 0.298, 243, 228, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
1258, p5cggF_, 0.9036, 2.08, 0.298, 243, 228, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
1259, p4y84G_, 0.9036, 1.94, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
1260, p4y7xT_, 0.9036, 2.06, 0.300, 243, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
1261, p4x6zU_, 0.9036, 2.25, 0.293, 244, 229, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
1262, d4rurT_, 0.9036, 2.08, 0.298, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
1263, d4rurF_, 0.9036, 2.08, 0.298, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
1264, d4qz6T_, 0.9036, 2.08, 0.298, 243, 228, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1265, d4qz6F_, 0.9036, 2.08, 0.298, 243, 228, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1266, d4qz0T_, 0.9036, 2.23, 0.285, 243, 228, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1267, d4qwuT_, 0.9036, 2.08, 0.298, 243, 228, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
1268, d4qvwU_, 0.9036, 1.95, 0.219, 241, 228, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
1269, d4qvvU_, 0.9036, 1.95, 0.219, 241, 228, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
1270, d4qvvG_, 0.9036, 1.95, 0.219, 241, 228, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
1271, d4qlqG_, 0.9036, 1.94, 0.219, 241, 228, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
1272, d4hrdT_, 0.9036, 2.09, 0.298, 244, 228, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
1273, d4hrcG_, 0.9036, 2.01, 0.223, 243, 229, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
1274, d3wxrQ_, 0.9036, 1.75, 0.308, 244, 224, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
1275, d3oeuD_, 0.9036, 1.68, 0.341, 242, 223, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
1276, d3dy3U_, 0.9036, 2.06, 0.223, 243, 229, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
1277, d2zcyT_, 0.9036, 2.23, 0.293, 244, 229, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
1278, d2fakF_, 0.9036, 2.23, 0.293, 244, 229, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
1279, d1ya7D_, 0.9036, 1.66, 0.335, 227, 224, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
1280, d5lf1F_, 0.9035, 2.09, 0.267, 239, 225, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
1281, p5leyF_, 0.9035, 2.08, 0.271, 239, 225, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
1282, d5l6cG_, 0.9035, 1.95, 0.219, 241, 228, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1283, d5l66U_, 0.9035, 1.95, 0.219, 241, 228, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1284, d5l63G_, 0.9035, 1.95, 0.219, 241, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1285, d5dkjU_, 0.9035, 1.95, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
1286, d5d0sT_, 0.9035, 2.08, 0.298, 243, 228, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
1287, d5d0sF_, 0.9035, 2.08, 0.298, 243, 228, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
1288, p4y8sT_, 0.9035, 2.24, 0.293, 243, 229, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
1289, p4y8sF_, 0.9035, 2.24, 0.293, 243, 229, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
1290, p4y8iU_, 0.9035, 1.94, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
1291, p4y8iG_, 0.9035, 1.95, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
1292, p4y80F_, 0.9035, 2.06, 0.295, 243, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
1293, p4y7xF_, 0.9035, 2.06, 0.300, 243, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
1294, p4y6aU_, 0.9035, 1.95, 0.219, 241, 228, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
1295, p4y6aG_, 0.9035, 1.96, 0.219, 241, 228, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
1296, d4qz5T_, 0.9035, 2.08, 0.298, 243, 228, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
1297, d4qz4T_, 0.9035, 2.24, 0.293, 243, 229, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1298, d4qz4F_, 0.9035, 2.24, 0.293, 243, 229, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1299, d4qz3T_, 0.9035, 2.08, 0.298, 243, 228, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1300, d4qz3F_, 0.9035, 2.08, 0.298, 243, 228, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1301, d4qz0F_, 0.9035, 2.23, 0.285, 243, 228, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1302, d4qwxF_, 0.9035, 2.09, 0.294, 243, 228, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1303, d4qwrT_, 0.9035, 2.06, 0.300, 243, 227, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
1304, d4qwrF_, 0.9035, 2.06, 0.300, 243, 227, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
1305, d4qwfU_, 0.9035, 1.94, 0.219, 241, 228, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
1306, d4qvwG_, 0.9035, 1.95, 0.219, 241, 228, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
1307, p4qbyU_, 0.9035, 1.94, 0.219, 241, 228, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
1308, p4qbyG_, 0.9035, 1.94, 0.219, 241, 228, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
1309, d4no9T_, 0.9035, 2.09, 0.298, 243, 228, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
1310, d4no1T_, 0.9035, 2.09, 0.298, 243, 228, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
1311, d4no1F_, 0.9035, 2.09, 0.298, 243, 228, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
1312, d4lqiP_, 0.9035, 1.73, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
1313, d4lqiB_, 0.9035, 1.73, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
1314, d3tddF_, 0.9035, 2.08, 0.298, 244, 228, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
1315, d3okjT_, 0.9035, 2.07, 0.298, 244, 228, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
1316, d3okjF_, 0.9035, 2.07, 0.298, 244, 228, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
1317, d3dy4T_, 0.9035, 2.09, 0.298, 244, 228, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
1318, d2zcyU_, 0.9035, 2.07, 0.223, 243, 229, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
1319, p5nifE_, 0.9034, 1.59, 0.342, 236, 222, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1320, d5lf7F_, 0.9034, 2.08, 0.271, 239, 225, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
1321, d5lf4F_, 0.9034, 2.08, 0.267, 239, 225, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
1322, d5l66G_, 0.9034, 1.95, 0.219, 241, 228, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1323, d5l5wU_, 0.9034, 1.95, 0.219, 241, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1324, d5l5vU_, 0.9034, 1.95, 0.219, 241, 228,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1325, d5l5vG_, 0.9034, 1.95, 0.219, 241, 228,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1326, d5fgiF_, 0.9034, 2.23, 0.285, 243, 228, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1327, d5dkjG_, 0.9034, 1.95, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
1328, d5d0zT_, 0.9034, 2.09, 0.298, 243, 228, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
1329, d5d0zF_, 0.9034, 2.09, 0.298, 243, 228, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
1330, d4z1lT_, 0.9034, 2.08, 0.298, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
1331, d4z1lF_, 0.9034, 2.08, 0.298, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
1332, p4y9zT_, 0.9034, 2.08, 0.298, 243, 228, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
1333, p4y9zF_, 0.9034, 2.08, 0.298, 243, 228, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
1334, p4y8nT_, 0.9034, 2.08, 0.298, 243, 228, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
1335, p4y8nF_, 0.9034, 2.08, 0.298, 243, 228, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
1336, p4y8hT_, 0.9034, 2.25, 0.293, 243, 229, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
1337, p4y8hF_, 0.9034, 2.25, 0.293, 243, 229, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
1338, p4y74T_, 0.9034, 2.08, 0.298, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
1339, p4y74F_, 0.9034, 2.08, 0.298, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
1340, p4y6zF_, 0.9034, 2.23, 0.285, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
1341, p4y6aT_, 0.9034, 2.09, 0.298, 243, 228, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
1342, p4y6aF_, 0.9034, 2.09, 0.298, 243, 228, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
1343, p4y69U_, 0.9034, 1.96, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
1344, p4y69G_, 0.9034, 1.96, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
1345, d4qwxT_, 0.9034, 2.09, 0.294, 243, 228, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1346, d4qwfG_, 0.9034, 1.94, 0.219, 241, 228, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
1347, d4no9F_, 0.9034, 2.09, 0.298, 243, 228, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
1348, d4nnwT_, 0.9034, 2.08, 0.298, 243, 228, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
1349, d4nnwF_, 0.9034, 2.08, 0.298, 243, 228, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
1350, d4hrdG_, 0.9034, 2.02, 0.223, 243, 229, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
1351, d4fzcP_, 0.9034, 1.74, 0.308, 244, 224, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
1352, d3dy4F_, 0.9034, 2.09, 0.298, 244, 228, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
1353, d3dy3G_, 0.9034, 2.06, 0.223, 243, 229, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
1354, p6avoQ_, 0.9033, 1.99, 0.271, 239, 225, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
1355, p6avoJ_, 0.9033, 1.99, 0.271, 239, 225, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
1356, d5l5wG_, 0.9033, 1.95, 0.219, 241, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1357, d5l5tU_, 0.9033, 1.95, 0.219, 241, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1358, d5l5qU_, 0.9033, 1.95, 0.219, 241, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
1359, d5l5qG_, 0.9033, 1.95, 0.219, 241, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
1360, d5fgiT_, 0.9033, 2.23, 0.285, 243, 228, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1361, d5d0xU_, 0.9033, 1.96, 0.219, 241, 228, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
1362, p4y6zU_, 0.9033, 1.95, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
1363, p4y6zG_, 0.9033, 1.95, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
1364, p4y69T_, 0.9033, 2.08, 0.298, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
1365, p4y69F_, 0.9033, 2.08, 0.298, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
1366, d4r18P_, 0.9033, 1.74, 0.308, 244, 224, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1367, d4qz5F_, 0.9033, 2.24, 0.293, 243, 229, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
1368, d4qw0U_, 0.9033, 1.96, 0.219, 241, 228, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
1369, d4j70R_, 0.9033, 1.67, 0.341, 242, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
1370, d4j70D_, 0.9033, 1.67, 0.341, 242, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
1371, d4fzcB_, 0.9033, 1.74, 0.308, 244, 224, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
1372, d3tddT_, 0.9033, 2.22, 0.293, 244, 229, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
1373, d3nzwT_, 0.9033, 2.22, 0.293, 244, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
1374, d3nzwF_, 0.9033, 2.22, 0.293, 244, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
1375, d3mg0T_, 0.9033, 2.07, 0.300, 244, 227, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
1376, d2zcyG_, 0.9033, 2.07, 0.223, 243, 229, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
1377, d1z7qU1, 0.9033, 2.18, 0.294, 243, 228, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
1378, d1z7qG1, 0.9033, 2.18, 0.294, 243, 228, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
1379, d1jd22_, 0.9033, 1.97, 0.219, 243, 228, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
1380, d5lf3F_, 0.9032, 2.08, 0.271, 239, 225, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
1381, d5l5zU_, 0.9032, 1.95, 0.219, 241, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1382, d5l5tG_, 0.9032, 1.95, 0.219, 241, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1383, d5l5dU_, 0.9032, 1.95, 0.219, 241, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1384, d5l5dG_, 0.9032, 1.95, 0.219, 241, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1385, d5fgfT_, 0.9032, 2.23, 0.285, 243, 228, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
1386, d5fgfF_, 0.9032, 2.23, 0.285, 243, 228, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
1387, d5dkjT_, 0.9032, 2.08, 0.298, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
1388, d5dkjF_, 0.9032, 2.08, 0.298, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
1389, d5d0xG_, 0.9032, 1.96, 0.219, 241, 228, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
1390, p4ya5F_, 0.9032, 2.09, 0.298, 243, 228, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
1391, p4y8uT_, 0.9032, 2.09, 0.298, 243, 228, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
1392, p4y8uF_, 0.9032, 2.09, 0.298, 243, 228, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
1393, p4y84T_, 0.9032, 2.25, 0.293, 243, 229, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
1394, p4y84F_, 0.9032, 2.25, 0.293, 243, 229, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
1395, p4y82T_, 0.9032, 2.09, 0.298, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
1396, p4y6vU_, 0.9032, 1.96, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
1397, p4y6vG_, 0.9032, 1.96, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
1398, d4qw7T_, 0.9032, 2.09, 0.298, 243, 228, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
1399, d4qw7F_, 0.9032, 2.09, 0.298, 243, 228, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
1400, d4qw4U_, 0.9032, 1.95, 0.219, 241, 228, YCP IN COMPLEX WITH CARFILZOMIB
1401, d4qw4G_, 0.9032, 1.95, 0.219, 241, 228, YCP IN COMPLEX WITH CARFILZOMIB
1402, d4qw0G_, 0.9032, 1.96, 0.219, 241, 228, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
1403, d4jsuT_, 0.9032, 2.23, 0.293, 244, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
1404, d4jsuF_, 0.9032, 2.23, 0.293, 244, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
1405, d3unbF_, 0.9032, 1.91, 0.271, 244, 225, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1406, d3nzxT_, 0.9032, 2.22, 0.293, 244, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
1407, d3nzxF_, 0.9032, 2.22, 0.293, 244, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
1408, d3gpwT_, 0.9032, 2.23, 0.293, 244, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
1409, d3gpwF_, 0.9032, 2.23, 0.293, 244, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
1410, d3gpjT_, 0.9032, 2.09, 0.298, 244, 228, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
1411, d5lajP_, 0.9031, 1.75, 0.308, 244, 224, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1412, d5lajB_, 0.9031, 1.75, 0.308, 244, 224, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1413, d5laiT_, 0.9031, 2.24, 0.293, 243, 229, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1414, d5laiF_, 0.9031, 2.24, 0.293, 243, 229, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1415, d5l5zG_, 0.9031, 1.95, 0.219, 241, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1416, d5l5sU_, 0.9031, 1.96, 0.219, 241, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
1417, d5l5sG_, 0.9031, 1.96, 0.219, 241, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
1418, d5l52T_, 0.9031, 2.08, 0.298, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1419, d5l52F_, 0.9031, 2.09, 0.298, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1420, d5d0xT_, 0.9031, 2.09, 0.298, 243, 228, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
1421, d5d0xF_, 0.9031, 2.09, 0.298, 243, 228, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
1422, d5d0tT_, 0.9031, 2.08, 0.298, 243, 228, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
1423, d5d0tF_, 0.9031, 2.08, 0.298, 243, 228, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
1424, d5cz9T_, 0.9031, 2.09, 0.298, 243, 228, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
1425, d5cz9F_, 0.9031, 2.09, 0.298, 243, 228, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
1426, p4ya5T_, 0.9031, 2.09, 0.298, 243, 228, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
1427, p4y8nU_, 0.9031, 1.96, 0.219, 241, 228, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
1428, p4r18B_, 0.9031, 1.75, 0.308, 244, 224, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1429, d4qz7T_, 0.9031, 2.25, 0.293, 243, 229, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1430, d4qz7F_, 0.9031, 2.25, 0.293, 243, 229, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1431, d4qwsU_, 0.9031, 1.95, 0.219, 241, 228, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
1432, d4qwkT_, 0.9031, 2.23, 0.285, 243, 228, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1433, d4qwkF_, 0.9031, 2.23, 0.285, 243, 228, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1434, d4qw5T_, 0.9031, 2.09, 0.298, 243, 228, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
1435, d4qw5F_, 0.9031, 2.09, 0.298, 243, 228, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
1436, d4qw0T_, 0.9031, 2.09, 0.298, 243, 228, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
1437, d4qw0F_, 0.9031, 2.09, 0.298, 243, 228, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
1438, d4qlvT_, 0.9031, 2.06, 0.295, 243, 227, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
1439, d4qlvF_, 0.9031, 2.06, 0.295, 243, 227, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
1440, d4qluT_, 0.9031, 2.07, 0.300, 243, 227, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
1441, d4qluF_, 0.9031, 2.07, 0.300, 243, 227, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
1442, d4no8T_, 0.9031, 2.08, 0.298, 243, 228, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
1443, d4no8F_, 0.9031, 2.08, 0.298, 243, 228, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
1444, d4inuT_, 0.9031, 2.24, 0.293, 244, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
1445, d4inuF_, 0.9031, 2.24, 0.293, 244, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
1446, d3mg7R_, 0.9031, 1.66, 0.341, 242, 223, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
1447, d3mg4F_, 0.9031, 2.20, 0.294, 244, 228, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
1448, d3mg0F_, 0.9031, 2.22, 0.294, 244, 228, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
1449, d3gpjF_, 0.9031, 2.09, 0.298, 244, 228, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
1450, d5fgdT_, 0.9030, 2.24, 0.285, 243, 228, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1451, d5d0vT_, 0.9030, 2.25, 0.293, 243, 229, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
1452, p4ya5U_, 0.9030, 1.96, 0.219, 241, 228, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
1453, p4ya3U_, 0.9030, 1.96, 0.219, 241, 228, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
1454, p4y8nG_, 0.9030, 1.96, 0.219, 241, 228, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
1455, p4y70T_, 0.9030, 2.09, 0.298, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
1456, p4y6zT_, 0.9030, 2.10, 0.294, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
1457, d4qz2T_, 0.9030, 2.23, 0.285, 243, 228, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1458, d4qz2F_, 0.9030, 2.23, 0.285, 243, 228, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1459, d4qwsG_, 0.9030, 1.95, 0.219, 241, 228, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
1460, d4qvmT_, 0.9030, 2.09, 0.298, 243, 228, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
1461, d4qvmF_, 0.9030, 2.09, 0.298, 243, 228, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
1462, d4q1sP_, 0.9030, 1.73, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
1463, d4j70P_, 0.9030, 1.75, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
1464, d4j70B_, 0.9030, 1.75, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
1465, d4intP_, 0.9030, 1.74, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
1466, d3wxrE_, 0.9030, 1.71, 0.341, 239, 223, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
1467, p3jcpJA_, 0.9030, 2.00, 0.219, 243, 228, 
1468, p3jcpJ_, 0.9030, 2.00, 0.219, 243, 228, 
1469, d5m2bU_, 0.9029, 1.96, 0.219, 241, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
1470, d5le5F_, 0.9029, 2.09, 0.271, 239, 225, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
1471, d5jhsT_, 0.9029, 2.09, 0.298, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
1472, d5jhsF_, 0.9029, 2.09, 0.298, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
1473, p5fghT_, 0.9029, 2.09, 0.298, 243, 228, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
1474, d5fgdF_, 0.9029, 2.24, 0.285, 243, 228, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1475, d5d0vF_, 0.9029, 2.25, 0.293, 243, 229, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
1476, p4zzgE_, 0.9029, 1.59, 0.342, 236, 222, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1477, p4ya5G_, 0.9029, 1.96, 0.219, 241, 228, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
1478, p4ya3G_, 0.9029, 1.97, 0.219, 241, 228, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
1479, p4y8oT_, 0.9029, 2.10, 0.294, 243, 228, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
1480, p4y8oF_, 0.9029, 2.10, 0.294, 243, 228, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
1481, p4y7wT_, 0.9029, 2.09, 0.298, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
1482, p4y70F_, 0.9029, 2.09, 0.298, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
1483, d4qzwT_, 0.9029, 2.09, 0.298, 243, 228, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1484, d4qzwF_, 0.9029, 2.09, 0.298, 243, 228, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1485, d4qlqT_, 0.9029, 2.26, 0.293, 243, 229, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
1486, d4qlqF_, 0.9029, 2.26, 0.293, 243, 229, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
1487, d4lqiD_, 0.9029, 1.68, 0.341, 242, 223, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
1488, d4j70T_, 0.9029, 2.24, 0.293, 244, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
1489, d4j70F_, 0.9029, 2.24, 0.293, 244, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
1490, d3mg0G_, 0.9029, 2.06, 0.227, 243, 229, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
1491, d1jd2F_, 0.9029, 2.10, 0.298, 244, 228, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
1492, d5m2bG_, 0.9028, 1.96, 0.219, 241, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
1493, d5l5iU_, 0.9028, 1.96, 0.219, 241, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
1494, p5fghF_, 0.9028, 2.09, 0.298, 243, 228, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
1495, p5cgiT_, 0.9028, 2.10, 0.294, 243, 228, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
1496, p4y8gP_, 0.9028, 1.75, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
1497, p4y84P_, 0.9028, 1.75, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
1498, p4y84B_, 0.9028, 1.75, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
1499, p4y7wF_, 0.9028, 2.09, 0.298, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
1500, d4qz1T_, 0.9028, 2.24, 0.289, 243, 228, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1501, d4qz1F_, 0.9028, 2.24, 0.289, 243, 228, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1502, d4qltT_, 0.9028, 2.09, 0.298, 243, 228, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
1503, d4qltF_, 0.9028, 2.09, 0.298, 243, 228, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
1504, d4lqiR_, 0.9028, 1.68, 0.341, 242, 223, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
1505, d4jt0T_, 0.9028, 2.23, 0.293, 244, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
1506, d4jt0F_, 0.9028, 2.23, 0.293, 244, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
1507, d4intB_, 0.9028, 1.74, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
1508, p4gk7P_, 0.9028, 1.74, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
1509, d3bdmT_, 0.9028, 2.10, 0.298, 244, 228, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
1510, d3bdmF_, 0.9028, 2.10, 0.298, 244, 228, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
1511, d5l5jU_, 0.9027, 1.96, 0.219, 241, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1512, d5l5jG_, 0.9027, 1.96, 0.219, 241, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1513, d5l5iG_, 0.9027, 1.96, 0.219, 241, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
1514, d5cz8D_, 0.9027, 1.50, 0.344, 235, 221, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
1515, d5cz5T_, 0.9027, 2.24, 0.285, 243, 228, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
1516, d5cz5F_, 0.9027, 2.24, 0.285, 243, 228, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
1517, d5cz4F_, 0.9027, 2.09, 0.298, 243, 228, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
1518, p5cgiF_, 0.9027, 2.09, 0.298, 243, 228, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
1519, d5bouU_, 0.9027, 1.96, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
1520, d5bouG_, 0.9027, 1.96, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
1521, p4y8qT_, 0.9027, 2.10, 0.298, 243, 228, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
1522, p4y8qF_, 0.9027, 2.10, 0.298, 243, 228, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
1523, p4y8iT_, 0.9027, 2.10, 0.294, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
1524, p4y8gB_, 0.9027, 1.75, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
1525, p4y80T_, 0.9027, 2.09, 0.298, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
1526, d4rurU_, 0.9027, 1.96, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
1527, d4rurG_, 0.9027, 1.97, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
1528, d4qxjT_, 0.9027, 2.05, 0.295, 243, 227, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1529, d4qwiT_, 0.9027, 2.09, 0.298, 243, 228, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
1530, d4qwiF_, 0.9027, 2.09, 0.298, 243, 228, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
1531, d4qlsP_, 0.9027, 1.75, 0.308, 244, 224, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
1532, p4qlsB_, 0.9027, 1.75, 0.308, 244, 224, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
1533, p4gk7B_, 0.9027, 1.74, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
1534, d4fzgP_, 0.9027, 1.75, 0.308, 244, 224, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
1535, d3nzjR_, 0.9027, 1.68, 0.341, 242, 223, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
1536, d3nzjD_, 0.9027, 1.68, 0.341, 242, 223, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
1537, d1g0uF_, 0.9027, 2.01, 0.300, 242, 227, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
1538, d5l68U_, 0.9026, 1.96, 0.219, 241, 228, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1539, d5l68G_, 0.9026, 1.96, 0.219, 241, 228, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1540, d5l60U_, 0.9026, 1.96, 0.219, 241, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1541, d5l5yU_, 0.9026, 1.96, 0.219, 241, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1542, d5cz8R_, 0.9026, 1.50, 0.344, 235, 221, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
1543, d5cz4T_, 0.9026, 2.09, 0.298, 243, 228, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
1544, p4y8lT_, 0.9026, 2.25, 0.293, 243, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
1545, p4y8lF_, 0.9026, 2.25, 0.293, 243, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
1546, p4y8jT_, 0.9026, 2.25, 0.293, 243, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
1547, p4y8jF_, 0.9026, 2.25, 0.293, 243, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
1548, p4y8iF_, 0.9026, 2.10, 0.294, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
1549, p4y81U_, 0.9026, 1.96, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
1550, d4qxjF_, 0.9026, 2.05, 0.295, 243, 227, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1551, d4qwgF_, 0.9026, 2.08, 0.295, 243, 227, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
1552, d4qltP_, 0.9026, 1.75, 0.308, 244, 224, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
1553, p4qltB_, 0.9026, 1.75, 0.308, 244, 224, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
1554, d4jsuR_, 0.9026, 1.68, 0.341, 242, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
1555, d4jsuD_, 0.9026, 1.68, 0.341, 242, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
1556, d4fzgT_, 0.9026, 2.23, 0.293, 244, 229, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
1557, d4fzgB_, 0.9026, 1.75, 0.308, 244, 224, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
1558, p3un4T_, 0.9026, 2.24, 0.293, 244, 229, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
1559, p3un4F_, 0.9026, 2.24, 0.293, 244, 229, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
1560, d3mg6D_, 0.9026, 1.70, 0.341, 242, 223, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
1561, d3jseG_, 0.9026, 1.66, 0.335, 227, 224, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
1562, d2fnyT_, 0.9026, 2.24, 0.293, 244, 229,  
1563, p5lf6F_, 0.9025, 1.85, 0.272, 239, 224, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
1564, d5l60G_, 0.9025, 1.96, 0.219, 241, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1565, d5l5yG_, 0.9025, 1.96, 0.219, 241, 228, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1566, d5cz4U_, 0.9025, 1.97, 0.219, 241, 228, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
1567, d5cz4G_, 0.9025, 1.97, 0.219, 241, 228, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
1568, p4y8tP_, 0.9025, 1.75, 0.308, 244, 224, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
1569, p4y8tB_, 0.9025, 1.75, 0.308, 244, 224, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
1570, p4y8hP_, 0.9025, 1.75, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
1571, p4y8hB_, 0.9025, 1.75, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
1572, p4y81G_, 0.9025, 1.96, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
1573, d4r02P_, 0.9025, 1.75, 0.308, 244, 224, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
1574, d4qz6P_, 0.9025, 1.76, 0.308, 244, 224, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1575, d4qwsT_, 0.9025, 2.24, 0.285, 243, 228, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
1576, d4qwsF_, 0.9025, 2.24, 0.285, 243, 228, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
1577, d4qwgT_, 0.9025, 2.08, 0.295, 243, 227, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
1578, d4qvvT_, 0.9025, 2.09, 0.298, 243, 228, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
1579, d4qvvF_, 0.9025, 2.09, 0.298, 243, 228, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
1580, d4qvmU_, 0.9025, 1.97, 0.219, 241, 228, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
1581, d4fzgF_, 0.9025, 2.23, 0.293, 244, 229, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
1582, d3wxrS_, 0.9025, 1.72, 0.341, 238, 223, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
1583, d3sdiU_, 0.9025, 1.82, 0.221, 240, 226, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
1584, d3oeuR_, 0.9025, 1.73, 0.341, 236, 223, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
1585, d3mg4T_, 0.9025, 2.07, 0.295, 244, 227, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
1586, d2fnyF_, 0.9025, 2.24, 0.293, 244, 229,  
1587, d1rypQ_, 0.9025, 1.75, 0.308, 244, 224, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
1588, d1jd21_, 0.9025, 2.10, 0.298, 244, 228, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
1589, d1g65U_, 0.9025, 2.09, 0.223, 243, 229, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
1590, d5fhsT_, 0.9024, 2.10, 0.298, 243, 228, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
1591, d5fhsF_, 0.9024, 2.10, 0.298, 243, 228, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
1592, p4ya0U_, 0.9024, 1.97, 0.219, 241, 228, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
1593, p4ya0G_, 0.9024, 1.97, 0.219, 241, 228, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
1594, p4y9zP_, 0.9024, 1.75, 0.308, 244, 224, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
1595, p4y9zB_, 0.9024, 1.75, 0.308, 244, 224, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
1596, p4y8sP_, 0.9024, 1.76, 0.308, 244, 224, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
1597, p4y7yT_, 0.9024, 2.09, 0.298, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
1598, p4y7yF_, 0.9024, 2.09, 0.298, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
1599, d4qz6B_, 0.9024, 1.76, 0.308, 244, 224, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1600, d4qz5P_, 0.9024, 1.76, 0.308, 244, 224, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
1601, d4qz4P_, 0.9024, 1.76, 0.308, 244, 224, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1602, d4qwjD_, 0.9024, 1.50, 0.344, 235, 221, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
1603, d4qw3T_, 0.9024, 2.24, 0.285, 243, 228, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
1604, d4qw3F_, 0.9024, 2.24, 0.285, 243, 228, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
1605, d4qvmG_, 0.9024, 1.97, 0.219, 241, 228, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
1606, d3oevR_, 0.9024, 1.67, 0.341, 242, 223, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
1607, d3mg6R_, 0.9024, 1.68, 0.341, 242, 223, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
1608, d3d29U2, 0.9024, 1.90, 0.220, 241, 227, PROTEASOME INHIBITION BY FELLUTAMIDE B
1609, d3d29G2, 0.9024, 1.90, 0.220, 241, 227, PROTEASOME INHIBITION BY FELLUTAMIDE B
1610, d5laiU_, 0.9023, 1.97, 0.219, 241, 228, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1611, d5l54P_, 0.9023, 1.76, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1612, d5jhsD_, 0.9023, 1.50, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
1613, d5fhsR_, 0.9023, 1.50, 0.344, 235, 221, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
1614, d5fhsD_, 0.9023, 1.50, 0.344, 235, 221, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
1615, d5fgiR_, 0.9023, 1.50, 0.344, 235, 221, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1616, d5fgiD_, 0.9023, 1.50, 0.344, 235, 221, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1617, d5fgfR_, 0.9023, 1.50, 0.344, 235, 221, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
1618, d5fgfD_, 0.9023, 1.50, 0.344, 235, 221, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
1619, p4ya3T_, 0.9023, 2.10, 0.298, 243, 228, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
1620, p4ya3F_, 0.9023, 2.10, 0.298, 243, 228, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
1621, p4y8sB_, 0.9023, 1.76, 0.308, 244, 224, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
1622, p4y8iP_, 0.9023, 1.76, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
1623, p4y8iB_, 0.9023, 1.76, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
1624, d4r02D_, 0.9023, 1.50, 0.344, 235, 221, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
1625, p4qzwR_, 0.9023, 1.51, 0.344, 235, 221, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1626, p4qzwD_, 0.9023, 1.50, 0.344, 235, 221, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1627, d4qz5B_, 0.9023, 1.76, 0.308, 244, 224, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
1628, d4qz4B_, 0.9023, 1.76, 0.308, 244, 224, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1629, d4qwjR_, 0.9023, 1.50, 0.344, 235, 221, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
1630, d4qw7R_, 0.9023, 1.50, 0.344, 235, 221, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
1631, d4qw7D_, 0.9023, 1.50, 0.344, 235, 221, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
1632, d4qlvP_, 0.9023, 1.76, 0.308, 244, 224, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
1633, p4qlvB_, 0.9023, 1.76, 0.308, 244, 224, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
1634, d4jsuP_, 0.9023, 1.74, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
1635, d4jsuB_, 0.9023, 1.75, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
1636, d4jsqP_, 0.9023, 1.74, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
1637, d4jsqB_, 0.9023, 1.74, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
1638, d4fzcT_, 0.9023, 2.03, 0.300, 244, 227, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
1639, d3mg7D_, 0.9023, 1.69, 0.341, 242, 223, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
1640, d2gplP_, 0.9023, 1.75, 0.308, 244, 224, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
1641, d1g0uT_, 0.9023, 2.01, 0.300, 242, 227, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
1642, d5laiG_, 0.9022, 1.97, 0.219, 241, 228, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1643, d5l54B_, 0.9022, 1.76, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1644, d5jhsR_, 0.9022, 1.50, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
1645, p5fghU_, 0.9022, 1.97, 0.219, 241, 228, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
1646, p5fghG_, 0.9022, 1.97, 0.219, 241, 228, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
1647, d5dkiT_, 0.9022, 2.25, 0.288, 243, 229, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
1648, d5cz5R_, 0.9022, 1.51, 0.344, 235, 221, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
1649, d5cz5D_, 0.9022, 1.51, 0.344, 235, 221, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
1650, p4ya9P_, 0.9022, 1.76, 0.308, 244, 224, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
1651, p4ya9B_, 0.9022, 1.76, 0.308, 244, 224, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
1652, p4ya0T_, 0.9022, 2.10, 0.294, 243, 228, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
1653, p4ya0F_, 0.9022, 2.10, 0.294, 243, 228, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
1654, p4y8oU_, 0.9022, 1.96, 0.219, 241, 228, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
1655, p4y8oG_, 0.9022, 1.96, 0.219, 241, 228, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
1656, p4y8iD_, 0.9022, 1.51, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
1657, d4qzxT_, 0.9022, 2.10, 0.298, 243, 228, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1658, d4qzxF_, 0.9022, 2.10, 0.298, 243, 228, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1659, d4qz6R_, 0.9022, 1.51, 0.344, 235, 221, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1660, d4qz6D_, 0.9022, 1.51, 0.344, 235, 221, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1661, d4qz2R_, 0.9022, 1.51, 0.344, 235, 221, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1662, d4qz2D_, 0.9022, 1.51, 0.344, 235, 221, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1663, d4qz1U_, 0.9022, 1.96, 0.219, 241, 228, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1664, d4qz1G_, 0.9022, 1.96, 0.219, 241, 228, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1665, p4qwfD_, 0.9022, 1.51, 0.344, 235, 221, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
1666, d4qw6D_, 0.9022, 1.51, 0.344, 235, 221, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
1667, d4inrP_, 0.9022, 1.75, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
1668, p4gk7D_, 0.9022, 1.68, 0.341, 242, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
1669, d4fzcF_, 0.9022, 2.03, 0.300, 244, 227, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
1670, d3shjT_, 0.9022, 2.23, 0.293, 244, 229, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
1671, d3shjF_, 0.9022, 2.23, 0.293, 244, 229, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
1672, d3oevD_, 0.9022, 1.70, 0.341, 242, 223, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
1673, d3mg8D_, 0.9022, 1.70, 0.341, 242, 223, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
1674, d3jseF_, 0.9022, 1.66, 0.335, 227, 224, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
1675, d3jseB_, 0.9022, 1.66, 0.335, 227, 224, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
1676, d3hyeP_, 0.9022, 1.75, 0.308, 244, 224, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
1677, d3e47T_, 0.9022, 2.24, 0.293, 244, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
1678, d3e47F_, 0.9022, 2.24, 0.293, 244, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
1679, d2gplT_, 0.9022, 2.24, 0.293, 244, 229, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
1680, d2gplF_, 0.9022, 2.24, 0.293, 244, 229, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
1681, d2gplB_, 0.9022, 1.75, 0.308, 244, 224, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
1682, d2fnyP_, 0.9022, 1.75, 0.308, 244, 224,  
1683, d2fnyB_, 0.9022, 1.75, 0.308, 244, 224,  
1684, d2f16T_, 0.9022, 2.24, 0.293, 244, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
1685, d2f16F_, 0.9022, 2.24, 0.293, 244, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
1686, d5l54T_, 0.9021, 2.26, 0.293, 243, 229, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1687, d5l54F_, 0.9021, 2.26, 0.293, 243, 229, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1688, d5l54D_, 0.9021, 1.51, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1689, d5fgdR_, 0.9021, 1.51, 0.344, 235, 221, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1690, d5fgdD_, 0.9021, 1.51, 0.344, 235, 221, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1691, d5dkiF_, 0.9021, 2.25, 0.288, 243, 229, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
1692, d5d0vD_, 0.9021, 1.51, 0.344, 235, 221, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
1693, d5d0sD_, 0.9021, 1.51, 0.344, 235, 221, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
1694, p4ya7P_, 0.9021, 1.76, 0.308, 244, 224, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
1695, p4ya7B_, 0.9021, 1.76, 0.308, 244, 224, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
1696, p4y8lR_, 0.9021, 1.51, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
1697, p4y8lD_, 0.9021, 1.51, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
1698, p4y8iR_, 0.9021, 1.51, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
1699, p4y78T_, 0.9021, 2.10, 0.298, 243, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
1700, d4qz7P_, 0.9021, 1.76, 0.308, 244, 224, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1701, d4qz7B_, 0.9021, 1.76, 0.308, 244, 224, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1702, d4qz5D_, 0.9021, 1.51, 0.344, 235, 221, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
1703, d4qxjR_, 0.9021, 1.51, 0.344, 235, 221, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1704, d4qxjD_, 0.9021, 1.51, 0.344, 235, 221, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1705, d4qwkR_, 0.9021, 1.51, 0.344, 235, 221, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1706, d4qwkD_, 0.9021, 1.51, 0.344, 235, 221, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1707, d4qwiR_, 0.9021, 1.51, 0.344, 235, 221, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
1708, d4qwiD_, 0.9021, 1.51, 0.344, 235, 221, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
1709, p4qwfR_, 0.9021, 1.51, 0.344, 235, 221, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
1710, d4qwfP_, 0.9021, 1.76, 0.308, 244, 224, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
1711, d4qwfB_, 0.9021, 1.76, 0.308, 244, 224, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
1712, d4qw6R_, 0.9021, 1.51, 0.344, 235, 221, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
1713, p4qw5R_, 0.9021, 1.51, 0.344, 235, 221, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
1714, p4qw5D_, 0.9021, 1.51, 0.344, 235, 221, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
1715, d4qw4R_, 0.9021, 1.51, 0.344, 235, 221, YCP IN COMPLEX WITH CARFILZOMIB
1716, d4qw4D_, 0.9021, 1.51, 0.344, 235, 221, YCP IN COMPLEX WITH CARFILZOMIB
1717, d4qlqP_, 0.9021, 1.76, 0.308, 244, 224, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
1718, p4qlqB_, 0.9021, 1.76, 0.308, 244, 224, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
1719, d4q1sD_, 0.9021, 1.73, 0.341, 242, 223, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
1720, d4intD_, 0.9021, 1.69, 0.341, 242, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
1721, p4gk7R_, 0.9021, 1.69, 0.341, 242, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
1722, d3sdiF_, 0.9021, 2.19, 0.294, 242, 228, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
1723, d3nzwD_, 0.9021, 1.69, 0.341, 242, 223, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
1724, d3jseD_, 0.9021, 1.66, 0.335, 227, 224, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
1725, d3jseA_, 0.9021, 1.66, 0.335, 227, 224, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
1726, d3hyeB_, 0.9021, 1.75, 0.308, 244, 224, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
1727, d3e47P_, 0.9021, 1.75, 0.308, 244, 224, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
1728, d3e47B_, 0.9021, 1.75, 0.308, 244, 224, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
1729, d3dy3B_, 0.9021, 1.75, 0.308, 244, 224, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
1730, d2gplD_, 0.9021, 1.68, 0.341, 242, 223, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
1731, p6gopB_, 0.9020, 1.76, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
1732, d5l54R_, 0.9020, 1.51, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1733, d5fgeD_, 0.9020, 1.51, 0.344, 235, 221, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1734, d5d0vR_, 0.9020, 1.51, 0.344, 235, 221, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
1735, d5d0sR_, 0.9020, 1.51, 0.344, 235, 221, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
1736, d5cz9R_, 0.9020, 1.51, 0.344, 235, 221, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
1737, d5cz9D_, 0.9020, 1.51, 0.344, 235, 221, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
1738, d5cz8T_, 0.9020, 2.26, 0.293, 243, 229, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
1739, d5cz8F_, 0.9020, 2.26, 0.293, 243, 229, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
1740, p4y8oB_, 0.9020, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
1741, p4y8jP_, 0.9020, 1.76, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
1742, p4y8jB_, 0.9020, 1.76, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
1743, p4y84D_, 0.9020, 1.51, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
1744, p4y7yR_, 0.9020, 1.51, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
1745, p4y7yD_, 0.9020, 1.51, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
1746, p4y70P_, 0.9020, 1.76, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
1747, p4y70B_, 0.9020, 1.76, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
1748, p4x6zQ_, 0.9020, 1.75, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
1749, d4r02G_, 0.9020, 1.97, 0.219, 241, 228, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
1750, d4qzxD_, 0.9020, 1.51, 0.344, 235, 221, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1751, d4qz5R_, 0.9020, 1.51, 0.344, 235, 221, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
1752, d4qz3R_, 0.9020, 1.51, 0.344, 235, 221, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1753, d4qz3P_, 0.9020, 1.76, 0.308, 244, 224, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1754, d4qz3D_, 0.9020, 1.51, 0.344, 235, 221, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1755, d4qz3B_, 0.9020, 1.76, 0.308, 244, 224, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1756, d4qz2P_, 0.9020, 1.77, 0.308, 244, 224, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1757, d4qz2B_, 0.9020, 1.77, 0.308, 244, 224, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1758, d4qwxP_, 0.9020, 1.76, 0.308, 244, 224, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1759, d4qwuP_, 0.9020, 1.76, 0.308, 244, 224, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
1760, d4qwuB_, 0.9020, 1.76, 0.308, 244, 224, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
1761, p4qwsD_, 0.9020, 1.51, 0.344, 235, 221, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
1762, d4qwrD_, 0.9020, 1.51, 0.344, 235, 221, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
1763, d4qw6P_, 0.9020, 1.76, 0.308, 244, 224, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
1764, d4qw6B_, 0.9020, 1.76, 0.308, 244, 224, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
1765, d4qv6P_, 0.9020, 1.76, 0.308, 244, 224, YCP BETA5-A49V MUTANT
1766, d4qv6B_, 0.9020, 1.76, 0.308, 244, 224, YCP BETA5-A49V MUTANT
1767, d4nnnP_, 0.9020, 1.76, 0.308, 244, 224, YCP IN COMPLEX WITH MG132
1768, d4nnnB_, 0.9020, 1.75, 0.308, 244, 224, YCP IN COMPLEX WITH MG132
1769, p4jt0R_, 0.9020, 1.69, 0.341, 242, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
1770, p4jt0D_, 0.9020, 1.69, 0.341, 242, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
1771, d4jsqD_, 0.9020, 1.69, 0.341, 242, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
1772, d4inrB_, 0.9020, 1.75, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
1773, d3un8P_, 0.9020, 1.75, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
1774, d3shjP_, 0.9020, 1.75, 0.308, 244, 224, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
1775, d3shjD_, 0.9020, 1.69, 0.341, 242, 223, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
1776, d3jseC_, 0.9020, 1.67, 0.335, 227, 224, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
1777, p3jcoJ_, 0.9020, 2.01, 0.219, 243, 228, 
1778, d3hyeD_, 0.9020, 1.69, 0.341, 242, 223, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
1779, d3dy3P_, 0.9020, 1.75, 0.308, 244, 224, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
1780, p6gopP_, 0.9019, 1.76, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
1781, d5lajR_, 0.9019, 1.52, 0.344, 235, 221, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1782, d5lajD_, 0.9019, 1.52, 0.344, 235, 221, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1783, d5jhrP_, 0.9019, 1.76, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
1784, d5fgeR_, 0.9019, 1.51, 0.344, 235, 221, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1785, d5d0zR_, 0.9019, 1.51, 0.344, 235, 221, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
1786, d5d0zD_, 0.9019, 1.51, 0.344, 235, 221, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
1787, d5d0vP_, 0.9019, 1.76, 0.308, 244, 224, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
1788, d5d0vB_, 0.9019, 1.76, 0.308, 244, 224, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
1789, p5cghR_, 0.9019, 1.51, 0.344, 235, 221, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
1790, p5cghD_, 0.9019, 1.51, 0.344, 235, 221, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
1791, p4ya2P_, 0.9019, 1.76, 0.308, 244, 224, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
1792, p4ya2B_, 0.9019, 1.76, 0.308, 244, 224, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
1793, p4y8pP_, 0.9019, 1.76, 0.308, 244, 224, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
1794, p4y8pB_, 0.9019, 1.76, 0.308, 244, 224, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
1795, p4y8oP_, 0.9019, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
1796, p4y8jR_, 0.9019, 1.51, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
1797, p4y8jD_, 0.9019, 1.51, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
1798, p4y84R_, 0.9019, 1.51, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
1799, p4y7yP_, 0.9019, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
1800, p4y7yB_, 0.9019, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
1801, p4y7wP_, 0.9019, 1.76, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
1802, p4y7wB_, 0.9019, 1.76, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
1803, p4y78F_, 0.9019, 2.26, 0.293, 243, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
1804, p4y78D_, 0.9019, 1.51, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
1805, p4y74P_, 0.9019, 1.76, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
1806, p4y74B_, 0.9019, 1.76, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
1807, d4qzxR_, 0.9019, 1.51, 0.344, 235, 221, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1808, d4qzwP_, 0.9019, 1.77, 0.308, 244, 224, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1809, d4qzwB_, 0.9019, 1.77, 0.308, 244, 224, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1810, d4qz7R_, 0.9019, 1.51, 0.344, 235, 221, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1811, d4qz7D_, 0.9019, 1.51, 0.344, 235, 221, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1812, d4qwxB_, 0.9019, 1.76, 0.308, 244, 224, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1813, p4qwsR_, 0.9019, 1.51, 0.344, 235, 221, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
1814, d4qwrR_, 0.9019, 1.51, 0.344, 235, 221, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
1815, d4qwlR_, 0.9019, 1.51, 0.344, 235, 221, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
1816, d4qwlD_, 0.9019, 1.51, 0.344, 235, 221, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
1817, d4qwjT_, 0.9019, 2.26, 0.293, 243, 229, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
1818, d4qwjF_, 0.9019, 2.26, 0.293, 243, 229, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
1819, d4qw4P_, 0.9019, 1.77, 0.308, 244, 224, YCP IN COMPLEX WITH CARFILZOMIB
1820, d4qw4B_, 0.9019, 1.77, 0.308, 244, 224, YCP IN COMPLEX WITH CARFILZOMIB
1821, d4qltR_, 0.9019, 1.51, 0.344, 235, 221, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
1822, d4qltD_, 0.9019, 1.51, 0.344, 235, 221, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
1823, d4qlqR_, 0.9019, 1.50, 0.344, 235, 221, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
1824, d4qlqD_, 0.9019, 1.50, 0.344, 235, 221, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
1825, d4q1sR_, 0.9019, 1.72, 0.341, 242, 223, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
1826, d4nnwP_, 0.9019, 1.76, 0.308, 244, 224, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
1827, d4nnwB_, 0.9019, 1.76, 0.308, 244, 224, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
1828, d4jsqR_, 0.9019, 1.69, 0.341, 242, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
1829, d3shjR_, 0.9019, 1.69, 0.341, 242, 223, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
1830, d3shjB_, 0.9019, 1.75, 0.308, 244, 224, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
1831, d3nzwR_, 0.9019, 1.69, 0.341, 242, 223, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
1832, d3nzjP_, 0.9019, 1.75, 0.308, 244, 224, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
1833, d3nzjB_, 0.9019, 1.75, 0.308, 244, 224, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
1834, d3jseE_, 0.9019, 1.67, 0.335, 227, 224, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
1835, d3jrmG_, 0.9019, 1.67, 0.335, 227, 224, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
1836, p3jcoJA_, 0.9019, 2.01, 0.219, 243, 228, 
1837, d2zcyD_, 0.9019, 1.68, 0.341, 242, 223, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
1838, d2gplR_, 0.9019, 1.68, 0.341, 242, 223, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
1839, d5jhrB_, 0.9018, 1.76, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
1840, d5fggR_, 0.9018, 1.51, 0.344, 235, 221, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1841, d5fggD_, 0.9018, 1.51, 0.344, 235, 221, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1842, d5cz8P_, 0.9018, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
1843, d5cz8B_, 0.9018, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
1844, p5cgiP_, 0.9018, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
1845, p5cgiB_, 0.9018, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
1846, p5cggR_, 0.9018, 1.51, 0.344, 235, 221, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
1847, p5cggD_, 0.9018, 1.51, 0.344, 235, 221, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
1848, p4y8sR_, 0.9018, 1.51, 0.344, 235, 221, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
1849, p4y8sD_, 0.9018, 1.51, 0.344, 235, 221, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
1850, p4y8hR_, 0.9018, 1.51, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
1851, p4y8hD_, 0.9018, 1.51, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
1852, p4y8gD_, 0.9018, 1.51, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
1853, p4y80D_, 0.9018, 1.51, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
1854, p4y7xR_, 0.9018, 1.51, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
1855, p4y7xD_, 0.9018, 1.51, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
1856, p4y78R_, 0.9018, 1.51, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
1857, p4y75P_, 0.9018, 1.76, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
1858, p4y75B_, 0.9018, 1.76, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
1859, p4qz0R_, 0.9018, 1.51, 0.344, 235, 221, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1860, d4qz0P_, 0.9018, 1.77, 0.308, 244, 224, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1861, p4qz0D_, 0.9018, 1.51, 0.344, 235, 221, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1862, d4qxjP_, 0.9018, 1.77, 0.308, 244, 224, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1863, d4qxjB_, 0.9018, 1.77, 0.308, 244, 224, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1864, d4qlvR_, 0.9018, 1.51, 0.344, 235, 221, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
1865, d4qlvD_, 0.9018, 1.51, 0.344, 235, 221, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
1866, d4qlsD_, 0.9018, 1.51, 0.344, 235, 221, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
1867, d4ltcD_, 0.9018, 1.72, 0.341, 242, 223, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
1868, d4intR_, 0.9018, 1.69, 0.341, 242, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
1869, d3tddP_, 0.9018, 1.75, 0.308, 244, 224, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
1870, d3nzwP_, 0.9018, 1.75, 0.308, 244, 224, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
1871, d3mg0R_, 0.9018, 1.70, 0.341, 242, 223, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
1872, d3hyeR_, 0.9018, 1.69, 0.341, 242, 223, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
1873, d3dy4P_, 0.9018, 1.76, 0.308, 244, 224, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
1874, d3dy4B_, 0.9018, 1.76, 0.308, 244, 224, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
1875, d2zcyR_, 0.9018, 1.68, 0.341, 242, 223, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
1876, d1rypE_, 0.9018, 1.69, 0.341, 242, 223, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
1877, d1rypC_, 0.9018, 1.75, 0.308, 244, 224, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
1878, d5l69P_, 0.9017, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1879, d5l69B_, 0.9017, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1880, d5fgaP_, 0.9017, 1.76, 0.308, 244, 224, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
1881, d5fgaB_, 0.9017, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
1882, p5cgiR_, 0.9017, 1.51, 0.344, 235, 221, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
1883, p5cgiD_, 0.9017, 1.51, 0.344, 235, 221, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
1884, p4ya9D_, 0.9017, 1.51, 0.344, 235, 221, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
1885, p4y9zR_, 0.9017, 1.51, 0.344, 235, 221, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
1886, p4y9zD_, 0.9017, 1.51, 0.344, 235, 221, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
1887, p4y8qR_, 0.9017, 1.51, 0.344, 235, 221, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
1888, p4y8qD_, 0.9017, 1.51, 0.344, 235, 221, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
1889, p4y8lP_, 0.9017, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
1890, p4y8lB_, 0.9017, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
1891, p4y8gR_, 0.9017, 1.51, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
1892, p4y80R_, 0.9017, 1.51, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
1893, p4y80P_, 0.9017, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
1894, p4y80B_, 0.9017, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
1895, d4r18D_, 0.9017, 1.52, 0.344, 235, 221, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1896, p4qz1R_, 0.9017, 1.51, 0.344, 235, 221, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1897, p4qz1D_, 0.9017, 1.51, 0.344, 235, 221, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1898, d4qz0B_, 0.9017, 1.77, 0.308, 244, 224, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1899, d4qw7P_, 0.9017, 1.77, 0.308, 244, 224, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
1900, d4qw7B_, 0.9017, 1.77, 0.308, 244, 224, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
1901, d4qw3U_, 0.9017, 1.98, 0.219, 241, 228, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
1902, d4qw3G_, 0.9017, 1.98, 0.219, 241, 228, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
1903, d4qlsR_, 0.9017, 1.51, 0.344, 235, 221, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
1904, d4nnwR_, 0.9017, 1.51, 0.344, 235, 221, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
1905, d4nnwD_, 0.9017, 1.50, 0.344, 235, 221, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
1906, d3un8D_, 0.9017, 1.69, 0.341, 242, 223, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
1907, d3tddB_, 0.9017, 1.75, 0.308, 244, 224, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
1908, d3nzwB_, 0.9017, 1.75, 0.308, 244, 224, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
1909, d3gpwD_, 0.9017, 1.69, 0.341, 242, 223, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
1910, d1g65B_, 0.9017, 1.76, 0.308, 244, 224, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
1911, d5laiP_, 0.9016, 1.77, 0.308, 244, 224, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1912, d5laiB_, 0.9016, 1.77, 0.308, 244, 224, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1913, d5l5iP_, 0.9016, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
1914, d5l5iB_, 0.9016, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
1915, d5l52R_, 0.9016, 1.51, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1916, d5l52D_, 0.9016, 1.51, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1917, d5jhrR_, 0.9016, 1.51, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
1918, d5jhrD_, 0.9016, 1.51, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
1919, p5dsvA_, 0.9016, 2.13, 0.265, 244, 226, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
1920, d5dkjR_, 0.9016, 1.52, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
1921, d5dkjD_, 0.9016, 1.52, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
1922, d5d0tD_, 0.9016, 1.52, 0.344, 235, 221, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
1923, d5bouP_, 0.9016, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
1924, d5bouB_, 0.9016, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
1925, p4ya9R_, 0.9016, 1.51, 0.344, 235, 221, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
1926, p4y8pR_, 0.9016, 1.51, 0.344, 235, 221, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
1927, p4y8pD_, 0.9016, 1.51, 0.344, 235, 221, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
1928, p4y7xP_, 0.9016, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
1929, p4y7xB_, 0.9016, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
1930, p4y69P_, 0.9016, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
1931, p4y69B_, 0.9016, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
1932, d4r18R_, 0.9016, 1.52, 0.344, 235, 221, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1933, d4qz1P_, 0.9016, 1.77, 0.308, 244, 224, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1934, d4qz1B_, 0.9016, 1.77, 0.308, 244, 224, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1935, p4qwuD_, 0.9016, 1.52, 0.344, 235, 221, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
1936, d4qw0P_, 0.9016, 1.77, 0.308, 244, 224, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
1937, d4qw0B_, 0.9016, 1.77, 0.308, 244, 224, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
1938, p4q1sB_, 0.9016, 1.76, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
1939, d4no9P_, 0.9016, 1.77, 0.308, 244, 224, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
1940, d4no9B_, 0.9016, 1.77, 0.308, 244, 224, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
1941, d3mg0D_, 0.9016, 1.70, 0.341, 242, 223, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
1942, d3jrmB_, 0.9016, 1.68, 0.335, 227, 224, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
1943, d3gpwR_, 0.9016, 1.69, 0.341, 242, 223, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
1944, d5l69U_, 0.9015, 1.97, 0.219, 241, 228, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1945, d5l69G_, 0.9015, 1.97, 0.219, 241, 228, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1946, d5l65P_, 0.9015, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1947, d5l65B_, 0.9015, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1948, d5l60P_, 0.9015, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1949, d5l60B_, 0.9015, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1950, d5jhsP_, 0.9015, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
1951, d5jhsB_, 0.9015, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
1952, p5dsvL_, 0.9015, 2.14, 0.265, 245, 226, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
1953, d5dkiU_, 0.9015, 1.98, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
1954, d5dkiP_, 0.9015, 1.78, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
1955, d5dkiG_, 0.9015, 1.98, 0.219, 241, 228, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
1956, d5dkiB_, 0.9015, 1.78, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
1957, d5d0tR_, 0.9015, 1.52, 0.344, 235, 221, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
1958, d5cz6P_, 0.9015, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
1959, p5cghP_, 0.9015, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
1960, p5cghB_, 0.9015, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
1961, d5bxlP_, 0.9015, 1.76, 0.308, 244, 224, YEAST 20S PROTEASOME BETA2-G170A MUTANT
1962, d5bxlB_, 0.9015, 1.76, 0.308, 244, 224, YEAST 20S PROTEASOME BETA2-G170A MUTANT
1963, p4ya7R_, 0.9015, 1.52, 0.344, 235, 221, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
1964, p4ya7D_, 0.9015, 1.52, 0.344, 235, 221, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
1965, d4y9yP_, 0.9015, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME BETA2-H116E MUTANT
1966, p4y8kR_, 0.9015, 1.51, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
1967, p4y8kD_, 0.9015, 1.51, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
1968, p4y7wR_, 0.9015, 1.52, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
1969, p4y7wD_, 0.9015, 1.52, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
1970, p4y78P_, 0.9015, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
1971, p4y78B_, 0.9015, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
1972, p4y77P_, 0.9015, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
1973, p4y77B_, 0.9015, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
1974, p4y70R_, 0.9015, 1.52, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
1975, p4y70D_, 0.9015, 1.52, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
1976, d4rurP_, 0.9015, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
1977, d4rurB_, 0.9015, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
1978, d4r17P_, 0.9015, 1.76, 0.308, 244, 224, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1979, d4r17B_, 0.9015, 1.76, 0.308, 244, 224, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1980, d4r02R_, 0.9015, 1.52, 0.344, 235, 221, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
1981, d4qzzP_, 0.9015, 1.77, 0.308, 244, 224, YCP IN COMPLEX WITH OMURALIDE
1982, d4qzzB_, 0.9015, 1.77, 0.308, 244, 224, YCP IN COMPLEX WITH OMURALIDE
1983, p4qz4R_, 0.9015, 1.52, 0.344, 235, 221, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1984, p4qz4D_, 0.9015, 1.52, 0.344, 235, 221, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1985, p4qwuR_, 0.9015, 1.52, 0.344, 235, 221, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
1986, d4qwkP_, 0.9015, 1.77, 0.308, 244, 224, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1987, d4qw5P_, 0.9015, 1.77, 0.308, 244, 224, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
1988, d4qw5B_, 0.9015, 1.77, 0.308, 244, 224, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
1989, d4qvyP_, 0.9015, 1.77, 0.308, 244, 224, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
1990, d4qvyB_, 0.9015, 1.77, 0.308, 244, 224, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
1991, d4qvwP_, 0.9015, 1.77, 0.308, 244, 224, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
1992, d4qvwB_, 0.9015, 1.77, 0.308, 244, 224, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
1993, d4qvqD_, 0.9015, 1.52, 0.344, 235, 221, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
1994, d4qvpR_, 0.9015, 1.52, 0.344, 235, 221, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
1995, d4qvpD_, 0.9015, 1.52, 0.344, 235, 221, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
1996, d4qv0P_, 0.9015, 1.76, 0.308, 244, 224, YCP BETA5-A49T-A50V-DOUBLE MUTANT
1997, d4qv0B_, 0.9015, 1.76, 0.308, 244, 224, YCP BETA5-A49T-A50V-DOUBLE MUTANT
1998, d4quyP_, 0.9015, 1.76, 0.308, 244, 224, YCP BETA5-A49S-MUTANT
1999, d4qluP_, 0.9015, 1.76, 0.308, 244, 224, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
2000, d4qluD_, 0.9015, 1.51, 0.344, 235, 221, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
2001, p4qluB_, 0.9015, 1.76, 0.308, 244, 224, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
2002, d4nnnR_, 0.9015, 1.52, 0.344, 235, 221, YCP IN COMPLEX WITH MG132
2003, d4nnnD_, 0.9015, 1.52, 0.344, 235, 221, YCP IN COMPLEX WITH MG132
2004, d4fzcD_, 0.9015, 1.69, 0.341, 242, 223, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
2005, d3wxrC_, 0.9015, 1.75, 0.308, 242, 224, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
2006, d3un8B_, 0.9015, 1.75, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
2007, d3tddD_, 0.9015, 1.69, 0.341, 242, 223, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
2008, d3mg0B_, 0.9015, 1.76, 0.308, 244, 224, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
2009, d3jrmD_, 0.9015, 1.68, 0.335, 227, 224, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
2010, d3jrmC_, 0.9015, 1.68, 0.335, 227, 224, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
2011, d3jrmA_, 0.9015, 1.68, 0.335, 227, 224, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
2012, d3dy3D_, 0.9015, 1.69, 0.341, 242, 223, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
2013, d2fakP_, 0.9015, 1.76, 0.308, 244, 224, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
2014, d2fakB_, 0.9015, 1.76, 0.308, 244, 224, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
2015, p5nifS_, 0.9014, 1.73, 0.341, 236, 223, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2016, d5l68P_, 0.9014, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2017, d5l68B_, 0.9014, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2018, d5l5sP_, 0.9014, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
2019, d5l5sB_, 0.9014, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
2020, d5l5jP_, 0.9014, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2021, d5l5jB_, 0.9014, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2022, d5l52P_, 0.9014, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2023, d5l52B_, 0.9014, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2024, d5fgfP_, 0.9014, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
2025, d5fgfB_, 0.9014, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
2026, d5fgdP_, 0.9014, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2027, d5fgdB_, 0.9014, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2028, d5fgaD_, 0.9014, 1.52, 0.344, 235, 221, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
2029, p5dsvI_, 0.9014, 2.14, 0.265, 244, 226, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2030, p5dsvE_, 0.9014, 2.14, 0.265, 245, 226, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2031, d5dkiD_, 0.9014, 1.53, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
2032, d5cz6B_, 0.9014, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
2033, d5cgfP_, 0.9014, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME BETA5-G48C MUTANT
2034, d5cgfD_, 0.9014, 1.52, 0.344, 235, 221, YEAST 20S PROTEASOME BETA5-G48C MUTANT
2035, d5cgfB_, 0.9014, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME BETA5-G48C MUTANT
2036, d4ya4P_, 0.9014, 1.76, 0.308, 244, 224, YEAST 20S PROTEASOME BETA2-H114D MUTANT
2037, p4ya0P_, 0.9014, 1.78, 0.308, 244, 224, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
2038, p4ya0B_, 0.9014, 1.78, 0.308, 244, 224, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
2039, d4y9yB_, 0.9014, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME BETA2-H116E MUTANT
2040, p4y82D_, 0.9014, 1.52, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
2041, p4y81P_, 0.9014, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
2042, p4y81B_, 0.9014, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
2043, p4y6vP_, 0.9014, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
2044, p4y6vB_, 0.9014, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
2045, p4v7oU_, 0.9014, 2.28, 0.288, 244, 229, 
2046, p4v7oG_, 0.9014, 2.28, 0.288, 244, 229, 
2047, d4qwkB_, 0.9014, 1.77, 0.308, 244, 224, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2048, d4qwiP_, 0.9014, 1.77, 0.308, 244, 224, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
2049, d4qwiB_, 0.9014, 1.77, 0.308, 244, 224, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
2050, d4qwgU_, 0.9014, 1.97, 0.219, 241, 228, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
2051, d4qwgG_, 0.9014, 1.97, 0.219, 241, 228, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
2052, d4qw1P_, 0.9014, 1.77, 0.308, 244, 224, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
2053, d4qw1B_, 0.9014, 1.77, 0.308, 244, 224, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
2054, d4qvqR_, 0.9014, 1.52, 0.344, 235, 221, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
2055, d4quyB_, 0.9014, 1.76, 0.308, 244, 224, YCP BETA5-A49S-MUTANT
2056, d4quxP_, 0.9014, 1.77, 0.308, 244, 224, YCP BETA5-A49T-MUTANT
2057, d4qluR_, 0.9014, 1.51, 0.344, 235, 221, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
2058, d4no9R_, 0.9014, 1.52, 0.344, 235, 221, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
2059, d4no9D_, 0.9014, 1.52, 0.344, 235, 221, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
2060, d4inrD_, 0.9014, 1.69, 0.341, 242, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
2061, d4hnpR_, 0.9014, 1.70, 0.341, 242, 223, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
2062, d4hnpD_, 0.9014, 1.71, 0.341, 242, 223, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
2063, d3un8R_, 0.9014, 1.69, 0.341, 242, 223, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
2064, d3l5qX_, 0.9014, 2.28, 0.288, 244, 229,  
2065, d3l5qL_, 0.9014, 2.28, 0.288, 244, 229,  
2066, d3jrmF_, 0.9014, 1.68, 0.335, 227, 224, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
2067, p3jcpPA_, 0.9014, 2.22, 0.293, 244, 229, 
2068, d3dy3R_, 0.9014, 1.69, 0.341, 242, 223, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
2069, d1g65P_, 0.9014, 1.76, 0.308, 244, 224, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
2070, d5l5zP_, 0.9013, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2071, d5l5zB_, 0.9013, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2072, d5l5yP_, 0.9013, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2073, d5l5yB_, 0.9013, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2074, d5l5xP_, 0.9013, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2075, d5l5xB_, 0.9013, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2076, d5l5wP_, 0.9013, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2077, d5l5wB_, 0.9013, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2078, d5l5tP_, 0.9013, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2079, d5l5tB_, 0.9013, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2080, d5l5eP_, 0.9013, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2081, d5l5eB_, 0.9013, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2082, d5l55R_, 0.9013, 1.52, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2083, d5l55D_, 0.9013, 1.52, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2084, d5fgaR_, 0.9013, 1.53, 0.344, 235, 221, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
2085, d5fg7R_, 0.9013, 1.52, 0.348, 235, 221, YEAST 20S PROTEASOME BETA2-T1A MUTANT
2086, p5dsvF_, 0.9013, 2.14, 0.265, 244, 226, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2087, d5dkjP_, 0.9013, 1.78, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
2088, d5dkiR_, 0.9013, 1.53, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
2089, d5d0xR_, 0.9013, 1.53, 0.344, 235, 221, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
2090, d5d0xD_, 0.9013, 1.53, 0.344, 235, 221, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
2091, d5cz7R_, 0.9013, 1.53, 0.344, 235, 221, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
2092, d5cz7D_, 0.9013, 1.52, 0.344, 235, 221, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
2093, p5cggP_, 0.9013, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
2094, d5cgfR_, 0.9013, 1.52, 0.344, 235, 221, YEAST 20S PROTEASOME BETA5-G48C MUTANT
2095, p4zzgS_, 0.9013, 1.73, 0.341, 236, 223, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2096, d4z1lP_, 0.9013, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
2097, d4z1lB_, 0.9013, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
2098, d4ya4B_, 0.9013, 1.76, 0.308, 244, 224, YEAST 20S PROTEASOME BETA2-H114D MUTANT
2099, p4ya2R_, 0.9013, 1.52, 0.344, 235, 221, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
2100, p4ya2D_, 0.9013, 1.52, 0.344, 235, 221, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
2101, p4y8uP_, 0.9013, 1.78, 0.308, 244, 224, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
2102, p4y8uB_, 0.9013, 1.78, 0.308, 244, 224, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
2103, d4y8rP_, 0.9013, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME BETA2-H116D MUTANT
2104, p4y8oR_, 0.9013, 1.52, 0.344, 235, 221, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
2105, p4y8oD_, 0.9013, 1.52, 0.344, 235, 221, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
2106, p4y8nP_, 0.9013, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
2107, p4y82R_, 0.9013, 1.52, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
2108, p4y81R_, 0.9013, 1.52, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
2109, p4y81D_, 0.9013, 1.52, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
2110, p4y77R_, 0.9013, 1.52, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
2111, p4y77D_, 0.9013, 1.52, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
2112, p4x6zC_, 0.9013, 1.76, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
2113, p4v7oOA_, 0.9013, 2.28, 0.288, 244, 229, 
2114, p4v7oCB_, 0.9013, 2.28, 0.288, 244, 229, 
2115, d4r02B_, 0.9013, 1.77, 0.308, 244, 224, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
2116, d4qzxP_, 0.9013, 1.78, 0.308, 244, 224, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2117, d4qzxB_, 0.9013, 1.78, 0.308, 244, 224, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2118, d4qwxR_, 0.9013, 1.52, 0.344, 235, 221, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2119, d4qwxD_, 0.9013, 1.52, 0.344, 235, 221, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2120, d4qwjP_, 0.9013, 1.78, 0.308, 244, 224, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
2121, d4qvvR_, 0.9013, 1.53, 0.344, 235, 221, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
2122, d4qvvD_, 0.9013, 1.53, 0.344, 235, 221, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
2123, d4qv8P_, 0.9013, 1.77, 0.308, 244, 224, YCP BETA5-C52F MUTANT
2124, d4qv8B_, 0.9013, 1.77, 0.308, 244, 224, YCP BETA5-C52F MUTANT
2125, d4quxB_, 0.9013, 1.77, 0.308, 244, 224, YCP BETA5-A49T-MUTANT
2126, p4qbyP_, 0.9013, 1.77, 0.308, 244, 224, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
2127, d4fzcR_, 0.9013, 1.69, 0.341, 242, 223, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
2128, d4eu2Q_, 0.9013, 1.76, 0.308, 244, 224, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
2129, d3tddR_, 0.9013, 1.69, 0.341, 242, 223, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
2130, d3gpwP_, 0.9013, 1.76, 0.308, 244, 224, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
2131, d3dy4D_, 0.9013, 1.70, 0.341, 242, 223, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
2132, d3d29B_, 0.9013, 1.76, 0.308, 244, 224, PROTEASOME INHIBITION BY FELLUTAMIDE B
2133, d2f16P_, 0.9013, 1.76, 0.308, 244, 224, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
2134, d2f16B_, 0.9013, 1.76, 0.308, 244, 224, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
2135, d1vsyU_, 0.9013, 2.28, 0.288, 244, 229,  
2136, d1vsyG_, 0.9013, 2.28, 0.288, 244, 229,  
2137, d1rypS_, 0.9013, 1.70, 0.341, 242, 223, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
2138, p6gopD_, 0.9012, 1.53, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
2139, d5l64P_, 0.9012, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2140, d5l63P_, 0.9012, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2141, d5l63B_, 0.9012, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2142, d5l62P_, 0.9012, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2143, d5l62B_, 0.9012, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2144, d5l61P_, 0.9012, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2145, d5l61B_, 0.9012, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2146, d5l5dP_, 0.9012, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2147, d5l5dB_, 0.9012, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2148, d5fggP_, 0.9012, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2149, d5fggB_, 0.9012, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2150, d5fgeP_, 0.9012, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2151, d5fgeB_, 0.9012, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2152, d5fg9P_, 0.9012, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
2153, d5fg9B_, 0.9012, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
2154, p5dsvN_, 0.9012, 2.14, 0.265, 244, 226, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2155, d5dkjB_, 0.9012, 1.78, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
2156, p5cggB_, 0.9012, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
2157, d4z1lD_, 0.9012, 1.53, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
2158, p4ya5P_, 0.9012, 1.78, 0.308, 244, 224, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
2159, p4ya5B_, 0.9012, 1.78, 0.308, 244, 224, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
2160, d4y8rB_, 0.9012, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME BETA2-H116D MUTANT
2161, p4y8qP_, 0.9012, 1.78, 0.308, 244, 224, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
2162, p4y8qB_, 0.9012, 1.78, 0.308, 244, 224, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
2163, p4y8nB_, 0.9012, 1.78, 0.308, 244, 224, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
2164, p4y8kP_, 0.9012, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
2165, p4y8kB_, 0.9012, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
2166, p4y6zP_, 0.9012, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
2167, p4y6zB_, 0.9012, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
2168, d4r00D_, 0.9012, 1.52, 0.344, 235, 221, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
2169, d4qzzR_, 0.9012, 1.53, 0.344, 235, 221, YCP IN COMPLEX WITH OMURALIDE
2170, d4qzzD_, 0.9012, 1.53, 0.344, 235, 221, YCP IN COMPLEX WITH OMURALIDE
2171, d4qwjB_, 0.9012, 1.78, 0.308, 244, 224, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
2172, d4qw1D_, 0.9012, 1.53, 0.344, 235, 221, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
2173, d4qw0R_, 0.9012, 1.53, 0.344, 235, 221, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
2174, d4qw0D_, 0.9012, 1.53, 0.344, 235, 221, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
2175, d4qvqP_, 0.9012, 1.78, 0.308, 244, 224, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
2176, d4qvqB_, 0.9012, 1.78, 0.308, 244, 224, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
2177, d4qvmR_, 0.9012, 1.53, 0.344, 235, 221, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
2178, d4qvmD_, 0.9012, 1.53, 0.344, 235, 221, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
2179, d4qvlP_, 0.9012, 1.77, 0.308, 244, 224, YCP IN COMPLEX WITH BORTEZOMIB
2180, p4qbyB_, 0.9012, 1.77, 0.308, 244, 224, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
2181, d4no6P_, 0.9012, 1.76, 0.308, 244, 224, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
2182, d4no6B_, 0.9012, 1.76, 0.308, 244, 224, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
2183, d4no1R_, 0.9012, 1.52, 0.344, 235, 221, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
2184, d4no1D_, 0.9012, 1.52, 0.344, 235, 221, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
2185, d4ltcR_, 0.9012, 1.72, 0.341, 242, 223, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
2186, d4hrcP_, 0.9012, 1.76, 0.308, 244, 224, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
2187, d3gpwB_, 0.9012, 1.76, 0.308, 244, 224, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
2188, d3dy4R_, 0.9012, 1.70, 0.341, 242, 223, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
2189, d3d29P_, 0.9012, 1.76, 0.308, 244, 224, PROTEASOME INHIBITION BY FELLUTAMIDE B
2190, d2zcyP_, 0.9012, 1.76, 0.308, 244, 224, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
2191, d2zcyB_, 0.9012, 1.76, 0.308, 244, 224, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
2192, d1g0uU_, 0.9012, 1.84, 0.221, 240, 226, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
2193, p6gopR_, 0.9011, 1.53, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
2194, d5l6bP_, 0.9011, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2195, d5l6bB_, 0.9011, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2196, d5l64B_, 0.9011, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2197, d5l5uP_, 0.9011, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2198, d5l5uB_, 0.9011, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2199, d5l5pP_, 0.9011, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2200, d5l5pB_, 0.9011, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2201, d5l5hP_, 0.9011, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2202, d5l5hB_, 0.9011, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2203, d5l55P_, 0.9011, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2204, d5l55B_, 0.9011, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2205, d5fhsP_, 0.9011, 1.78, 0.308, 244, 224, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
2206, p5fghR_, 0.9011, 1.53, 0.344, 235, 221, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
2207, p5fghD_, 0.9011, 1.53, 0.344, 235, 221, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
2208, d5czaP_, 0.9011, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME BETA5-D166N MUTANT
2209, d5czaB_, 0.9011, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME BETA5-D166N MUTANT
2210, d5cz9P_, 0.9011, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
2211, d5cz9B_, 0.9011, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
2212, d5bxlD_, 0.9011, 1.53, 0.344, 235, 221, YEAST 20S PROTEASOME BETA2-G170A MUTANT
2213, d5ahjR_, 0.9011, 1.52, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
2214, d5ahjD_, 0.9011, 1.52, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
2215, d4z1lR_, 0.9011, 1.53, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
2216, p4y82P_, 0.9011, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
2217, p4y82B_, 0.9011, 1.78, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
2218, p4y74R_, 0.9011, 1.52, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
2219, p4y74D_, 0.9011, 1.52, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
2220, d4r17R_, 0.9011, 1.53, 0.344, 235, 221, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
2221, d4r17D_, 0.9011, 1.53, 0.344, 235, 221, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
2222, d4r00R_, 0.9011, 1.53, 0.344, 235, 221, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
2223, d4qwrP_, 0.9011, 1.78, 0.308, 244, 224, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
2224, d4qwrB_, 0.9011, 1.78, 0.308, 244, 224, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
2225, d4qwlP_, 0.9011, 1.77, 0.308, 244, 224, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
2226, d4qwlB_, 0.9011, 1.77, 0.308, 244, 224, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
2227, d4qw1R_, 0.9011, 1.53, 0.344, 235, 221, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
2228, d4qvyR_, 0.9011, 1.53, 0.344, 235, 221, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
2229, d4qvyD_, 0.9011, 1.53, 0.344, 235, 221, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
2230, p4qvwD_, 0.9011, 1.53, 0.344, 235, 221, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
2231, d4qvvP_, 0.9011, 1.78, 0.308, 244, 224, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
2232, d4qvnP_, 0.9011, 1.77, 0.308, 244, 224, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
2233, d4qvnB_, 0.9011, 1.77, 0.308, 244, 224, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
2234, d4qvmP_, 0.9011, 1.78, 0.308, 244, 224, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
2235, d4qvmB_, 0.9011, 1.78, 0.308, 244, 224, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
2236, d4qvlD_, 0.9011, 1.53, 0.344, 235, 221, YCP IN COMPLEX WITH BORTEZOMIB
2237, d4qvlB_, 0.9011, 1.77, 0.308, 244, 224, YCP IN COMPLEX WITH BORTEZOMIB
2238, d4qv9P_, 0.9011, 1.77, 0.308, 244, 224, YCP BETA5-C63F MUTANT
2239, d4qv8D_, 0.9011, 1.53, 0.344, 235, 221, YCP BETA5-C52F MUTANT
2240, d4qv1P_, 0.9011, 1.77, 0.308, 244, 224, YCP BETA5-M45A MUTANT
2241, d4qv1B_, 0.9011, 1.77, 0.308, 244, 224, YCP BETA5-M45A MUTANT
2242, d4no8P_, 0.9011, 1.77, 0.308, 244, 224, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
2243, d4no8B_, 0.9011, 1.77, 0.308, 244, 224, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
2244, d4inuP_, 0.9011, 1.76, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
2245, d4hnpP_, 0.9011, 1.76, 0.308, 244, 224, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
2246, p3un4P_, 0.9011, 1.76, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
2247, p3un4B_, 0.9011, 1.76, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
2248, d3sdiT_, 0.9011, 2.22, 0.294, 242, 228, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
2249, d3nzxP_, 0.9011, 1.76, 0.308, 244, 224, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
2250, d3nzxD_, 0.9011, 1.69, 0.341, 242, 223, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
2251, d3nzxB_, 0.9011, 1.76, 0.308, 244, 224, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
2252, d3jrmE_, 0.9011, 1.68, 0.335, 227, 224, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
2253, d3d29R_, 0.9011, 1.69, 0.341, 242, 223, PROTEASOME INHIBITION BY FELLUTAMIDE B
2254, d3d29D_, 0.9011, 1.69, 0.341, 242, 223, PROTEASOME INHIBITION BY FELLUTAMIDE B
2255, d5lttP_, 0.9010, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
2256, d5lttB_, 0.9010, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
2257, d5l6cP_, 0.9010, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2258, d5l6cB_, 0.9010, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2259, d5l67P_, 0.9010, 1.78, 0.308, 244, 224, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2260, d5l67B_, 0.9010, 1.78, 0.308, 244, 224, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2261, d5l5qP_, 0.9010, 1.78, 0.308, 244, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
2262, d5l5qB_, 0.9010, 1.78, 0.308, 244, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
2263, d5l5aP_, 0.9010, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
2264, d5l5aB_, 0.9010, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
2265, d5fhsB_, 0.9010, 1.78, 0.308, 244, 224, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
2266, d5fgiP_, 0.9010, 1.78, 0.308, 244, 224, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2267, d5fgiB_, 0.9010, 1.78, 0.308, 244, 224, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2268, p5fghP_, 0.9010, 1.78, 0.308, 244, 224, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
2269, p5fghB_, 0.9010, 1.78, 0.308, 244, 224, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
2270, d5fg9R_, 0.9010, 1.53, 0.344, 235, 221, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
2271, d5fg9D_, 0.9010, 1.53, 0.344, 235, 221, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
2272, d5fg7P_, 0.9010, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME BETA2-T1A MUTANT
2273, d5fg7D_, 0.9010, 1.53, 0.344, 235, 221, YEAST 20S PROTEASOME BETA2-T1A MUTANT
2274, d5fg7B_, 0.9010, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME BETA2-T1A MUTANT
2275, p5dsvD_, 0.9010, 2.14, 0.265, 244, 226, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2276, p5dsvB_, 0.9010, 2.14, 0.265, 245, 226, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2277, d5d0zP_, 0.9010, 1.78, 0.308, 244, 224, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
2278, d5d0zB_, 0.9010, 1.78, 0.308, 244, 224, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
2279, d5d0xP_, 0.9010, 1.78, 0.308, 244, 224, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
2280, d5d0xB_, 0.9010, 1.78, 0.308, 244, 224, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
2281, d5d0wP_, 0.9010, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME BETA5-T1S MUTANT
2282, d5d0wB_, 0.9010, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME BETA5-T1S MUTANT
2283, d5czaD_, 0.9010, 1.53, 0.344, 235, 221, YEAST 20S PROTEASOME BETA5-D166N MUTANT
2284, d5cz5P_, 0.9010, 1.78, 0.308, 244, 224, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
2285, d5cz5B_, 0.9010, 1.78, 0.308, 244, 224, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
2286, d5cz4P_, 0.9010, 1.78, 0.308, 244, 224, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
2287, d5cz4B_, 0.9010, 1.78, 0.308, 244, 224, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
2288, d5bxlR_, 0.9010, 1.53, 0.344, 235, 221, YEAST 20S PROTEASOME BETA2-G170A MUTANT
2289, p4ya3P_, 0.9010, 1.78, 0.308, 244, 224, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
2290, p4ya3B_, 0.9010, 1.78, 0.308, 244, 224, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
2291, d4y9yD_, 0.9010, 1.53, 0.344, 235, 221, YEAST 20S PROTEASOME BETA2-H116E MUTANT
2292, p4y8uR_, 0.9010, 1.53, 0.344, 235, 221, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
2293, p4y8uD_, 0.9010, 1.53, 0.344, 235, 221, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
2294, d4y8rR_, 0.9010, 1.53, 0.344, 235, 221, YEAST 20S PROTEASOME BETA2-H116D MUTANT
2295, d4y8rD_, 0.9010, 1.53, 0.344, 235, 221, YEAST 20S PROTEASOME BETA2-H116D MUTANT
2296, p4y6zR_, 0.9010, 1.52, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
2297, p4y6zD_, 0.9010, 1.52, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
2298, p4y6aP_, 0.9010, 1.78, 0.308, 244, 224, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
2299, p4y6aB_, 0.9010, 1.78, 0.308, 244, 224, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
2300, p4qvwR_, 0.9010, 1.53, 0.344, 235, 221, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
2301, d4qvvB_, 0.9010, 1.78, 0.308, 244, 224, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
2302, d4qvpP_, 0.9010, 1.78, 0.308, 244, 224, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
2303, d4qvpB_, 0.9010, 1.78, 0.308, 244, 224, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
2304, d4qvlR_, 0.9010, 1.53, 0.344, 235, 221, YCP IN COMPLEX WITH BORTEZOMIB
2305, d4qv9R_, 0.9010, 1.53, 0.344, 235, 221, YCP BETA5-C63F MUTANT
2306, d4qv9D_, 0.9010, 1.53, 0.344, 235, 221, YCP BETA5-C63F MUTANT
2307, d4qv9B_, 0.9010, 1.77, 0.308, 244, 224, YCP BETA5-C63F MUTANT
2308, d4qv8R_, 0.9010, 1.53, 0.344, 235, 221, YCP BETA5-C52F MUTANT
2309, d4qv7P_, 0.9010, 1.77, 0.308, 244, 224, YCP BETA5-A50V MUTANT
2310, d4qv7D_, 0.9010, 1.53, 0.344, 235, 221, YCP BETA5-A50V MUTANT
2311, d4qv7B_, 0.9010, 1.77, 0.308, 244, 224, YCP BETA5-A50V MUTANT
2312, d4qv6D_, 0.9010, 1.53, 0.344, 235, 221, YCP BETA5-A49V MUTANT
2313, p4qv0D_, 0.9010, 1.53, 0.344, 235, 221, YCP BETA5-A49T-A50V-DOUBLE MUTANT
2314, d4ltcP_, 0.9010, 1.77, 0.308, 244, 224, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
2315, d4inuB_, 0.9010, 1.76, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
2316, d4hrdP_, 0.9010, 1.77, 0.308, 244, 224, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
2317, d3nzxR_, 0.9010, 1.70, 0.341, 242, 223, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
2318, d3mg0P_, 0.9010, 1.77, 0.308, 244, 224, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
2319, d2fakD_, 0.9010, 1.70, 0.341, 242, 223, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
2320, d1jd2G_, 0.9010, 2.00, 0.219, 243, 228, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
2321, d1g65G_, 0.9010, 2.11, 0.227, 243, 229, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
2322, d5m2bP_, 0.9009, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
2323, d5m2bB_, 0.9009, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
2324, d5laiR_, 0.9009, 1.53, 0.344, 235, 221, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
2325, d5laiD_, 0.9009, 1.53, 0.344, 235, 221, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
2326, d5l66P_, 0.9009, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2327, d5l66B_, 0.9009, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2328, d5l5oP_, 0.9009, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2329, d5l5oB_, 0.9009, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2330, d5l5fP_, 0.9009, 1.78, 0.308, 244, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2331, d5l5fB_, 0.9009, 1.78, 0.308, 244, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2332, d5d0tP_, 0.9009, 1.78, 0.308, 244, 224, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
2333, d5czaR_, 0.9009, 1.53, 0.344, 235, 221, YEAST 20S PROTEASOME BETA5-D166N MUTANT
2334, d5cz7P_, 0.9009, 1.78, 0.308, 244, 224, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
2335, d4ya4D_, 0.9009, 1.53, 0.344, 235, 221, YEAST 20S PROTEASOME BETA2-H114D MUTANT
2336, d4ya1P_, 0.9009, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME BETA2-H116N MUTANT
2337, d4ya1B_, 0.9009, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME BETA2-H116N MUTANT
2338, p4ya0R_, 0.9009, 1.53, 0.344, 235, 221, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
2339, p4ya0D_, 0.9009, 1.53, 0.344, 235, 221, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
2340, d4y9yR_, 0.9009, 1.53, 0.344, 235, 221, YEAST 20S PROTEASOME BETA2-H116E MUTANT
2341, d4y8mP_, 0.9009, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
2342, d4y8mB_, 0.9009, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
2343, p4y75R_, 0.9009, 1.52, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
2344, p4y75D_, 0.9009, 1.52, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
2345, p4y69R_, 0.9009, 1.53, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
2346, p4y69D_, 0.9009, 1.53, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
2347, d4r00P_, 0.9009, 1.78, 0.308, 244, 224, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
2348, d4r00B_, 0.9009, 1.78, 0.308, 244, 224, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
2349, d4qwsP_, 0.9009, 1.78, 0.308, 244, 224, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
2350, d4qwsB_, 0.9009, 1.78, 0.308, 244, 224, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
2351, d4qwgR_, 0.9009, 1.52, 0.344, 235, 221, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
2352, d4qwgD_, 0.9009, 1.52, 0.344, 235, 221, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
2353, d4qv7R_, 0.9009, 1.53, 0.344, 235, 221, YCP BETA5-A50V MUTANT
2354, d4qv6R_, 0.9009, 1.53, 0.344, 235, 221, YCP BETA5-A49V MUTANT
2355, d4qv4P_, 0.9009, 1.77, 0.308, 244, 224, YCP BETA5-M45T MUTANT
2356, d4qv4B_, 0.9009, 1.77, 0.308, 244, 224, YCP BETA5-M45T MUTANT
2357, p4qv0R_, 0.9009, 1.53, 0.344, 235, 221, YCP BETA5-A49T-A50V-DOUBLE MUTANT
2358, d4quyD_, 0.9009, 1.53, 0.344, 235, 221, YCP BETA5-A49S-MUTANT
2359, p4qbyD_, 0.9009, 1.53, 0.344, 235, 221, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
2360, d4inrR_, 0.9009, 1.70, 0.341, 242, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
2361, p3jcpP_, 0.9009, 2.22, 0.293, 244, 229, 
2362, d2f16D_, 0.9009, 1.70, 0.341, 242, 223, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
2363, d5l5rP_, 0.9008, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
2364, d5l5rB_, 0.9008, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
2365, p5dsvK_, 0.9008, 2.14, 0.265, 244, 226, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2366, p5dsvG_, 0.9008, 2.14, 0.265, 242, 226, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2367, d5d0tB_, 0.9008, 1.78, 0.308, 244, 224, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
2368, d5d0sP_, 0.9008, 1.78, 0.308, 244, 224, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
2369, d5cz7B_, 0.9008, 1.78, 0.308, 244, 224, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
2370, d5cz4R_, 0.9008, 1.53, 0.344, 235, 221, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
2371, d5cz4D_, 0.9008, 1.53, 0.344, 235, 221, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
2372, d5bouR_, 0.9008, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
2373, d5bouD_, 0.9008, 1.53, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
2374, p4ya5R_, 0.9008, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
2375, p4ya5D_, 0.9008, 1.53, 0.344, 235, 221, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
2376, d4ya4R_, 0.9008, 1.53, 0.344, 235, 221, YEAST 20S PROTEASOME BETA2-H114D MUTANT
2377, p4ya3R_, 0.9008, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
2378, p4ya3D_, 0.9008, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
2379, d4y8mR_, 0.9008, 1.53, 0.344, 235, 221, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
2380, d4y8mD_, 0.9008, 1.53, 0.344, 235, 221, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
2381, p4y6vD_, 0.9008, 1.53, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
2382, d4qw3R_, 0.9008, 1.54, 0.344, 235, 221, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
2383, d4qw3D_, 0.9008, 1.54, 0.344, 235, 221, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
2384, d4qvnR_, 0.9008, 1.53, 0.344, 235, 221, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
2385, d4qvnD_, 0.9008, 1.53, 0.344, 235, 221, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
2386, d4quyR_, 0.9008, 1.53, 0.344, 235, 221, YCP BETA5-A49S-MUTANT
2387, p4quxD_, 0.9008, 1.53, 0.344, 235, 221, YCP BETA5-A49T-MUTANT
2388, p4qbyR_, 0.9008, 1.53, 0.344, 235, 221, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
2389, d4no8R_, 0.9008, 1.53, 0.344, 235, 221, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
2390, d4no8D_, 0.9008, 1.52, 0.344, 235, 221, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
2391, d4jt0P_, 0.9008, 1.76, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
2392, d4jt0B_, 0.9008, 1.76, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
2393, d3mg4D_, 0.9008, 1.74, 0.341, 242, 223, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
2394, d3gptR_, 0.9008, 1.71, 0.341, 242, 223, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
2395, d3gptD_, 0.9008, 1.70, 0.341, 242, 223, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
2396, d2fakR_, 0.9008, 1.70, 0.341, 242, 223, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
2397, d5l6aP_, 0.9007, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2398, d5l6aB_, 0.9007, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2399, d5l5vP_, 0.9007, 1.78, 0.308, 244, 224,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2400, d5l5vB_, 0.9007, 1.78, 0.308, 244, 224,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2401, d5d0sB_, 0.9007, 1.78, 0.308, 244, 224, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
2402, d5cz6R_, 0.9007, 1.53, 0.344, 235, 221, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
2403, d5cz6D_, 0.9007, 1.53, 0.344, 235, 221, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
2404, d5bxnR_, 0.9007, 1.53, 0.344, 235, 221, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
2405, d5bxnD_, 0.9007, 1.53, 0.344, 235, 221, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
2406, d4ya1R_, 0.9007, 1.53, 0.344, 235, 221, YEAST 20S PROTEASOME BETA2-H116N MUTANT
2407, d4ya1D_, 0.9007, 1.53, 0.344, 235, 221, YEAST 20S PROTEASOME BETA2-H116N MUTANT
2408, p4y8tR_, 0.9007, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
2409, p4y8tD_, 0.9007, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
2410, p4y8nR_, 0.9007, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
2411, p4y8nD_, 0.9007, 1.53, 0.344, 235, 221, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
2412, p4y6vR_, 0.9007, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
2413, p4y6aR_, 0.9007, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
2414, p4y6aD_, 0.9007, 1.53, 0.344, 235, 221, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
2415, d4rurR_, 0.9007, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
2416, d4rurD_, 0.9007, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
2417, d4qw3P_, 0.9007, 1.79, 0.308, 244, 224, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
2418, d4qw3B_, 0.9007, 1.79, 0.308, 244, 224, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
2419, d4qv5P_, 0.9007, 1.77, 0.308, 244, 224, YCP BETA5-M45I MUTANT
2420, d4qv5B_, 0.9007, 1.77, 0.308, 244, 224, YCP BETA5-M45I MUTANT
2421, d4qv3P_, 0.9007, 1.77, 0.308, 244, 224, YCP BETA5-M45V MUTANT
2422, p4qv3D_, 0.9007, 1.53, 0.344, 235, 221, YCP BETA5-M45V MUTANT
2423, d4qv1R_, 0.9007, 1.53, 0.344, 235, 221, YCP BETA5-M45A MUTANT
2424, d4qv1D_, 0.9007, 1.53, 0.344, 235, 221, YCP BETA5-M45A MUTANT
2425, p4quxR_, 0.9007, 1.53, 0.344, 235, 221, YCP BETA5-A49T-MUTANT
2426, p4inuD_, 0.9007, 1.70, 0.341, 242, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
2427, d4hrcB_, 0.9007, 1.77, 0.308, 244, 224, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
2428, p3un4R_, 0.9007, 1.70, 0.341, 242, 223, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
2429, p3un4D_, 0.9007, 1.70, 0.341, 242, 223, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
2430, d3okjD_, 0.9007, 1.70, 0.341, 242, 223, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
2431, p3jcpLA_, 0.9007, 1.75, 0.308, 244, 224, 
2432, p3jcpL_, 0.9007, 1.75, 0.308, 244, 224, 
2433, d5l60R_, 0.9006, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2434, d5l60D_, 0.9006, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2435, d5l5bP_, 0.9006, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2436, d5d0wR_, 0.9006, 1.53, 0.344, 235, 221, YEAST 20S PROTEASOME BETA5-T1S MUTANT
2437, d5d0wD_, 0.9006, 1.53, 0.344, 235, 221, YEAST 20S PROTEASOME BETA5-T1S MUTANT
2438, d5bxnP_, 0.9006, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
2439, d5bxnB_, 0.9006, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
2440, d5ahjP_, 0.9006, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
2441, d5ahjB_, 0.9006, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
2442, d4qv4D_, 0.9006, 1.53, 0.344, 235, 221, YCP BETA5-M45T MUTANT
2443, p4qv3R_, 0.9006, 1.53, 0.344, 235, 221, YCP BETA5-M45V MUTANT
2444, d4qv3B_, 0.9006, 1.77, 0.308, 244, 224, YCP BETA5-M45V MUTANT
2445, d4no1P_, 0.9006, 1.77, 0.308, 244, 224, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
2446, d4no1B_, 0.9006, 1.77, 0.308, 244, 224, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
2447, d4hnpB_, 0.9006, 1.78, 0.308, 244, 224, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
2448, d3okjR_, 0.9006, 1.70, 0.341, 242, 223, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
2449, d2f16R_, 0.9006, 1.70, 0.341, 242, 223, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
2450, p5mp9G_, 0.9005, 2.19, 0.289, 243, 228, 26S PROTEASOME IN PRESENCE OF ATP (S1)
2451, d5l62R_, 0.9005, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2452, d5l5bB_, 0.9005, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2453, d4qv4R_, 0.9005, 1.53, 0.344, 235, 221, YCP BETA5-M45T MUTANT
2454, p4fzgR_, 0.9005, 1.71, 0.341, 242, 223, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
2455, p4fzgD_, 0.9005, 1.71, 0.341, 242, 223, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
2456, d3mg4P_, 0.9005, 1.77, 0.308, 244, 224, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
2457, d1g65D_, 0.9005, 1.71, 0.341, 242, 223, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
2458, d5lttR_, 0.9004, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
2459, d5lttD_, 0.9004, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
2460, d5l62D_, 0.9004, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2461, d5l5uR_, 0.9004, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2462, d5l5uD_, 0.9004, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2463, p4no6R_, 0.9004, 1.54, 0.344, 235, 221, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
2464, p4no6D_, 0.9004, 1.54, 0.344, 235, 221, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
2465, d4ltcB_, 0.9004, 1.78, 0.308, 244, 224, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
2466, d4hrdD_, 0.9004, 1.74, 0.341, 242, 223, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
2467, d3sdiG_, 0.9004, 1.86, 0.221, 240, 226, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
2468, d3gpjR_, 0.9004, 1.71, 0.341, 242, 223, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
2469, d3gpjD_, 0.9004, 1.71, 0.341, 242, 223, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
2470, p3e47D_, 0.9004, 1.70, 0.341, 242, 223, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
2471, d3bdmP_, 0.9004, 1.76, 0.308, 244, 224, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
2472, d3bdmB_, 0.9004, 1.77, 0.308, 244, 224, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
2473, p5mp9g_, 0.9003, 2.24, 0.289, 243, 228, 26S PROTEASOME IN PRESENCE OF ATP (S1)
2474, d5l61R_, 0.9003, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2475, d5l61D_, 0.9003, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2476, d5l5zR_, 0.9003, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2477, d5l5zD_, 0.9003, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2478, d5l5xR_, 0.9003, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2479, d5l5sR_, 0.9003, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
2480, d5l5sD_, 0.9003, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
2481, d5l5eR_, 0.9003, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2482, d5l5eD_, 0.9003, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2483, d4qv5R_, 0.9003, 1.54, 0.344, 235, 221, YCP BETA5-M45I MUTANT
2484, d4qv5D_, 0.9003, 1.54, 0.344, 235, 221, YCP BETA5-M45I MUTANT
2485, d4hrdR_, 0.9003, 1.74, 0.341, 242, 223, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
2486, d4hrdB_, 0.9003, 1.78, 0.308, 244, 224, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
2487, d5l65D_, 0.9002, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2488, d5l63R_, 0.9002, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2489, d5l63D_, 0.9002, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2490, d5l5xD_, 0.9002, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2491, d5l5wR_, 0.9002, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2492, d5l5wD_, 0.9002, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2493, d5l5iR_, 0.9002, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
2494, d5l5iD_, 0.9002, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
2495, d5l5fR_, 0.9002, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2496, d5l5fD_, 0.9002, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2497, d4qwgP_, 0.9002, 1.79, 0.308, 244, 224, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
2498, d4qwgB_, 0.9002, 1.79, 0.308, 244, 224, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
2499, d3okjP_, 0.9002, 1.77, 0.308, 244, 224, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
2500, p3e47R_, 0.9002, 1.70, 0.341, 242, 223, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
2501, d5l6cR_, 0.9001, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2502, d5l6cD_, 0.9001, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2503, d5l6bR_, 0.9001, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2504, d5l6bD_, 0.9001, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2505, d5l67R_, 0.9001, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2506, d5l67D_, 0.9001, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2507, d5l65R_, 0.9001, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2508, d5l5yR_, 0.9001, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2509, d5l5yD_, 0.9001, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2510, d5l5vR_, 0.9001, 1.54, 0.344, 235, 221,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2511, d5l5vD_, 0.9001, 1.54, 0.344, 235, 221,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2512, d5l5tR_, 0.9001, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2513, d5l5tD_, 0.9001, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2514, d5l5qR_, 0.9001, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
2515, d5l5pR_, 0.9001, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2516, d5l5pD_, 0.9001, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2517, d5l5hR_, 0.9001, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2518, d5l5hD_, 0.9001, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2519, d5l5aR_, 0.9001, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
2520, d5l5aD_, 0.9001, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
2521, p4inuR_, 0.9001, 1.71, 0.341, 242, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
2522, d3okjB_, 0.9001, 1.77, 0.308, 244, 224, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
2523, d3gptP_, 0.9001, 1.77, 0.308, 244, 224, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
2524, d3gptB_, 0.9001, 1.77, 0.308, 244, 224, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
2525, d3gpjP_, 0.9001, 1.77, 0.308, 244, 224, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
2526, d3gpjB_, 0.9001, 1.77, 0.308, 244, 224, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
2527, d5l68R_, 0.9000, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2528, d5l68D_, 0.9000, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2529, d5l64R_, 0.9000, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2530, d5l64D_, 0.9000, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2531, d5l5qD_, 0.9000, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
2532, d5l5oR_, 0.9000, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2533, d5l5oD_, 0.9000, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2534, d5l5jR_, 0.9000, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2535, d5l5jD_, 0.9000, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2536, d5l5bR_, 0.9000, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2537, d5l5bD_, 0.9000, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2538, d4eu2S_, 0.9000, 1.71, 0.341, 242, 223, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
2539, d1g0uG_, 0.9000, 1.86, 0.221, 240, 226, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
2540, p5nifQ_, 0.8999, 1.78, 0.308, 242, 224, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2541, d5l69R_, 0.8999, 1.55, 0.344, 235, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2542, d5l69D_, 0.8999, 1.55, 0.344, 235, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2543, p4x6zE_, 0.8999, 1.75, 0.341, 242, 223, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
2544, d4hrcD_, 0.8999, 1.75, 0.341, 242, 223, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
2545, d4eu2E_, 0.8999, 1.74, 0.341, 242, 223, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
2546, p3unbw_, 0.8999, 1.94, 0.242, 243, 227, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2547, p5wvkV_, 0.8998, 1.98, 0.215, 243, 228, 
2548, d5lf4R_, 0.8998, 1.78, 0.318, 233, 223, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
2549, d5l6aR_, 0.8998, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2550, d5l6aD_, 0.8998, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2551, d5l66R_, 0.8998, 1.55, 0.344, 235, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2552, d5l66D_, 0.8998, 1.55, 0.344, 235, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2553, d5l5rR_, 0.8998, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
2554, d5l5rD_, 0.8998, 1.54, 0.344, 235, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
2555, d3bdmD_, 0.8998, 1.71, 0.341, 242, 223, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
2556, d1z7qO1, 0.8998, 2.04, 0.223, 243, 229, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2557, d1z7qA1, 0.8998, 2.04, 0.223, 243, 229, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2558, d5lf7R_, 0.8997, 1.78, 0.318, 233, 223, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
2559, p5leyR_, 0.8997, 1.77, 0.318, 233, 223, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
2560, d5l5dR_, 0.8997, 1.55, 0.344, 235, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2561, d5l5dD_, 0.8997, 1.55, 0.344, 235, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2562, d4eu2C_, 0.8997, 1.78, 0.308, 244, 224, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
2563, d3bdmR_, 0.8997, 1.72, 0.341, 242, 223, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
2564, d1g65R_, 0.8997, 1.72, 0.341, 242, 223, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
2565, d5m2bR_, 0.8996, 1.55, 0.344, 235, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
2566, d5m2bD_, 0.8996, 1.55, 0.344, 235, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
2567, d5lf3R_, 0.8996, 1.78, 0.318, 233, 223, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
2568, p4zzgQ_, 0.8996, 1.78, 0.308, 242, 224, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2569, d3unbU_, 0.8996, 1.94, 0.242, 243, 227, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2570, d5le5R_, 0.8995, 1.77, 0.318, 233, 223, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
2571, d3mg4R_, 0.8995, 1.72, 0.341, 242, 223, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
2572, p5lezR_, 0.8994, 1.77, 0.318, 233, 223, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
2573, d4hrcR_, 0.8994, 1.63, 0.342, 242, 222, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
2574, p5lf0R_, 0.8993, 1.78, 0.318, 233, 223, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
2575, d5lf1R_, 0.8992, 1.78, 0.318, 233, 223, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
2576, d5lexR_, 0.8992, 1.77, 0.318, 233, 223, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
2577, p4r67u_, 0.8991, 1.61, 0.320, 234, 222, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2578, d4r67S_, 0.8991, 1.61, 0.320, 234, 222, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2579, d4r67E_, 0.8991, 1.61, 0.320, 234, 222, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2580, d3mg4B_, 0.8991, 1.79, 0.308, 244, 224, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
2581, d1iruS_, 0.8991, 1.85, 0.312, 234, 224, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
2582, d1iruE_, 0.8991, 1.85, 0.312, 234, 224, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
2583, p4r67g_, 0.8990, 1.61, 0.320, 234, 222, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2584, p5gjrW_, 0.8989, 1.62, 0.320, 234, 222, 
2585, p5gjrKA_, 0.8989, 1.62, 0.320, 234, 222, 
2586, d3unbG_, 0.8989, 1.93, 0.242, 243, 227, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2587, p5gjqF_, 0.8988, 1.63, 0.324, 234, 222, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
2588, p3uneG_, 0.8987, 1.94, 0.242, 244, 227, MOUSE CONSTITUTIVE 20S PROTEASOME
2589, p3unbi_, 0.8987, 1.95, 0.242, 243, 227, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2590, p5lf6R_, 0.8986, 1.79, 0.318, 233, 223, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
2591, p4x6zS_, 0.8986, 1.64, 0.342, 242, 222, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
2592, d2ku2E1, 0.8986, 1.79, 0.320, 233, 225, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
2593, d1z7qP1, 0.8985, 1.78, 0.283, 249, 226, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2594, d1z7qB1, 0.8984, 1.78, 0.283, 249, 226, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2595, p4zzgC_, 0.8983, 1.80, 0.308, 241, 224, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2596, p5nifC_, 0.8982, 1.80, 0.308, 241, 224, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2597, p3jcoLA_, 0.8981, 1.79, 0.308, 244, 224, 
2598, p3jcoL_, 0.8981, 1.79, 0.308, 244, 224, 
2599, d5lf4D_, 0.8980, 1.80, 0.318, 233, 223, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
2600, p5leyD_, 0.8980, 1.80, 0.318, 233, 223, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
2601, d1jd2D_, 0.8980, 1.74, 0.341, 242, 223, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
2602, p5gjql_, 0.8979, 1.72, 0.318, 234, 223, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
2603, p3jtlG_, 0.8978, 1.73, 0.335, 227, 224, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
2604, d4r3oS_, 0.8977, 1.64, 0.324, 234, 222, HUMAN CONSTITUTIVE 20S PROTEASOME
2605, d4r3oO_, 0.8977, 1.97, 0.242, 244, 227, HUMAN CONSTITUTIVE 20S PROTEASOME
2606, d4r3oE_, 0.8977, 1.63, 0.324, 234, 222, HUMAN CONSTITUTIVE 20S PROTEASOME
2607, p3uneU_, 0.8977, 1.95, 0.242, 244, 227, MOUSE CONSTITUTIVE 20S PROTEASOME
2608, p3jtlD_, 0.8977, 1.73, 0.335, 227, 224, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
2609, p3jtlC_, 0.8977, 1.73, 0.335, 227, 224, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
2610, p3jtlB_, 0.8977, 1.73, 0.335, 227, 224, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
2611, p5vfoM_, 0.8976, 2.15, 0.270, 240, 226, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2612, p3jtlF_, 0.8976, 1.73, 0.335, 227, 224, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
2613, p3jtlA_, 0.8976, 1.73, 0.335, 227, 224, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
2614, p5vfrM_, 0.8975, 2.14, 0.270, 240, 226, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2615, d5lf7D_, 0.8975, 1.81, 0.318, 233, 223, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
2616, d1jd2Y_, 0.8975, 1.74, 0.341, 242, 223, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
2617, d1jd2W_, 0.8975, 1.81, 0.308, 244, 224, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
2618, p5vfqB_, 0.8974, 1.70, 0.290, 230, 224, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2619, p5mpaC_, 0.8974, 1.96, 0.307, 244, 225, 26S PROTEASOME IN PRESENCE OF ATP (S2)
2620, p5m32T_, 0.8974, 2.13, 0.270, 240, 226, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
2621, p5lf0D_, 0.8974, 1.81, 0.318, 233, 223, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
2622, p5lezD_, 0.8974, 1.80, 0.318, 233, 223, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
2623, p3jtlE_, 0.8974, 1.73, 0.335, 227, 224, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
2624, d5lf1D_, 0.8973, 1.82, 0.318, 233, 223, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
2625, d1jd2B_, 0.8973, 1.81, 0.308, 244, 224, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
2626, d5lf3D_, 0.8972, 1.82, 0.318, 233, 223, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
2627, d1z7qE1, 0.8972, 1.61, 0.342, 242, 222, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2628, d1z7qS1, 0.8971, 1.61, 0.342, 242, 222, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2629, p5vfqG_, 0.8970, 2.15, 0.270, 240, 226, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2630, p5mp9A_, 0.8970, 2.02, 0.215, 241, 228, 26S PROTEASOME IN PRESENCE OF ATP (S1)
2631, d5lexD_, 0.8970, 1.82, 0.318, 233, 223, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
2632, d1ya7E_, 0.8970, 1.74, 0.335, 227, 224, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
2633, p5lf6D_, 0.8969, 1.82, 0.318, 233, 223, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
2634, d5le5D_, 0.8969, 1.82, 0.318, 233, 223, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
2635, p5vfpG_, 0.8968, 2.00, 0.271, 240, 225, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2636, d4r3oA_, 0.8968, 1.98, 0.242, 244, 227, HUMAN CONSTITUTIVE 20S PROTEASOME
2637, d4r67O_, 0.8965, 1.98, 0.242, 244, 227, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2638, p3unbf_, 0.8965, 1.81, 0.318, 233, 223, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2639, p5vfpEA_, 0.8964, 2.14, 0.265, 240, 226, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2640, p5dsvH_, 0.8964, 1.79, 0.270, 239, 222, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2641, p4r67q_, 0.8964, 1.98, 0.242, 244, 227, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2642, p4r67c_, 0.8964, 1.98, 0.242, 244, 227, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2643, d4r67A_, 0.8964, 1.98, 0.242, 244, 227, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2644, d1iruO_, 0.8964, 1.97, 0.242, 244, 227, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
2645, p5mp9a_, 0.8963, 2.04, 0.215, 241, 228, 26S PROTEASOME IN PRESENCE OF ATP (S1)
2646, d1iruA_, 0.8963, 1.97, 0.242, 244, 227, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
2647, p5vfqFA_, 0.8962, 2.16, 0.270, 240, 226, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2648, p5vfom_, 0.8961, 2.15, 0.265, 240, 226, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2649, p5l4gS_, 0.8958, 1.65, 0.320, 234, 222, 
2650, p5l4gE_, 0.8958, 1.66, 0.320, 234, 222, 
2651, p3jcpNA_, 0.8958, 1.78, 0.341, 242, 223, 
2652, p3jcpN_, 0.8958, 1.78, 0.341, 242, 223, 
2653, p6avoM_, 0.8957, 1.80, 0.318, 233, 223, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
2654, p5vfrm_, 0.8957, 2.16, 0.265, 240, 226, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2655, p3unei_, 0.8957, 1.98, 0.242, 244, 227, MOUSE CONSTITUTIVE 20S PROTEASOME
2656, d3unbD_, 0.8957, 1.82, 0.318, 233, 223, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2657, p6avoH_, 0.8956, 1.80, 0.318, 233, 223, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
2658, p5vfoH_, 0.8956, 1.72, 0.290, 230, 224, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2659, p5mpcQ_, 0.8955, 1.89, 0.308, 244, 227, 
2660, p5vfrH_, 0.8954, 1.72, 0.290, 230, 224, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2661, d3sdkR_, 0.8954, 1.46, 0.347, 232, 219, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
2662, d2ku2D1, 0.8954, 1.85, 0.320, 233, 225, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
2663, d3unfU_, 0.8952, 1.99, 0.242, 243, 227, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
2664, d3unfG_, 0.8952, 1.99, 0.242, 243, 227, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
2665, p3unew_, 0.8952, 1.98, 0.242, 244, 227, MOUSE CONSTITUTIVE 20S PROTEASOME
2666, p5mp9C_, 0.8951, 1.85, 0.308, 244, 224, 26S PROTEASOME IN PRESENCE OF ATP (S1)
2667, d5lf4B_, 0.8951, 1.99, 0.333, 248, 225, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
2668, p5lf0B_, 0.8951, 1.99, 0.333, 248, 225, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
2669, p5t0cY_, 0.8949, 2.32, 0.264, 240, 227, 
2670, p5t0cEB_, 0.8949, 2.32, 0.264, 240, 227, 
2671, d5le5B_, 0.8948, 1.99, 0.333, 248, 225, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
2672, p5mpag_, 0.8947, 2.32, 0.294, 243, 228, 26S PROTEASOME IN PRESENCE OF ATP (S2)
2673, p5mp9c_, 0.8947, 1.86, 0.308, 244, 224, 26S PROTEASOME IN PRESENCE OF ATP (S1)
2674, d3unbR_, 0.8946, 1.83, 0.318, 233, 223, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2675, p3jcoNA_, 0.8946, 1.77, 0.341, 242, 223, 
2676, p3jcoN_, 0.8946, 1.77, 0.341, 242, 223, 
2677, p5mpac_, 0.8945, 1.86, 0.308, 244, 224, 26S PROTEASOME IN PRESENCE OF ATP (S2)
2678, p3unbt_, 0.8945, 1.84, 0.318, 233, 223, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2679, d5lf7B_, 0.8943, 2.00, 0.333, 248, 225, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
2680, d5lf3B_, 0.8943, 2.00, 0.333, 248, 225, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
2681, p5vfuX_, 0.8942, 2.29, 0.265, 240, 226, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2682, p5vftM_, 0.8942, 2.29, 0.265, 240, 226, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2683, p5leyB_, 0.8942, 2.00, 0.333, 248, 225, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
2684, p3unfB_, 0.8942, 1.98, 0.338, 248, 225, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
2685, d3unfP_, 0.8941, 1.98, 0.338, 248, 225, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
2686, p5vfsG_, 0.8940, 2.12, 0.262, 240, 225, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2687, p5vfpB_, 0.8940, 1.74, 0.290, 230, 224, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2688, d5lf1B_, 0.8940, 2.00, 0.333, 248, 225, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
2689, p3jcoP_, 0.8940, 2.27, 0.293, 244, 229, 
2690, p3jcoPA_, 0.8939, 2.27, 0.293, 244, 229, 
2691, d3unfO_, 0.8938, 1.75, 0.294, 230, 221, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
2692, d3unfA_, 0.8938, 1.75, 0.294, 230, 221, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
2693, p5lezB_, 0.8935, 2.00, 0.333, 248, 225, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
2694, d1j2pF_, 0.8935, 1.82, 0.338, 243, 225, ALPHA-RING FROM THE PROTEASOME FROM ARCHAEOGLOBUS FULGIDUS
2695, d5le5P_, 0.8934, 2.01, 0.333, 247, 225, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
2696, p5mp9e_, 0.8933, 1.81, 0.341, 242, 223, 26S PROTEASOME IN PRESENCE OF ATP (S1)
2697, p3unhP_, 0.8933, 2.00, 0.338, 248, 225, MOUSE 20S IMMUNOPROTEASOME
2698, p3unhO_, 0.8933, 1.76, 0.294, 230, 221, MOUSE 20S IMMUNOPROTEASOME
2699, p3unhB_, 0.8933, 2.00, 0.338, 248, 225, MOUSE 20S IMMUNOPROTEASOME
2700, p3unhA_, 0.8933, 1.76, 0.294, 230, 221, MOUSE 20S IMMUNOPROTEASOME
2701, d1j2pC_, 0.8933, 1.83, 0.338, 243, 225, ALPHA-RING FROM THE PROTEASOME FROM ARCHAEOGLOBUS FULGIDUS
2702, d3sdkD_, 0.8932, 1.64, 0.345, 233, 220, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
2703, d1j2pG_, 0.8932, 1.83, 0.338, 243, 225, ALPHA-RING FROM THE PROTEASOME FROM ARCHAEOGLOBUS FULGIDUS
2704, d1j2pE_, 0.8932, 1.83, 0.338, 243, 225, ALPHA-RING FROM THE PROTEASOME FROM ARCHAEOGLOBUS FULGIDUS
2705, d1j2pA_, 0.8932, 1.83, 0.338, 243, 225, ALPHA-RING FROM THE PROTEASOME FROM ARCHAEOGLOBUS FULGIDUS
2706, p5wvkU_, 0.8931, 2.38, 0.297, 244, 229, 
2707, p5lf6B_, 0.8931, 2.01, 0.333, 248, 225, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
2708, d1j2pD_, 0.8931, 1.83, 0.338, 243, 225, ALPHA-RING FROM THE PROTEASOME FROM ARCHAEOGLOBUS FULGIDUS
2709, d1j2pB_, 0.8931, 1.83, 0.338, 243, 225, ALPHA-RING FROM THE PROTEASOME FROM ARCHAEOGLOBUS FULGIDUS
2710, d5lexB_, 0.8930, 2.01, 0.333, 248, 225, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
2711, p3uneD_, 0.8930, 1.61, 0.321, 233, 221, MOUSE CONSTITUTIVE 20S PROTEASOME
2712, p3unet_, 0.8929, 1.62, 0.321, 233, 221, MOUSE CONSTITUTIVE 20S PROTEASOME
2713, d2ku2F1, 0.8929, 1.99, 0.320, 233, 225, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
2714, d2ku1F1, 0.8928, 1.90, 0.329, 233, 225, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
2715, p3uneA_, 0.8927, 1.60, 0.295, 233, 220, MOUSE CONSTITUTIVE 20S PROTEASOME
2716, p3unbB_, 0.8927, 2.14, 0.336, 248, 226, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2717, d5lf4P_, 0.8926, 2.03, 0.333, 248, 225, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
2718, p5mp9E_, 0.8925, 1.86, 0.341, 242, 223, 26S PROTEASOME IN PRESENCE OF ATP (S1)
2719, d4r67B_, 0.8924, 1.77, 0.294, 233, 221, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2720, p5vfsFA_, 0.8923, 2.14, 0.262, 240, 225, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2721, p5mpaa_, 0.8923, 2.07, 0.215, 241, 228, 26S PROTEASOME IN PRESENCE OF ATP (S2)
2722, p5m32F_, 0.8923, 1.78, 0.270, 232, 222, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
2723, d3unbO_, 0.8923, 1.77, 0.294, 231, 221, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2724, d5lf1P_, 0.8921, 2.04, 0.333, 248, 225, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
2725, d4r67r_, 0.8921, 1.78, 0.294, 233, 221, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2726, d4r67P_, 0.8921, 1.78, 0.294, 233, 221, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2727, p3unec_, 0.8921, 1.78, 0.294, 233, 221, MOUSE CONSTITUTIVE 20S PROTEASOME
2728, d4r67d_, 0.8920, 1.78, 0.294, 233, 221, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2729, d5lf7P_, 0.8919, 2.04, 0.333, 247, 225, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
2730, p3uneR_, 0.8919, 1.63, 0.321, 233, 221, MOUSE CONSTITUTIVE 20S PROTEASOME
2731, p3uneq_, 0.8919, 1.60, 0.295, 233, 220, MOUSE CONSTITUTIVE 20S PROTEASOME
2732, p3unef_, 0.8919, 1.63, 0.321, 233, 221, MOUSE CONSTITUTIVE 20S PROTEASOME
2733, d3unbc_, 0.8919, 1.60, 0.295, 231, 220, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2734, p5wvkBA_, 0.8917, 2.32, 0.289, 244, 228, 
2735, p5lf0P_, 0.8917, 2.04, 0.333, 248, 225, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
2736, p5lezP_, 0.8917, 2.04, 0.333, 247, 225, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
2737, p5leyP_, 0.8917, 2.04, 0.333, 247, 225, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
2738, p5dsvJ_, 0.8917, 1.80, 0.271, 239, 221, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2739, d3unfR_, 0.8916, 1.64, 0.321, 233, 221, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
2740, d3unfD_, 0.8916, 1.64, 0.321, 233, 221, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
2741, d3unbA_, 0.8916, 1.61, 0.295, 231, 220, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2742, d3oevB_, 0.8916, 1.60, 0.309, 235, 220, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
2743, d5lf3P_, 0.8915, 2.04, 0.333, 248, 225, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
2744, d3unbq_, 0.8915, 1.60, 0.295, 231, 220, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2745, p5lf6P_, 0.8914, 2.05, 0.333, 248, 225, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
2746, p3unhR_, 0.8914, 1.64, 0.321, 233, 221, MOUSE 20S IMMUNOPROTEASOME
2747, p3unhD_, 0.8914, 1.64, 0.321, 233, 221, MOUSE 20S IMMUNOPROTEASOME
2748, p5lf0O_, 0.8912, 1.78, 0.294, 230, 221, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
2749, d3mg8B_, 0.8912, 1.61, 0.309, 235, 220, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
2750, p5mpaG_, 0.8911, 2.32, 0.289, 243, 228, 26S PROTEASOME IN PRESENCE OF ATP (S2)
2751, d5lf3O_, 0.8911, 1.78, 0.294, 230, 221, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
2752, d5lexP_, 0.8911, 2.05, 0.333, 247, 225, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
2753, d3mg6B_, 0.8911, 1.61, 0.305, 235, 220, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
2754, p3unbd_, 0.8910, 2.16, 0.336, 248, 226, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2755, p5t0gM_, 0.8909, 2.18, 0.270, 240, 226, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
2756, d1iruP_, 0.8909, 1.79, 0.294, 233, 221, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
2757, d3sdiP_, 0.8908, 1.61, 0.309, 235, 220, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
2758, d5lexO_, 0.8906, 1.79, 0.294, 230, 221, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
2759, p3uneO_, 0.8905, 1.80, 0.294, 233, 221, MOUSE CONSTITUTIVE 20S PROTEASOME
2760, d3sdkB_, 0.8905, 1.61, 0.309, 235, 220, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
2761, d1g0uP_, 0.8905, 1.61, 0.309, 235, 220, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
2762, d1g0uB_, 0.8905, 1.61, 0.309, 235, 220, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
2763, p5leyO_, 0.8904, 1.79, 0.294, 230, 221, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
2764, d3sdiB_, 0.8904, 1.62, 0.309, 235, 220, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
2765, d2ku1G1, 0.8904, 1.90, 0.321, 233, 224, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
2766, p5lf6O_, 0.8903, 1.79, 0.294, 230, 221, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
2767, p5lf0A_, 0.8903, 1.79, 0.294, 230, 221, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
2768, d4r3oP_, 0.8903, 1.62, 0.295, 233, 220, HUMAN CONSTITUTIVE 20S PROTEASOME
2769, d4r3oB_, 0.8903, 1.62, 0.295, 233, 220, HUMAN CONSTITUTIVE 20S PROTEASOME
2770, d3oevP_, 0.8903, 1.61, 0.309, 235, 220, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
2771, d3oeuP_, 0.8903, 1.61, 0.309, 235, 220, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
2772, d3oeuB_, 0.8903, 1.62, 0.309, 235, 220, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
2773, p5mpbQ_, 0.8902, 1.91, 0.308, 244, 224, 
2774, d5lf1O_, 0.8902, 1.79, 0.294, 230, 221, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
2775, d3mg7B_, 0.8902, 1.63, 0.309, 235, 220, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
2776, d3mg6P_, 0.8902, 1.62, 0.309, 235, 220, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
2777, d5lf4O_, 0.8901, 1.79, 0.294, 230, 221, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
2778, d3sdkP_, 0.8901, 1.62, 0.309, 235, 220, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
2779, d3mg8P_, 0.8901, 1.62, 0.309, 235, 220, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
2780, p3uneP_, 0.8900, 2.03, 0.338, 248, 225, MOUSE CONSTITUTIVE 20S PROTEASOME
2781, d3mg7P_, 0.8899, 1.62, 0.309, 235, 220, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
2782, p5lezO_, 0.8898, 1.63, 0.295, 230, 220, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
2783, d5lf7O_, 0.8897, 1.80, 0.294, 230, 221, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
2784, d5lf3A_, 0.8897, 1.80, 0.294, 230, 221, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
2785, d5lexA_, 0.8897, 1.80, 0.294, 230, 221, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
2786, d5le5O_, 0.8897, 1.80, 0.294, 230, 221, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
2787, p1fntG_, 0.8897, 2.23, 0.292, 240, 226, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2788, p5gjqD_, 0.8896, 2.05, 0.333, 240, 225, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
2789, p1fntU_, 0.8896, 2.23, 0.292, 240, 226, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2790, p5mpaE_, 0.8895, 1.73, 0.342, 242, 222, 26S PROTEASOME IN PRESENCE OF ATP (S2)
2791, d4cr2E_, 0.8895, 1.93, 0.341, 243, 223, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
2792, p5gjrIA_, 0.8894, 2.06, 0.333, 250, 225, 
2793, p1fntP_, 0.8894, 1.85, 0.280, 247, 225, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2794, p1fntB_, 0.8894, 1.85, 0.280, 247, 225, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2795, p6avoZ_, 0.8893, 2.18, 0.332, 240, 226, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
2796, p6avoO_, 0.8893, 2.18, 0.332, 240, 226, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
2797, p5lezA_, 0.8893, 1.64, 0.295, 230, 220, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
2798, p5gjrU_, 0.8893, 2.06, 0.333, 250, 225, 
2799, p4cr4E_, 0.8893, 1.86, 0.345, 243, 223, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
2800, p3uneB_, 0.8893, 2.06, 0.338, 248, 225, MOUSE CONSTITUTIVE 20S PROTEASOME
2801, p5t0hM_, 0.8892, 2.23, 0.270, 240, 226, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
2802, d5lf4A_, 0.8892, 1.81, 0.294, 230, 221, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
2803, p5gjrHA_, 0.8891, 1.81, 0.294, 231, 221, 
2804, d2ku1C1, 0.8891, 1.94, 0.330, 233, 224, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
2805, d5le5A_, 0.8890, 1.81, 0.294, 230, 221, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
2806, p5gjrT_, 0.8890, 1.81, 0.294, 231, 221, 
2807, p5lf6A_, 0.8889, 1.81, 0.294, 230, 221, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
2808, p5leyA_, 0.8889, 1.81, 0.294, 230, 221, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
2809, d1z7qD1, 0.8889, 2.07, 0.310, 241, 226, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2810, d5lf1A_, 0.8888, 1.81, 0.294, 230, 221, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
2811, p5l4gP_, 0.8888, 1.81, 0.294, 233, 221, 
2812, d1z7qR1, 0.8888, 2.07, 0.310, 241, 226, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2813, d5lf7A_, 0.8887, 1.81, 0.294, 230, 221, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
2814, d2ku1E1, 0.8887, 1.82, 0.323, 233, 223, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
2815, p4r67e_, 0.8886, 2.06, 0.333, 239, 225, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2816, p3unbr_, 0.8886, 2.06, 0.338, 248, 225, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2817, p6avoP_, 0.8885, 1.81, 0.294, 230, 221, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
2818, p6avob_, 0.8885, 1.81, 0.294, 230, 221, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
2819, p4r67s_, 0.8885, 2.06, 0.333, 240, 225, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2820, d4r67Q_, 0.8885, 2.06, 0.333, 250, 225, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2821, d4r67C_, 0.8885, 2.06, 0.333, 250, 225, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2822, p5l4gQ_, 0.8884, 2.05, 0.333, 240, 225, 
2823, p3unbP_, 0.8882, 2.06, 0.338, 248, 225, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2824, p5l4gB_, 0.8881, 1.65, 0.295, 233, 220, 
2825, p5vfuLA_, 0.8880, 2.15, 0.270, 240, 226, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2826, p5vftm_, 0.8880, 2.15, 0.270, 240, 226, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2827, d4cr2C_, 0.8878, 1.86, 0.305, 245, 223, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
2828, p3j9iU_, 0.8878, 1.70, 0.335, 224, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
2829, p3j9iT_, 0.8878, 1.70, 0.335, 224, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
2830, p3j9iS_, 0.8878, 1.70, 0.335, 224, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
2831, p3j9iR_, 0.8878, 1.70, 0.335, 224, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
2832, p3j9iQ_, 0.8878, 1.70, 0.335, 224, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
2833, p3j9iP_, 0.8878, 1.70, 0.335, 224, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
2834, p3j9iO_, 0.8878, 1.70, 0.335, 224, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
2835, p3j9iG_, 0.8878, 1.70, 0.335, 224, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
2836, p3j9iF_, 0.8878, 1.70, 0.335, 224, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
2837, p3j9iE_, 0.8878, 1.70, 0.335, 224, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
2838, p3j9iD_, 0.8878, 1.70, 0.335, 224, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
2839, p3j9iC_, 0.8878, 1.70, 0.335, 224, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
2840, p3j9iB_, 0.8878, 1.70, 0.335, 224, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
2841, p3j9iA_, 0.8878, 1.70, 0.335, 224, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
2842, d1iruQ_, 0.8878, 2.06, 0.333, 250, 225, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
2843, d1iruC_, 0.8878, 2.06, 0.333, 250, 225, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
2844, d4cr2G_, 0.8876, 2.33, 0.289, 245, 228, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
2845, p3uner_, 0.8874, 2.08, 0.338, 248, 225, MOUSE CONSTITUTIVE 20S PROTEASOME
2846, p5mpae_, 0.8873, 1.70, 0.348, 242, 221, 26S PROTEASOME IN PRESENCE OF ATP (S2)
2847, p4zzgD_, 0.8873, 2.00, 0.305, 241, 223, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2848, d1iruB_, 0.8873, 1.86, 0.294, 233, 221, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
2849, d4r3oQ_, 0.8872, 2.08, 0.333, 250, 225, HUMAN CONSTITUTIVE 20S PROTEASOME
2850, d4r3oC_, 0.8872, 2.08, 0.333, 250, 225, HUMAN CONSTITUTIVE 20S PROTEASOME
2851, d1rypP_, 0.8872, 1.70, 0.285, 250, 221, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
2852, p5nifD_, 0.8870, 2.00, 0.305, 241, 223, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2853, d4q1sQ_, 0.8870, 2.01, 0.305, 241, 223, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
2854, p5gjqj_, 0.8869, 2.09, 0.333, 240, 225, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
2855, p3uned_, 0.8869, 2.08, 0.338, 248, 225, MOUSE CONSTITUTIVE 20S PROTEASOME
2856, d1g0uD_, 0.8869, 1.47, 0.350, 230, 217, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
2857, d1rypB_, 0.8868, 1.71, 0.285, 250, 221, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
2858, p5wvkS_, 0.8867, 1.88, 0.341, 242, 223, 
2859, p5m32R_, 0.8866, 1.92, 0.305, 233, 223, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
2860, p5m32D_, 0.8866, 1.92, 0.305, 233, 223, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
2861, p6epcG_, 0.8864, 2.10, 0.265, 245, 226, GROUND STATE 26S PROTEASOME (GS2)
2862, d4q1sC_, 0.8864, 2.02, 0.305, 241, 223, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
2863, p3ipmF_, 0.8864, 1.86, 0.332, 227, 223, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
2864, p3ipmA_, 0.8864, 1.86, 0.332, 227, 223, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
2865, d4eu2P_, 0.8863, 1.71, 0.285, 249, 221, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
2866, p3ipmG_, 0.8863, 1.86, 0.332, 227, 223, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
2867, p3ipmE_, 0.8863, 1.86, 0.332, 227, 223, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
2868, p3ipmC_, 0.8863, 1.86, 0.332, 227, 223, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
2869, p3ipmB_, 0.8863, 1.86, 0.332, 227, 223, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
2870, d2ku2G1, 0.8863, 2.11, 0.321, 233, 224, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
2871, d1jd2V_, 0.8863, 1.71, 0.285, 250, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
2872, p5nifP_, 0.8862, 1.72, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2873, p3ipmD_, 0.8862, 1.86, 0.332, 227, 223, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
2874, d1yauG_, 0.8862, 1.61, 0.333, 222, 219, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
2875, d3bdmO_, 0.8861, 1.72, 0.285, 250, 221, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
2876, d3bdmA_, 0.8861, 1.72, 0.285, 250, 221, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
2877, p5mpcC_, 0.8860, 2.04, 0.310, 244, 226, 
2878, d2zcyO_, 0.8860, 1.71, 0.285, 250, 221, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
2879, d2zcyA_, 0.8860, 1.71, 0.285, 250, 221, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
2880, d1g0uA_, 0.8860, 1.72, 0.285, 246, 221, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
2881, p4zzgP_, 0.8859, 1.72, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2882, d3mg8O_, 0.8859, 1.71, 0.285, 250, 221, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
2883, d3gpjA_, 0.8859, 1.72, 0.285, 250, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
2884, d3dy4C_, 0.8859, 2.02, 0.305, 241, 223, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
2885, d1g0uR_, 0.8859, 1.48, 0.350, 230, 217, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
2886, p4x6zP_, 0.8858, 1.72, 0.285, 249, 221, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
2887, d4cr2A_, 0.8858, 2.20, 0.224, 243, 228, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
2888, d3mg4O_, 0.8858, 1.71, 0.285, 250, 221, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
2889, d3gpjO_, 0.8858, 1.72, 0.285, 250, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
2890, d3dy4Q_, 0.8858, 2.02, 0.305, 241, 223, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
2891, d2gplA_, 0.8858, 1.72, 0.285, 250, 221, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
2892, d4qv5O_, 0.8857, 1.72, 0.285, 250, 221, YCP BETA5-M45I MUTANT
2893, d4qv5A_, 0.8857, 1.72, 0.285, 250, 221, YCP BETA5-M45I MUTANT
2894, d3un8O_, 0.8857, 1.72, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
2895, d3dy3O_, 0.8857, 1.72, 0.285, 250, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
2896, d3dy3A_, 0.8857, 1.72, 0.285, 250, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
2897, d2gplO_, 0.8857, 1.72, 0.285, 250, 221, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
2898, d1jd2A_, 0.8856, 1.72, 0.285, 250, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
2899, d1g65A_, 0.8856, 1.72, 0.285, 250, 221, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
2900, d4ltcO_, 0.8855, 1.72, 0.285, 250, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
2901, d3sdiO_, 0.8855, 1.72, 0.285, 246, 221, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
2902, d3oeuO_, 0.8855, 1.72, 0.285, 250, 221, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
2903, d3mg0O_, 0.8855, 1.72, 0.285, 250, 221, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
2904, d4qv3O_, 0.8854, 1.72, 0.285, 250, 221, YCP BETA5-M45V MUTANT
2905, d4qv3A_, 0.8854, 1.72, 0.285, 250, 221, YCP BETA5-M45V MUTANT
2906, d4no6O_, 0.8854, 1.72, 0.285, 250, 221, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
2907, d4no6A_, 0.8854, 1.72, 0.285, 250, 221, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
2908, d3sdiA_, 0.8854, 1.72, 0.285, 246, 221, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
2909, d3mg7O_, 0.8854, 1.72, 0.285, 250, 221, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
2910, d2zcyC_, 0.8854, 2.03, 0.305, 241, 223, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
2911, d1yauF_, 0.8854, 1.61, 0.333, 222, 219, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
2912, d1g0uO_, 0.8854, 1.72, 0.285, 246, 221, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
2913, p5nifR_, 0.8853, 2.03, 0.305, 241, 223, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2914, p5gjqC_, 0.8853, 1.69, 0.295, 233, 220, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
2915, p4zzgR_, 0.8853, 2.03, 0.305, 241, 223, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2916, d4inrA_, 0.8853, 1.72, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
2917, d4g4sB_, 0.8853, 1.72, 0.285, 246, 221, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
2918, d3un8A_, 0.8853, 1.72, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
2919, d3mg7A_, 0.8853, 1.72, 0.285, 250, 221, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
2920, d3e47O_, 0.8853, 1.72, 0.285, 250, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
2921, d3e47A_, 0.8853, 1.72, 0.285, 250, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
2922, d3dy4A_, 0.8853, 1.72, 0.285, 250, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
2923, d2zcyQ_, 0.8853, 2.03, 0.305, 241, 223, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
2924, d4qv4O_, 0.8852, 1.73, 0.285, 250, 221, YCP BETA5-M45T MUTANT
2925, d4qv4A_, 0.8852, 1.73, 0.285, 250, 221, YCP BETA5-M45T MUTANT
2926, d4no1O_, 0.8852, 1.73, 0.285, 250, 221, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
2927, d4no1A_, 0.8852, 1.73, 0.285, 250, 221, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
2928, d4ltcA_, 0.8852, 1.73, 0.285, 250, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
2929, d4inrO_, 0.8852, 1.72, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
2930, d3wxrB_, 0.8852, 1.73, 0.285, 249, 221, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
2931, d3sdkO_, 0.8852, 1.72, 0.285, 250, 221, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
2932, d3dy4O_, 0.8852, 1.72, 0.285, 250, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
2933, d2fnyO_, 0.8852, 1.72, 0.285, 250, 221,  
2934, d2fnyA_, 0.8852, 1.72, 0.285, 250, 221,  
2935, d1g65O_, 0.8852, 1.73, 0.285, 250, 221, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
2936, d5l55O_, 0.8851, 1.72, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2937, d5l55A_, 0.8851, 1.72, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2938, d4inuO_, 0.8851, 1.72, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
2939, d3d29A_, 0.8851, 1.73, 0.285, 250, 221, PROTEASOME INHIBITION BY FELLUTAMIDE B
2940, d2fakO_, 0.8851, 1.73, 0.285, 250, 221, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
2941, d2fakA_, 0.8851, 1.73, 0.285, 250, 221, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
2942, d2f16O_, 0.8851, 1.73, 0.285, 250, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
2943, d2f16A_, 0.8851, 1.73, 0.285, 250, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
2944, p5nifB_, 0.8850, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2945, d5l52A_, 0.8850, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2946, p4zzgB_, 0.8850, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2947, d4qv7O_, 0.8850, 1.73, 0.285, 250, 221, YCP BETA5-A50V MUTANT
2948, d4qv7A_, 0.8850, 1.73, 0.285, 250, 221, YCP BETA5-A50V MUTANT
2949, d4qv1O_, 0.8850, 1.73, 0.285, 250, 221, YCP BETA5-M45A MUTANT
2950, d4qv1A_, 0.8850, 1.73, 0.285, 250, 221, YCP BETA5-M45A MUTANT
2951, d4intO_, 0.8850, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
2952, d4hnpA_, 0.8850, 1.73, 0.285, 250, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
2953, d3sdkA_, 0.8850, 1.73, 0.285, 250, 221, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
2954, d3dy3Q_, 0.8850, 2.03, 0.305, 241, 223, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
2955, d3dy3C_, 0.8850, 2.03, 0.305, 241, 223, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
2956, d3d29O_, 0.8850, 1.73, 0.285, 250, 221, PROTEASOME INHIBITION BY FELLUTAMIDE B
2957, d5l52O_, 0.8849, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2958, p4y8pO_, 0.8849, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
2959, p4x6zB_, 0.8849, 1.73, 0.285, 248, 221, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
2960, d4qz7O_, 0.8849, 1.73, 0.285, 250, 221, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2961, d4qz7A_, 0.8849, 1.73, 0.285, 250, 221, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2962, d4qz4O_, 0.8849, 1.73, 0.285, 250, 221, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2963, d4qz4A_, 0.8849, 1.73, 0.285, 250, 221, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2964, d4qz0O_, 0.8849, 1.73, 0.285, 250, 221, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2965, d4qz0A_, 0.8849, 1.73, 0.285, 250, 221, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2966, d4qv9O_, 0.8849, 1.73, 0.285, 250, 221, YCP BETA5-C63F MUTANT
2967, d4qv9A_, 0.8849, 1.73, 0.285, 250, 221, YCP BETA5-C63F MUTANT
2968, d4qv8O_, 0.8849, 1.73, 0.285, 250, 221, YCP BETA5-C52F MUTANT
2969, d4qv8A_, 0.8849, 1.73, 0.285, 250, 221, YCP BETA5-C52F MUTANT
2970, d4quyO_, 0.8849, 1.73, 0.285, 250, 221, YCP BETA5-A49S-MUTANT
2971, d4quyA_, 0.8849, 1.73, 0.285, 250, 221, YCP BETA5-A49S-MUTANT
2972, d4jsqO_, 0.8849, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
2973, d4jsqA_, 0.8849, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
2974, d4inuA_, 0.8849, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
2975, d3okjO_, 0.8849, 1.73, 0.285, 250, 221, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
2976, d3okjA_, 0.8849, 1.73, 0.285, 250, 221, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
2977, d3mg6A_, 0.8849, 1.73, 0.285, 250, 221, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
2978, d5l5rO_, 0.8848, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
2979, d5jhrA_, 0.8848, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
2980, d5d0wO_, 0.8848, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME BETA5-T1S MUTANT
2981, d5d0wA_, 0.8848, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME BETA5-T1S MUTANT
2982, p5cggO_, 0.8848, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
2983, d4qz6O_, 0.8848, 1.73, 0.285, 250, 221, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2984, d4qz6A_, 0.8848, 1.73, 0.285, 250, 221, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2985, d4qwxO_, 0.8848, 1.73, 0.285, 250, 221, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2986, d4qwxA_, 0.8848, 1.73, 0.285, 250, 221, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2987, d4qv0O_, 0.8848, 1.73, 0.285, 250, 221, YCP BETA5-A49T-A50V-DOUBLE MUTANT
2988, d4qv0A_, 0.8848, 1.73, 0.285, 250, 221, YCP BETA5-A49T-A50V-DOUBLE MUTANT
2989, d3mg4A_, 0.8848, 1.73, 0.285, 250, 221, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
2990, d1yarG_, 0.8848, 1.57, 0.339, 221, 218, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
2991, p5t0jM_, 0.8847, 2.32, 0.274, 240, 226, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
2992, d5l5rA_, 0.8847, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
2993, p5l4gC_, 0.8847, 2.12, 0.333, 240, 225, 
2994, d5jhrO_, 0.8847, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
2995, d5fggO_, 0.8847, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2996, d5fggA_, 0.8847, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2997, p5cgiO_, 0.8847, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
2998, p5cghO_, 0.8847, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
2999, d5ahjO_, 0.8847, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
3000, d5ahjA_, 0.8847, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
3001, p4ya9O_, 0.8847, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
3002, p4ya7O_, 0.8847, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
3003, d4y9yA_, 0.8847, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME BETA2-H116E MUTANT
3004, p4y8kO_, 0.8847, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
3005, d4qzwO_, 0.8847, 1.73, 0.285, 250, 221, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3006, d4qzwA_, 0.8847, 1.73, 0.285, 250, 221, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3007, d4qz3O_, 0.8847, 1.73, 0.285, 250, 221, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3008, d4qz3A_, 0.8847, 1.73, 0.285, 250, 221, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3009, d4qz2O_, 0.8847, 1.73, 0.285, 250, 221, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3010, d4qz2A_, 0.8847, 1.73, 0.285, 250, 221, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3011, d4no8O_, 0.8847, 1.73, 0.285, 250, 221, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
3012, d4no8A_, 0.8847, 1.73, 0.285, 250, 221, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
3013, d4nnwO_, 0.8847, 1.73, 0.285, 250, 221, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
3014, d4nnwA_, 0.8847, 1.73, 0.285, 250, 221, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
3015, d4nnnO_, 0.8847, 1.73, 0.285, 250, 221, YCP IN COMPLEX WITH MG132
3016, d4nnnA_, 0.8847, 1.73, 0.285, 250, 221, YCP IN COMPLEX WITH MG132
3017, d4intA_, 0.8847, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
3018, d4eu2B_, 0.8847, 1.74, 0.285, 249, 221, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
3019, p3un4O_, 0.8847, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
3020, d3sdkC_, 0.8847, 2.06, 0.305, 241, 223, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
3021, d3sdiR_, 0.8847, 1.43, 0.352, 229, 216, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
3022, d3oevA_, 0.8847, 1.73, 0.285, 250, 221, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
3023, d3gpjQ_, 0.8847, 2.03, 0.305, 241, 223, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
3024, d3gpjC_, 0.8847, 2.03, 0.305, 241, 223, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
3025, p6gopO_, 0.8846, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
3026, d5l5wO_, 0.8846, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
3027, d5l5wA_, 0.8846, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
3028, d5l5bO_, 0.8846, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
3029, d5l5bA_, 0.8846, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
3030, d5bxlO_, 0.8846, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME BETA2-G170A MUTANT
3031, d5bxlA_, 0.8846, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME BETA2-G170A MUTANT
3032, d4ya1O_, 0.8846, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME BETA2-H116N MUTANT
3033, d4ya1A_, 0.8846, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME BETA2-H116N MUTANT
3034, p4y9zO_, 0.8846, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
3035, d4y9yO_, 0.8846, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME BETA2-H116E MUTANT
3036, p4y8sO_, 0.8846, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
3037, d4r00O_, 0.8846, 1.73, 0.285, 250, 221, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
3038, d4r00A_, 0.8846, 1.73, 0.285, 250, 221, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
3039, d4qwlO_, 0.8846, 1.73, 0.285, 250, 221, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
3040, d4qwlA_, 0.8846, 1.73, 0.285, 250, 221, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
3041, d4qw6O_, 0.8846, 1.73, 0.285, 250, 221, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
3042, d4qw6A_, 0.8846, 1.73, 0.285, 250, 221, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
3043, d3mg8A_, 0.8846, 1.74, 0.285, 250, 221, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
3044, d3mg6O_, 0.8846, 1.73, 0.285, 250, 221, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
3045, d1yauA_, 0.8846, 1.63, 0.333, 222, 219, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
3046, d5l6aO_, 0.8845, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3047, d5l6aA_, 0.8845, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3048, p5gjqi_, 0.8845, 1.86, 0.294, 231, 221, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
3049, d5d0sO_, 0.8845, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
3050, d5d0sA_, 0.8845, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
3051, d5czaO_, 0.8845, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME BETA5-D166N MUTANT
3052, d5czaA_, 0.8845, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME BETA5-D166N MUTANT
3053, p4ya2O_, 0.8845, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
3054, d4y8rO_, 0.8845, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME BETA2-H116D MUTANT
3055, d4y8rA_, 0.8845, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME BETA2-H116D MUTANT
3056, p4y77O_, 0.8845, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
3057, p4y75O_, 0.8845, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
3058, d4qzzO_, 0.8845, 1.73, 0.285, 250, 221, YCP IN COMPLEX WITH OMURALIDE
3059, d4qzzA_, 0.8845, 1.74, 0.285, 250, 221, YCP IN COMPLEX WITH OMURALIDE
3060, d4qz5O_, 0.8845, 1.74, 0.285, 250, 221, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
3061, d4qz5A_, 0.8845, 1.74, 0.285, 250, 221, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
3062, p4qbyO_, 0.8845, 1.74, 0.285, 250, 221, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
3063, d4jt0O_, 0.8845, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
3064, d4jt0A_, 0.8845, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
3065, d3shjC_, 0.8845, 2.03, 0.305, 241, 223, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
3066, d3oevO_, 0.8845, 1.73, 0.285, 250, 221, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
3067, d3oeuA_, 0.8845, 1.74, 0.285, 250, 221, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
3068, d3bdmC_, 0.8845, 2.03, 0.305, 241, 223, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
3069, d5l6bO_, 0.8844, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3070, d5l6bA_, 0.8844, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3071, d5l5uO_, 0.8844, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3072, d5l5uA_, 0.8844, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3073, d5l5oO_, 0.8844, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3074, d5l5hO_, 0.8844, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3075, d5l5hA_, 0.8844, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3076, d5fgfO_, 0.8844, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
3077, d5fgfA_, 0.8844, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
3078, d5fgaO_, 0.8844, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
3079, d5fg9O_, 0.8844, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
3080, d5fg7O_, 0.8844, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME BETA2-T1A MUTANT
3081, d5fg7A_, 0.8844, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME BETA2-T1A MUTANT
3082, d5d0vO_, 0.8844, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
3083, d5d0vA_, 0.8844, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
3084, d5cz9O_, 0.8844, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
3085, d5cz9A_, 0.8844, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
3086, d4ya4O_, 0.8844, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME BETA2-H114D MUTANT
3087, d4ya4A_, 0.8844, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME BETA2-H114D MUTANT
3088, d4qzxO_, 0.8844, 1.74, 0.285, 250, 221, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3089, d4qzxA_, 0.8844, 1.74, 0.285, 250, 221, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3090, d4qwfO_, 0.8844, 1.74, 0.285, 250, 221, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
3091, d4qwfA_, 0.8844, 1.74, 0.285, 250, 221, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
3092, d4qw7O_, 0.8844, 1.73, 0.285, 250, 221, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
3093, d4qw7A_, 0.8844, 1.73, 0.285, 250, 221, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
3094, d4qw5O_, 0.8844, 1.74, 0.285, 250, 221, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
3095, d4qw5A_, 0.8844, 1.73, 0.285, 250, 221, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
3096, d4qv6O_, 0.8844, 1.73, 0.285, 250, 221, YCP BETA5-A49V MUTANT
3097, d4qv6A_, 0.8844, 1.73, 0.285, 250, 221, YCP BETA5-A49V MUTANT
3098, d4no9O_, 0.8844, 1.73, 0.285, 250, 221, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
3099, d4no9A_, 0.8844, 1.73, 0.285, 250, 221, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
3100, d4hrcO_, 0.8844, 1.73, 0.285, 249, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
3101, p4gk7O_, 0.8844, 1.73, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
3102, d3shjQ_, 0.8844, 2.03, 0.305, 241, 223, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
3103, d3nzxO_, 0.8844, 1.74, 0.285, 250, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
3104, d3nzxA_, 0.8844, 1.74, 0.285, 250, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
3105, d3d29Q2, 0.8844, 2.04, 0.305, 234, 223, PROTEASOME INHIBITION BY FELLUTAMIDE B
3106, d3d29C2, 0.8844, 2.04, 0.305, 234, 223, PROTEASOME INHIBITION BY FELLUTAMIDE B
3107, d3bdmQ_, 0.8844, 2.04, 0.305, 241, 223, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
3108, d5m2bO_, 0.8843, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
3109, d5lttO_, 0.8843, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
3110, d5l64O_, 0.8843, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3111, d5l64A_, 0.8843, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3112, d5l63O_, 0.8843, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3113, d5l61O_, 0.8843, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3114, d5l61A_, 0.8843, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3115, d5l5xO_, 0.8843, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3116, d5l5xA_, 0.8843, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3117, d5l5tO_, 0.8843, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3118, d5l5tA_, 0.8843, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3119, d5l5sO_, 0.8843, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
3120, d5l5sA_, 0.8843, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
3121, d5l5qO_, 0.8843, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
3122, d5l5oA_, 0.8843, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3123, d5l5iO_, 0.8843, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
3124, d5l5iA_, 0.8843, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
3125, d5l5dO_, 0.8843, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3126, d5l5dA_, 0.8843, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3127, d5l5aO_, 0.8843, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
3128, d5jhsO_, 0.8843, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
3129, d5jhsA_, 0.8843, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
3130, d5fgaA_, 0.8843, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
3131, d5fg9A_, 0.8843, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
3132, d5d0zO_, 0.8843, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
3133, d5d0zA_, 0.8843, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
3134, d5cgfO_, 0.8843, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME BETA5-G48C MUTANT
3135, d5cgfA_, 0.8843, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME BETA5-G48C MUTANT
3136, d5bxnA_, 0.8843, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
3137, p4y8lO_, 0.8843, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
3138, d4r02O_, 0.8843, 1.74, 0.285, 250, 221, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
3139, d4qwuO_, 0.8843, 1.74, 0.285, 250, 221, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
3140, d4qwuA_, 0.8843, 1.74, 0.285, 250, 221, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
3141, d4qwrO_, 0.8843, 1.74, 0.285, 250, 221, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
3142, d4qwrA_, 0.8843, 1.74, 0.285, 250, 221, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
3143, d4quxO_, 0.8843, 1.74, 0.285, 250, 221, YCP BETA5-A49T-MUTANT
3144, d4quxA_, 0.8843, 1.74, 0.285, 250, 221, YCP BETA5-A49T-MUTANT
3145, d4qluO_, 0.8843, 1.74, 0.285, 250, 221, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
3146, d4qluA_, 0.8843, 1.74, 0.285, 250, 221, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
3147, d4qltO_, 0.8843, 1.74, 0.285, 250, 221, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
3148, d4qltA_, 0.8843, 1.74, 0.285, 250, 221, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
3149, d4hnpO_, 0.8843, 1.73, 0.285, 250, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
3150, d4fzcO_, 0.8843, 1.74, 0.285, 250, 221, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
3151, d4fzcA_, 0.8843, 1.74, 0.285, 250, 221, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
3152, d3tddO_, 0.8843, 1.74, 0.285, 250, 221, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
3153, d3shjO_, 0.8843, 1.74, 0.285, 250, 221, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
3154, d3shjA_, 0.8843, 1.74, 0.285, 250, 221, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
3155, d1yauC_, 0.8843, 1.63, 0.333, 222, 219, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
3156, d1g0uC_, 0.8843, 2.03, 0.305, 238, 223, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
3157, p5vfqC_, 0.8842, 2.10, 0.335, 248, 227, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3158, p5t0cW_, 0.8842, 1.81, 0.320, 228, 222, 
3159, p5t0cCB_, 0.8842, 1.81, 0.320, 228, 222, 
3160, d5m2bA_, 0.8842, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
3161, d5lttA_, 0.8842, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
3162, d5l6cO_, 0.8842, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3163, d5l6cA_, 0.8842, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3164, d5l67O_, 0.8842, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3165, d5l67A_, 0.8842, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3166, d5l65O_, 0.8842, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3167, d5l65A_, 0.8842, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3168, d5l63A_, 0.8842, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3169, d5l62O_, 0.8842, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3170, d5l62A_, 0.8842, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3171, d5l5qA_, 0.8842, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
3172, d5l5jO_, 0.8842, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3173, d5l5jA_, 0.8842, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3174, d5l5aA_, 0.8842, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
3175, d5fgeO_, 0.8842, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3176, d5fgeA_, 0.8842, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3177, d5cz6O_, 0.8842, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
3178, d5cz6A_, 0.8842, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
3179, d5bxnO_, 0.8842, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
3180, d4y8mO_, 0.8842, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
3181, d4y8mA_, 0.8842, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
3182, p4y8jO_, 0.8842, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
3183, p4y82O_, 0.8842, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
3184, p4y7xO_, 0.8842, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
3185, p4y70O_, 0.8842, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
3186, d4r17O_, 0.8842, 1.74, 0.285, 249, 221, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
3187, d4r17A_, 0.8842, 1.74, 0.285, 249, 221, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
3188, d4qxjO_, 0.8842, 1.74, 0.285, 250, 221, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3189, d4qxjA_, 0.8842, 1.74, 0.285, 250, 221, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3190, d4qvlO_, 0.8842, 1.74, 0.285, 250, 221, YCP IN COMPLEX WITH BORTEZOMIB
3191, d4qvlA_, 0.8842, 1.74, 0.285, 250, 221, YCP IN COMPLEX WITH BORTEZOMIB
3192, d4jsuO_, 0.8842, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
3193, d4j70C_, 0.8842, 2.05, 0.305, 241, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
3194, d4hrcA_, 0.8842, 1.74, 0.285, 249, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
3195, d3tddA_, 0.8842, 1.74, 0.285, 250, 221, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
3196, d3sdiC_, 0.8842, 2.06, 0.305, 238, 223, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
3197, d2ku1D1, 0.8842, 1.92, 0.329, 233, 222, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
3198, p5vfoI_, 0.8841, 2.11, 0.335, 248, 227, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3199, d5l68O_, 0.8841, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3200, d5l68A_, 0.8841, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3201, d5l66O_, 0.8841, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3202, d5l66A_, 0.8841, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3203, d5l60O_, 0.8841, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3204, d5l60A_, 0.8841, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3205, d5l5zO_, 0.8841, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3206, d5l5zA_, 0.8841, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3207, d5l5vO_, 0.8841, 1.74, 0.285, 250, 221,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3208, d5l5vA_, 0.8841, 1.74, 0.285, 250, 221,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3209, d5l5pO_, 0.8841, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3210, d5l5pA_, 0.8841, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3211, d5l54O_, 0.8841, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3212, d5l54A_, 0.8841, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3213, d5fgiO_, 0.8841, 1.74, 0.285, 249, 221, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3214, d5fgiA_, 0.8841, 1.74, 0.285, 249, 221, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3215, d5cz8O_, 0.8841, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
3216, d5cz8A_, 0.8841, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
3217, d4z1lO_, 0.8841, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
3218, d4z1lA_, 0.8841, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
3219, p4y8qO_, 0.8841, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
3220, p4y8iO_, 0.8841, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
3221, p4y80O_, 0.8841, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
3222, p4y7yO_, 0.8841, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
3223, p4y7wO_, 0.8841, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
3224, p4y74O_, 0.8841, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
3225, d4qz1O_, 0.8841, 1.74, 0.285, 250, 221, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3226, d4qw4O_, 0.8841, 1.74, 0.285, 250, 221, YCP IN COMPLEX WITH CARFILZOMIB
3227, d4qw4A_, 0.8841, 1.74, 0.285, 250, 221, YCP IN COMPLEX WITH CARFILZOMIB
3228, d4qw1O_, 0.8841, 1.74, 0.285, 250, 221, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
3229, d4qw1A_, 0.8841, 1.74, 0.285, 250, 221, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
3230, d4qlsO_, 0.8841, 1.74, 0.285, 250, 221, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
3231, d4qlsA_, 0.8841, 1.74, 0.285, 250, 221, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
3232, d4no6Q_, 0.8841, 2.04, 0.305, 240, 223, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
3233, d4no6C_, 0.8841, 2.04, 0.305, 240, 223, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
3234, d4jsuA_, 0.8841, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
3235, d4hrdA_, 0.8841, 1.74, 0.285, 250, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
3236, d4hrcC_, 0.8841, 2.05, 0.305, 241, 223, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
3237, d4fzgO_, 0.8841, 1.74, 0.285, 250, 221, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
3238, d4fzgA_, 0.8841, 1.74, 0.285, 250, 221, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
3239, d3un8Q_, 0.8841, 2.05, 0.305, 241, 223, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
3240, d3nzjA_, 0.8841, 1.74, 0.285, 250, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
3241, d3gpwO_, 0.8841, 1.74, 0.285, 250, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
3242, d3gpwA_, 0.8841, 1.74, 0.285, 250, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
3243, d3gptO_, 0.8841, 1.74, 0.285, 250, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
3244, d3gptA_, 0.8841, 1.74, 0.285, 250, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
3245, p6epfG_, 0.8840, 2.17, 0.268, 245, 224, GROUND STATE 26S PROTEASOME (GS1)
3246, p5mpcU_, 0.8840, 2.38, 0.293, 243, 229, 
3247, d5l69O_, 0.8840, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3248, d5l69A_, 0.8840, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3249, d5l5yA_, 0.8840, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3250, d5fhsO_, 0.8840, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
3251, d5fhsA_, 0.8840, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
3252, d5fgdO_, 0.8840, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3253, d5fgdA_, 0.8840, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3254, d5cz7O_, 0.8840, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
3255, d5cz7A_, 0.8840, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
3256, d5bouO_, 0.8840, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
3257, p4y8tO_, 0.8840, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
3258, p4y8oO_, 0.8840, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
3259, d4qz1A_, 0.8840, 1.74, 0.285, 250, 221, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3260, d4qwiO_, 0.8840, 1.74, 0.285, 250, 221, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
3261, d4qwiA_, 0.8840, 1.74, 0.285, 250, 221, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
3262, d4qvyO_, 0.8840, 1.74, 0.285, 250, 221, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
3263, d4qvyA_, 0.8840, 1.74, 0.285, 250, 221, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
3264, d4qvnO_, 0.8840, 1.74, 0.285, 250, 221, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
3265, d4qvnA_, 0.8840, 1.74, 0.285, 250, 221, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
3266, d4qlqO_, 0.8840, 1.74, 0.285, 250, 221, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
3267, d4qlqA_, 0.8840, 1.74, 0.285, 250, 221, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
3268, d4q1sO_, 0.8840, 1.75, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
3269, d4j70Q_, 0.8840, 2.05, 0.305, 241, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
3270, d4inrC_, 0.8840, 2.05, 0.305, 241, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
3271, d4hrdO_, 0.8840, 1.74, 0.285, 250, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
3272, d3un8C_, 0.8840, 2.05, 0.305, 241, 223, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
3273, d3nzjO_, 0.8840, 1.74, 0.285, 250, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
3274, d3mg8C_, 0.8840, 2.07, 0.305, 241, 223, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
3275, d3mg6C_, 0.8840, 2.06, 0.305, 241, 223, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
3276, d3mg0A_, 0.8840, 1.74, 0.285, 250, 221, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
3277, d3hyeO_, 0.8840, 1.74, 0.285, 250, 221, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
3278, d3hyeA_, 0.8840, 1.74, 0.285, 250, 221, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
3279, d5l5yO_, 0.8839, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3280, d5l5fO_, 0.8839, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3281, d5l5fA_, 0.8839, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3282, d5bouA_, 0.8839, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
3283, p4y8hO_, 0.8839, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
3284, p4y8gO_, 0.8839, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
3285, p4y81O_, 0.8839, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
3286, p4y6zO_, 0.8839, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
3287, p4y6vO_, 0.8839, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
3288, p4x6zD_, 0.8839, 2.04, 0.305, 241, 223, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
3289, d4qz5C_, 0.8839, 2.05, 0.305, 240, 223, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
3290, d4qvwO_, 0.8839, 1.74, 0.285, 250, 221, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
3291, d4qvwA_, 0.8839, 1.74, 0.285, 250, 221, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
3292, d3gptQ_, 0.8839, 2.04, 0.305, 241, 223, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
3293, d3gptC_, 0.8839, 2.04, 0.305, 241, 223, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
3294, d5l5eO_, 0.8838, 1.75, 0.285, 250, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3295, d5l5eA_, 0.8838, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3296, d5cz5O_, 0.8838, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
3297, d5cz5A_, 0.8838, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
3298, d4rurO_, 0.8838, 1.75, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
3299, d4rurA_, 0.8838, 1.75, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
3300, d4qz5Q_, 0.8838, 2.05, 0.305, 240, 223, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
3301, d4qwkO_, 0.8838, 1.75, 0.285, 250, 221, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3302, d4qwkA_, 0.8838, 1.75, 0.285, 250, 221, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3303, d4qvpO_, 0.8838, 1.74, 0.285, 250, 221, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
3304, d4qvpA_, 0.8838, 1.74, 0.285, 250, 221, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
3305, d4inrQ_, 0.8838, 2.05, 0.305, 241, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
3306, d3nzwO_, 0.8838, 1.74, 0.285, 250, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
3307, d3nzwA_, 0.8838, 1.74, 0.285, 250, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
3308, d3mg4C_, 0.8838, 2.06, 0.305, 241, 223, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
3309, d5dkjO_, 0.8837, 1.75, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
3310, d5dkjA_, 0.8837, 1.75, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
3311, d5d0tO_, 0.8837, 1.75, 0.285, 250, 221, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
3312, d5d0tA_, 0.8837, 1.75, 0.285, 250, 221, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
3313, p4y8uO_, 0.8837, 1.75, 0.285, 250, 221, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
3314, p4y8sQ_, 0.8837, 2.05, 0.305, 240, 223, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
3315, p4y8sC_, 0.8837, 2.05, 0.305, 240, 223, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
3316, p4y8nO_, 0.8837, 1.75, 0.285, 250, 221, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
3317, p4y78O_, 0.8837, 1.75, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
3318, p4y69O_, 0.8837, 1.75, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
3319, d4qwjO_, 0.8837, 1.75, 0.285, 250, 221, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
3320, d4qwjA_, 0.8837, 1.75, 0.285, 250, 221, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
3321, d4qw0O_, 0.8837, 1.75, 0.285, 250, 221, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
3322, d4qvqO_, 0.8837, 1.74, 0.285, 250, 221, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
3323, d4qvqA_, 0.8837, 1.74, 0.285, 250, 221, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
3324, d4qlvO_, 0.8837, 1.75, 0.285, 250, 221, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
3325, d4qlvA_, 0.8837, 1.75, 0.285, 250, 221, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
3326, d4qlqC_, 0.8837, 2.05, 0.305, 240, 223, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
3327, p4gk7Q_, 0.8837, 2.05, 0.305, 241, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
3328, p4gk7C_, 0.8837, 2.05, 0.305, 241, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
3329, d3oevC_, 0.8837, 2.07, 0.305, 241, 223, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
3330, d3oeuC_, 0.8837, 2.07, 0.305, 241, 223, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
3331, d1yauB_, 0.8837, 1.65, 0.333, 222, 219, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
3332, p5vfpC_, 0.8836, 2.11, 0.335, 248, 227, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3333, d5lajO_, 0.8836, 1.75, 0.285, 250, 221, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3334, d5lajA_, 0.8836, 1.75, 0.285, 250, 221, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3335, d5l54C_, 0.8836, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3336, p4ya5O_, 0.8836, 1.75, 0.285, 250, 221, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
3337, p4y84O_, 0.8836, 1.75, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
3338, p4y6aO_, 0.8836, 1.75, 0.285, 250, 221, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
3339, d4qz3Q_, 0.8836, 2.06, 0.305, 240, 223, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3340, d4qz3C_, 0.8836, 2.06, 0.305, 240, 223, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3341, d4qwlQ_, 0.8836, 2.05, 0.305, 240, 223, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
3342, d4qwlC_, 0.8836, 2.05, 0.305, 240, 223, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
3343, d4qw0A_, 0.8836, 1.75, 0.285, 250, 221, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
3344, d4qlqQ_, 0.8836, 2.05, 0.305, 240, 223, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
3345, d4lqiO_, 0.8836, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
3346, d4lqiA_, 0.8836, 1.74, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
3347, d5laiO_, 0.8835, 1.75, 0.285, 250, 221, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3348, d5laiA_, 0.8835, 1.75, 0.285, 250, 221, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3349, d5l54Q_, 0.8835, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3350, d5d0xA_, 0.8835, 1.75, 0.285, 250, 221, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
3351, p4x6zR_, 0.8835, 2.06, 0.305, 241, 223, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
3352, d4r18O_, 0.8835, 1.75, 0.285, 250, 221, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
3353, d4r18A_, 0.8835, 1.75, 0.285, 250, 221, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
3354, d4hrdC_, 0.8835, 2.06, 0.305, 241, 223, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
3355, d4hnpC_, 0.8835, 2.06, 0.305, 241, 223, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
3356, d1g65C_, 0.8835, 2.04, 0.305, 241, 223, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
3357, p5fghO_, 0.8834, 1.75, 0.285, 250, 221, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
3358, d5d0xO_, 0.8834, 1.75, 0.285, 250, 221, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
3359, p4y9zC_, 0.8834, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
3360, p4y8jQ_, 0.8834, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
3361, p4y8jC_, 0.8834, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
3362, p4y8hQ_, 0.8834, 2.05, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
3363, p4y8hC_, 0.8834, 2.05, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
3364, p4y7yQ_, 0.8834, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
3365, p4y7yC_, 0.8834, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
3366, d4r02A_, 0.8834, 1.75, 0.285, 250, 221, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
3367, d4qz6Q_, 0.8834, 2.06, 0.305, 240, 223, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3368, d4qz6C_, 0.8834, 2.06, 0.305, 240, 223, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3369, d4qwjQ_, 0.8834, 2.07, 0.305, 240, 223, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
3370, d4qwjC_, 0.8834, 2.07, 0.305, 240, 223, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
3371, d4qltQ_, 0.8834, 2.06, 0.305, 240, 223, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
3372, d4qltC_, 0.8834, 2.06, 0.305, 240, 223, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
3373, d4q1sA_, 0.8834, 1.75, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
3374, d4no9Q_, 0.8834, 2.06, 0.305, 240, 223, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
3375, d4no9C_, 0.8834, 2.06, 0.305, 240, 223, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
3376, d4inuC_, 0.8834, 2.06, 0.305, 241, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
3377, d3tddQ_, 0.8834, 2.05, 0.305, 241, 223, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
3378, d3tddC_, 0.8834, 2.05, 0.305, 241, 223, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
3379, d1g0uQ_, 0.8834, 2.04, 0.305, 238, 223, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
3380, p6gopQ_, 0.8833, 2.05, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
3381, p6gopC_, 0.8833, 2.05, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
3382, d5dkiA_, 0.8833, 1.75, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
3383, d5cz8Q_, 0.8833, 2.07, 0.305, 240, 223, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
3384, d5cz8C_, 0.8833, 2.07, 0.305, 240, 223, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
3385, p5a0qQ_, 0.8833, 1.96, 0.333, 237, 222, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
3386, p5a0qC_, 0.8833, 1.96, 0.333, 237, 222, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
3387, p4ya7C_, 0.8833, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
3388, p4y9zQ_, 0.8833, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
3389, p4y84Q_, 0.8833, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
3390, p4y7wQ_, 0.8833, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
3391, p4y7wC_, 0.8833, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
3392, p4y70C_, 0.8833, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
3393, d4qzwQ_, 0.8833, 2.06, 0.305, 240, 223, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3394, d4qzwC_, 0.8833, 2.06, 0.305, 240, 223, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3395, d4qwsA_, 0.8833, 1.75, 0.285, 250, 221, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
3396, d4qvmO_, 0.8833, 1.75, 0.285, 250, 221, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
3397, d4qvmA_, 0.8833, 1.75, 0.285, 250, 221, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
3398, d4no1Q_, 0.8833, 2.05, 0.305, 240, 223, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
3399, d4no1C_, 0.8833, 2.05, 0.305, 240, 223, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
3400, d4ltcC_, 0.8833, 2.07, 0.305, 241, 223, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
3401, d4inuQ_, 0.8833, 2.06, 0.305, 241, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
3402, d4eu2R_, 0.8833, 2.05, 0.305, 241, 223, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
3403, d3nzwC_, 0.8833, 2.05, 0.305, 241, 223, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
3404, d3nzjQ_, 0.8833, 2.06, 0.305, 241, 223, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
3405, d3nzjC_, 0.8833, 2.06, 0.305, 241, 223, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
3406, d3e47C_, 0.8833, 2.05, 0.305, 241, 223, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
3407, d2fnyC_, 0.8833, 2.05, 0.305, 241, 223,  
3408, d1j2qB_, 0.8833, 1.81, 0.344, 237, 221, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
3409, p1fntO_, 0.8833, 1.97, 0.219, 238, 224, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3410, d5dkiO_, 0.8832, 1.75, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
3411, d5d0sQ_, 0.8832, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
3412, d5d0sC_, 0.8832, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
3413, d5cz4O_, 0.8832, 1.76, 0.285, 250, 221, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
3414, d5cz4A_, 0.8832, 1.76, 0.285, 250, 221, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
3415, p4ya7Q_, 0.8832, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
3416, p4y8lC_, 0.8832, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
3417, p4y84C_, 0.8832, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
3418, p4y70Q_, 0.8832, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
3419, d4r02C_, 0.8832, 2.07, 0.305, 240, 223, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
3420, d4qwsO_, 0.8832, 1.75, 0.285, 250, 221, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
3421, d4qwiQ_, 0.8832, 2.07, 0.305, 240, 223, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
3422, d4qwiC_, 0.8832, 2.07, 0.305, 240, 223, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
3423, d4qw7Q_, 0.8832, 2.07, 0.305, 240, 223, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
3424, d4qw7C_, 0.8832, 2.06, 0.305, 240, 223, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
3425, d4nnnQ_, 0.8832, 2.06, 0.305, 240, 223, YCP IN COMPLEX WITH MG132
3426, d4nnnC_, 0.8832, 2.06, 0.305, 240, 223, YCP IN COMPLEX WITH MG132
3427, d3okjC_, 0.8832, 2.05, 0.305, 241, 223, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
3428, d3nzxQ_, 0.8832, 2.05, 0.305, 241, 223, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
3429, d3nzxC_, 0.8832, 2.05, 0.305, 241, 223, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
3430, d3nzwQ_, 0.8832, 2.05, 0.305, 241, 223, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
3431, d3hyeC_, 0.8832, 2.05, 0.305, 241, 223, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
3432, d3gpwQ_, 0.8832, 2.05, 0.305, 241, 223, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
3433, d3gpwC_, 0.8832, 2.05, 0.305, 241, 223, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
3434, d3e47Q_, 0.8832, 2.05, 0.305, 241, 223, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
3435, d2fnyQ_, 0.8832, 2.05, 0.305, 241, 223,  
3436, p1fntA_, 0.8832, 1.97, 0.219, 238, 224, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3437, d5d0zC_, 0.8831, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
3438, p4y8lQ_, 0.8831, 2.07, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
3439, p4y8gQ_, 0.8831, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
3440, p4y8gC_, 0.8831, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
3441, p4y78Q_, 0.8831, 2.07, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
3442, p4y78C_, 0.8831, 2.07, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
3443, d4qz7Q_, 0.8831, 2.06, 0.305, 240, 223, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3444, d4qz7C_, 0.8831, 2.06, 0.305, 240, 223, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3445, d4qwkQ_, 0.8831, 2.07, 0.305, 240, 223, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3446, d4qwkC_, 0.8831, 2.07, 0.305, 240, 223, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3447, d4qv9Q_, 0.8831, 2.05, 0.305, 240, 223, YCP BETA5-C63F MUTANT
3448, d4qv9C_, 0.8831, 2.05, 0.305, 240, 223, YCP BETA5-C63F MUTANT
3449, d4lqiC_, 0.8831, 2.05, 0.305, 241, 223, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
3450, d4jsuQ_, 0.8831, 2.06, 0.305, 241, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
3451, d4jsuC_, 0.8831, 2.06, 0.305, 241, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
3452, d3wxrP_, 0.8831, 1.75, 0.285, 249, 221, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
3453, p3un4C_, 0.8831, 2.05, 0.305, 241, 223, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
3454, d3okjQ_, 0.8831, 2.05, 0.305, 241, 223, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
3455, d3hyeQ_, 0.8831, 2.05, 0.305, 241, 223, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
3456, d2fakC_, 0.8831, 2.06, 0.305, 241, 223, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
3457, d5lajQ_, 0.8830, 2.06, 0.305, 240, 223, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3458, d5lajC_, 0.8830, 2.06, 0.305, 240, 223, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3459, d5l55Q_, 0.8830, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3460, d5l55C_, 0.8830, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3461, d5jhrQ_, 0.8830, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
3462, d5jhrC_, 0.8830, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
3463, d5d0zQ_, 0.8830, 2.07, 0.305, 240, 223, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
3464, p4ya3O_, 0.8830, 1.76, 0.285, 250, 221, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
3465, p4ya0O_, 0.8830, 1.76, 0.285, 250, 221, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
3466, p4y8qC_, 0.8830, 2.07, 0.305, 240, 223, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
3467, p4y8iQ_, 0.8830, 2.07, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
3468, p4y8iC_, 0.8830, 2.07, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
3469, p4y80C_, 0.8830, 2.07, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
3470, d4qw6Q_, 0.8830, 2.07, 0.305, 240, 223, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
3471, d4qw6C_, 0.8830, 2.07, 0.305, 240, 223, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
3472, d4qv7Q_, 0.8830, 2.06, 0.305, 240, 223, YCP BETA5-A50V MUTANT
3473, d4qv7C_, 0.8830, 2.06, 0.305, 240, 223, YCP BETA5-A50V MUTANT
3474, d4qv6Q_, 0.8830, 2.06, 0.305, 240, 223, YCP BETA5-A49V MUTANT
3475, d4qv6C_, 0.8830, 2.06, 0.305, 240, 223, YCP BETA5-A49V MUTANT
3476, d4qv3C_, 0.8830, 2.06, 0.305, 240, 223, YCP BETA5-M45V MUTANT
3477, d4lqiQ_, 0.8830, 2.05, 0.305, 241, 223, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
3478, d4jsqQ_, 0.8830, 2.06, 0.305, 241, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
3479, d4jsqC_, 0.8830, 2.06, 0.305, 241, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
3480, d4intC_, 0.8830, 2.06, 0.305, 241, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
3481, p3un4Q_, 0.8830, 2.05, 0.305, 241, 223, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
3482, d3mg0Q_, 0.8830, 2.06, 0.305, 241, 223, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
3483, d2fakQ_, 0.8830, 2.06, 0.305, 241, 223, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
3484, d1j2qF_, 0.8830, 1.81, 0.344, 237, 221, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
3485, d5l52Q_, 0.8829, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3486, d5l52C_, 0.8829, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3487, d5jhsQ_, 0.8829, 2.07, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
3488, d5jhsC_, 0.8829, 2.07, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
3489, d5fhsQ_, 0.8829, 2.07, 0.305, 240, 223, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
3490, d5fhsC_, 0.8829, 2.07, 0.305, 240, 223, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
3491, d5fggQ_, 0.8829, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3492, d5fggC_, 0.8829, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3493, d5cz5Q_, 0.8829, 2.07, 0.305, 240, 223, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
3494, d5cz5C_, 0.8829, 2.07, 0.305, 240, 223, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
3495, p5cgiC_, 0.8829, 2.07, 0.305, 240, 223, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
3496, p5cggC_, 0.8829, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
3497, p4ya2C_, 0.8829, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
3498, p4y8qQ_, 0.8829, 2.07, 0.305, 240, 223, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
3499, p4y80Q_, 0.8829, 2.07, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
3500, d4qzxC_, 0.8829, 2.07, 0.305, 240, 223, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3501, d4qz4Q_, 0.8829, 2.06, 0.305, 240, 223, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3502, d4qz4C_, 0.8829, 2.06, 0.305, 240, 223, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3503, d4qxjQ_, 0.8829, 2.07, 0.305, 240, 223, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3504, d4qxjC_, 0.8829, 2.07, 0.305, 240, 223, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3505, d4qwrQ_, 0.8829, 2.07, 0.305, 240, 223, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
3506, d4qwrC_, 0.8829, 2.07, 0.305, 240, 223, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
3507, d4qw5Q_, 0.8829, 2.07, 0.305, 240, 223, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
3508, d4qw5C_, 0.8829, 2.07, 0.305, 240, 223, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
3509, d4qw4Q_, 0.8829, 2.07, 0.305, 240, 223, YCP IN COMPLEX WITH CARFILZOMIB
3510, d4qw4C_, 0.8829, 2.07, 0.305, 240, 223, YCP IN COMPLEX WITH CARFILZOMIB
3511, d4qw3O_, 0.8829, 1.76, 0.285, 250, 221, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
3512, d4qw3A_, 0.8829, 1.76, 0.285, 250, 221, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
3513, d4qvvO_, 0.8829, 1.76, 0.285, 250, 221, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
3514, d4qvvA_, 0.8829, 1.76, 0.285, 250, 221, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
3515, d4qv8Q_, 0.8829, 2.06, 0.305, 240, 223, YCP BETA5-C52F MUTANT
3516, d4qv8C_, 0.8829, 2.06, 0.305, 240, 223, YCP BETA5-C52F MUTANT
3517, d4qv3Q_, 0.8829, 2.06, 0.305, 240, 223, YCP BETA5-M45V MUTANT
3518, d4qv0Q_, 0.8829, 2.06, 0.305, 240, 223, YCP BETA5-A49T-A50V-DOUBLE MUTANT
3519, d4qv0C_, 0.8829, 2.06, 0.305, 240, 223, YCP BETA5-A49T-A50V-DOUBLE MUTANT
3520, d1j2qD_, 0.8829, 1.81, 0.344, 237, 221, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
3521, p5vfrI_, 0.8828, 2.12, 0.335, 248, 227, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3522, d5d0vC_, 0.8828, 2.07, 0.305, 240, 223, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
3523, d5cz9Q_, 0.8828, 2.07, 0.305, 240, 223, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
3524, d5cz9C_, 0.8828, 2.07, 0.305, 240, 223, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
3525, p5cgiQ_, 0.8828, 2.07, 0.305, 240, 223, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
3526, p5cggQ_, 0.8828, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
3527, d5cgfC_, 0.8828, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME BETA5-G48C MUTANT
3528, p4ya9Q_, 0.8828, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
3529, p4ya9C_, 0.8828, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
3530, p4ya2Q_, 0.8828, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
3531, p4y8pQ_, 0.8828, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
3532, p4y8pC_, 0.8828, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
3533, p4y77C_, 0.8828, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
3534, d4r00C_, 0.8828, 2.07, 0.305, 240, 223, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
3535, d4qzxQ_, 0.8828, 2.07, 0.305, 240, 223, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3536, d4qwgO_, 0.8828, 1.76, 0.285, 250, 221, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
3537, d4qwgA_, 0.8828, 1.76, 0.285, 250, 221, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
3538, d4qw1C_, 0.8828, 2.06, 0.305, 240, 223, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
3539, d4qvvQ_, 0.8828, 2.07, 0.305, 240, 223, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
3540, d4qvvC_, 0.8828, 2.07, 0.305, 240, 223, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
3541, d4no8C_, 0.8828, 2.06, 0.305, 240, 223, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
3542, d3mg0C_, 0.8828, 2.06, 0.305, 241, 223, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
3543, d1yauD_, 0.8828, 1.66, 0.333, 222, 219, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
3544, d1g65Q_, 0.8828, 2.05, 0.305, 241, 223, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
3545, d5fg7Q_, 0.8827, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME BETA2-T1A MUTANT
3546, d5fg7C_, 0.8827, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME BETA2-T1A MUTANT
3547, d5d0wQ_, 0.8827, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME BETA5-T1S MUTANT
3548, d5d0wC_, 0.8827, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME BETA5-T1S MUTANT
3549, d5d0vQ_, 0.8827, 2.07, 0.305, 240, 223, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
3550, d5d0tQ_, 0.8827, 2.07, 0.305, 240, 223, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
3551, d5d0tC_, 0.8827, 2.07, 0.305, 240, 223, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
3552, d5cgfQ_, 0.8827, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME BETA5-G48C MUTANT
3553, d5ahjC_, 0.8827, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
3554, d4y9yC_, 0.8827, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME BETA2-H116E MUTANT
3555, d4y8rQ_, 0.8827, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME BETA2-H116D MUTANT
3556, d4y8rC_, 0.8827, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME BETA2-H116D MUTANT
3557, p4y77Q_, 0.8827, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
3558, p4y75C_, 0.8827, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
3559, p4y74Q_, 0.8827, 2.07, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
3560, p4y74C_, 0.8827, 2.07, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
3561, d4r00Q_, 0.8827, 2.07, 0.305, 240, 223, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
3562, d4qwfQ_, 0.8827, 2.07, 0.305, 240, 223, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
3563, d4qwfC_, 0.8827, 2.07, 0.305, 240, 223, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
3564, d4qw1Q_, 0.8827, 2.06, 0.305, 240, 223, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
3565, d4qv5Q_, 0.8827, 2.06, 0.305, 240, 223, YCP BETA5-M45I MUTANT
3566, d4qv5C_, 0.8827, 2.06, 0.305, 240, 223, YCP BETA5-M45I MUTANT
3567, d4qlsC_, 0.8827, 2.07, 0.305, 240, 223, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
3568, d4no8Q_, 0.8827, 2.06, 0.305, 240, 223, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
3569, d4nnwQ_, 0.8827, 2.06, 0.305, 240, 223, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
3570, d4nnwC_, 0.8827, 2.06, 0.305, 240, 223, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
3571, d4intQ_, 0.8827, 2.06, 0.305, 241, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
3572, d3sdiD_, 0.8827, 1.39, 0.353, 228, 215, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
3573, d1j2qG_, 0.8827, 1.81, 0.344, 237, 221, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
3574, d1j2qE_, 0.8827, 1.81, 0.344, 237, 221, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
3575, d1j2qA_, 0.8827, 1.81, 0.344, 237, 221, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
3576, p5wvkZ_, 0.8826, 1.95, 0.341, 242, 223, 
3577, p5vfsE_, 0.8826, 1.84, 0.324, 228, 222, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3578, d5fgaQ_, 0.8826, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
3579, d5fgaC_, 0.8826, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
3580, p5cghQ_, 0.8826, 2.07, 0.305, 240, 223, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
3581, p5cghC_, 0.8826, 2.07, 0.305, 240, 223, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
3582, d5ahjQ_, 0.8826, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
3583, d4z1lQ_, 0.8826, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
3584, d4z1lC_, 0.8826, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
3585, d4y9yQ_, 0.8826, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME BETA2-H116E MUTANT
3586, p4y8oC_, 0.8826, 2.07, 0.305, 240, 223, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
3587, p4y82Q_, 0.8826, 2.07, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
3588, p4y82C_, 0.8826, 2.07, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
3589, p4y75Q_, 0.8826, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
3590, d4r18Q_, 0.8826, 2.06, 0.305, 240, 223, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
3591, d4r18C_, 0.8826, 2.06, 0.305, 240, 223, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
3592, d4qzzQ_, 0.8826, 2.07, 0.305, 240, 223, YCP IN COMPLEX WITH OMURALIDE
3593, d4qzzC_, 0.8826, 2.07, 0.305, 240, 223, YCP IN COMPLEX WITH OMURALIDE
3594, d4qz2C_, 0.8826, 2.08, 0.305, 240, 223, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3595, d4qvpQ_, 0.8826, 2.07, 0.305, 240, 223, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
3596, d4qvpC_, 0.8826, 2.07, 0.305, 240, 223, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
3597, d4qvlC_, 0.8826, 2.06, 0.305, 240, 223, YCP IN COMPLEX WITH BORTEZOMIB
3598, d4qv4Q_, 0.8826, 2.06, 0.305, 240, 223, YCP BETA5-M45T MUTANT
3599, d4qv4C_, 0.8826, 2.06, 0.305, 240, 223, YCP BETA5-M45T MUTANT
3600, d4qv1Q_, 0.8826, 2.06, 0.305, 240, 223, YCP BETA5-M45A MUTANT
3601, d4qv1C_, 0.8826, 2.06, 0.305, 240, 223, YCP BETA5-M45A MUTANT
3602, d4quyQ_, 0.8826, 2.06, 0.305, 240, 223, YCP BETA5-A49S-MUTANT
3603, d4quyC_, 0.8826, 2.06, 0.305, 240, 223, YCP BETA5-A49S-MUTANT
3604, d4qlvQ_, 0.8826, 2.07, 0.305, 240, 223, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
3605, d4qlvC_, 0.8826, 2.07, 0.305, 240, 223, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
3606, d4qlsQ_, 0.8826, 2.07, 0.305, 240, 223, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
3607, d4ltcQ_, 0.8826, 2.07, 0.305, 241, 223, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
3608, d4j70A_, 0.8826, 1.76, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
3609, d5fgiQ_, 0.8825, 2.08, 0.305, 240, 223, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3610, d5fgiC_, 0.8825, 2.08, 0.305, 240, 223, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3611, d5fgdC_, 0.8825, 2.08, 0.305, 240, 223, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3612, d5fg9Q_, 0.8825, 2.07, 0.305, 240, 223, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
3613, d5fg9C_, 0.8825, 2.07, 0.305, 240, 223, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
3614, d5d0xQ_, 0.8825, 2.07, 0.305, 240, 223, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
3615, d5d0xC_, 0.8825, 2.07, 0.305, 240, 223, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
3616, d5czaQ_, 0.8825, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME BETA5-D166N MUTANT
3617, d5czaC_, 0.8825, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME BETA5-D166N MUTANT
3618, p4y8oQ_, 0.8825, 2.07, 0.305, 240, 223, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
3619, p4y81C_, 0.8825, 2.07, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
3620, p4y7xQ_, 0.8825, 2.07, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
3621, p4y7xC_, 0.8825, 2.07, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
3622, d4qz2Q_, 0.8825, 2.08, 0.305, 240, 223, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3623, d4qwxQ_, 0.8825, 2.07, 0.305, 240, 223, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3624, d4qwxC_, 0.8825, 2.07, 0.305, 240, 223, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3625, d4qwuC_, 0.8825, 2.07, 0.305, 240, 223, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
3626, d4qvlQ_, 0.8825, 2.06, 0.305, 240, 223, YCP IN COMPLEX WITH BORTEZOMIB
3627, d4jt0Q_, 0.8825, 2.07, 0.305, 241, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
3628, d4jt0C_, 0.8825, 2.07, 0.305, 241, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
3629, d3sdiQ_, 0.8825, 2.08, 0.305, 238, 223, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
3630, d3mg4Q_, 0.8825, 2.07, 0.305, 241, 223, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
3631, d1j2qC_, 0.8825, 1.82, 0.344, 237, 221, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
3632, d5fgfQ_, 0.8824, 2.08, 0.305, 240, 223, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
3633, d5fgfC_, 0.8824, 2.08, 0.305, 240, 223, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
3634, d5fgeQ_, 0.8824, 2.08, 0.305, 240, 223, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3635, d5fgeC_, 0.8824, 2.08, 0.305, 240, 223, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3636, d5fgdQ_, 0.8824, 2.08, 0.305, 240, 223, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3637, d5dkjQ_, 0.8824, 2.07, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
3638, d5dkjC_, 0.8824, 2.07, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
3639, d5dkiQ_, 0.8824, 2.08, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
3640, d5dkiC_, 0.8824, 2.08, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
3641, d5bxnC_, 0.8824, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
3642, p4y81Q_, 0.8824, 2.07, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
3643, d4qwuQ_, 0.8824, 2.07, 0.305, 240, 223, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
3644, d4qvyQ_, 0.8824, 2.07, 0.305, 240, 223, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
3645, d4qvyC_, 0.8824, 2.07, 0.305, 240, 223, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
3646, d4qluQ_, 0.8824, 2.06, 0.305, 240, 223, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
3647, d4qluC_, 0.8824, 2.06, 0.305, 240, 223, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
3648, d4j70O_, 0.8824, 1.76, 0.285, 250, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
3649, d4eu2D_, 0.8824, 2.06, 0.305, 241, 223, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
3650, d2ku2B1, 0.8824, 1.85, 0.326, 233, 221, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
3651, p5vfsDA_, 0.8823, 1.84, 0.324, 228, 222, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3652, d5bxnQ_, 0.8823, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
3653, d5bxlQ_, 0.8823, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME BETA2-G170A MUTANT
3654, d5bxlC_, 0.8823, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME BETA2-G170A MUTANT
3655, d4ya1Q_, 0.8823, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME BETA2-H116N MUTANT
3656, d4ya1C_, 0.8823, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME BETA2-H116N MUTANT
3657, d4qz0C_, 0.8823, 2.07, 0.305, 240, 223, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3658, d4qw0Q_, 0.8823, 2.07, 0.305, 240, 223, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
3659, d4qw0C_, 0.8823, 2.07, 0.305, 240, 223, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
3660, d4qvqQ_, 0.8823, 2.08, 0.305, 240, 223, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
3661, d4qvqC_, 0.8823, 2.08, 0.305, 240, 223, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
3662, d4fzcQ_, 0.8823, 2.06, 0.305, 241, 223, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
3663, d4fzcC_, 0.8823, 2.06, 0.305, 241, 223, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
3664, d3mg6Q_, 0.8823, 2.08, 0.305, 241, 223, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
3665, d2ku1B1, 0.8823, 1.85, 0.326, 233, 221, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
3666, p5fghC_, 0.8822, 2.08, 0.305, 240, 223, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
3667, d4ya4Q_, 0.8822, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME BETA2-H114D MUTANT
3668, d4ya4C_, 0.8822, 2.06, 0.305, 240, 223, YEAST 20S PROTEASOME BETA2-H114D MUTANT
3669, p4ya0C_, 0.8822, 2.08, 0.305, 240, 223, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
3670, p4y8tQ_, 0.8822, 2.07, 0.305, 240, 223, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
3671, p4y8tC_, 0.8822, 2.07, 0.305, 240, 223, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
3672, d4y8mC_, 0.8822, 2.07, 0.305, 240, 223, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
3673, p4y6zC_, 0.8822, 2.08, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
3674, d4qz0Q_, 0.8822, 2.07, 0.305, 240, 223, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3675, d4qwsQ_, 0.8822, 2.08, 0.305, 240, 223, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
3676, d4qwsC_, 0.8822, 2.08, 0.305, 240, 223, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
3677, d4qvwQ_, 0.8822, 2.07, 0.305, 240, 223, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
3678, d4qvwC_, 0.8822, 2.07, 0.305, 240, 223, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
3679, d4quxQ_, 0.8822, 2.07, 0.305, 240, 223, YCP BETA5-A49T-MUTANT
3680, d4quxC_, 0.8822, 2.07, 0.305, 240, 223, YCP BETA5-A49T-MUTANT
3681, d3mg7C_, 0.8822, 2.09, 0.305, 241, 223, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
3682, d2f16C_, 0.8822, 2.06, 0.305, 241, 223, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
3683, d1rypD_, 0.8822, 2.06, 0.305, 241, 223, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
3684, p5mpcP_, 0.8821, 1.99, 0.274, 250, 226, 
3685, p5fghQ_, 0.8821, 2.08, 0.305, 240, 223, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
3686, d5cz6Q_, 0.8821, 2.07, 0.305, 240, 223, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
3687, p4ya3C_, 0.8821, 2.08, 0.305, 240, 223, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
3688, p4ya0Q_, 0.8821, 2.08, 0.305, 240, 223, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
3689, p4y8uQ_, 0.8821, 2.08, 0.305, 240, 223, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
3690, p4y8uC_, 0.8821, 2.08, 0.305, 240, 223, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
3691, d4y8mQ_, 0.8821, 2.07, 0.305, 240, 223, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
3692, p4y6zQ_, 0.8821, 2.08, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
3693, d4qvnC_, 0.8821, 2.07, 0.305, 240, 223, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
3694, p4qbyQ_, 0.8821, 2.07, 0.305, 240, 223, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
3695, p4qbyC_, 0.8821, 2.07, 0.305, 240, 223, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
3696, d4hnpQ_, 0.8821, 2.08, 0.305, 241, 223, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
3697, d2ku2C1, 0.8821, 1.86, 0.326, 233, 221, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
3698, d2ku2A1, 0.8821, 1.82, 0.326, 233, 221, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
3699, d2ku1A1, 0.8821, 1.81, 0.326, 233, 221, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
3700, d2f16Q_, 0.8821, 2.07, 0.305, 241, 223, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
3701, d1yarF_, 0.8821, 1.61, 0.339, 221, 218, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
3702, p5mpbC_, 0.8820, 1.91, 0.305, 244, 223, 
3703, d5cz6C_, 0.8820, 2.07, 0.305, 240, 223, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
3704, d5cz4Q_, 0.8820, 2.08, 0.305, 240, 223, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
3705, d5cz4C_, 0.8820, 2.08, 0.305, 240, 223, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
3706, p5a5bG_, 0.8820, 2.43, 0.289, 245, 228, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
3707, p4ya3Q_, 0.8820, 2.08, 0.305, 240, 223, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
3708, p4y8kC_, 0.8820, 2.08, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
3709, d4qvnQ_, 0.8820, 2.07, 0.305, 240, 223, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
3710, p4cr4G_, 0.8820, 2.42, 0.293, 245, 229, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
3711, p4cr3G_, 0.8820, 2.43, 0.289, 245, 228, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
3712, d3sdkQ_, 0.8820, 2.08, 0.305, 241, 223, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
3713, d5cz7Q_, 0.8819, 2.08, 0.305, 240, 223, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
3714, p4ya5C_, 0.8819, 2.08, 0.305, 240, 223, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
3715, p4y8kQ_, 0.8819, 2.08, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
3716, p4y6vQ_, 0.8819, 2.07, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
3717, p4y6vC_, 0.8819, 2.07, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
3718, p4y69Q_, 0.8819, 2.08, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
3719, p4y69C_, 0.8819, 2.08, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
3720, d4qvmQ_, 0.8819, 2.08, 0.305, 240, 223, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
3721, d4qvmC_, 0.8819, 2.08, 0.305, 240, 223, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
3722, d5cz7C_, 0.8818, 2.08, 0.305, 240, 223, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
3723, p4ya5Q_, 0.8818, 2.08, 0.305, 240, 223, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
3724, p4y8nQ_, 0.8818, 2.08, 0.305, 240, 223, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
3725, p4y8nC_, 0.8818, 2.08, 0.305, 240, 223, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
3726, d4r02Q_, 0.8818, 2.07, 0.305, 240, 223, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
3727, d4qz1Q_, 0.8818, 2.09, 0.305, 240, 223, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3728, d4fzgC_, 0.8818, 2.07, 0.305, 241, 223, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
3729, d4rurQ_, 0.8817, 2.08, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
3730, d4rurC_, 0.8817, 2.08, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
3731, d4qz1C_, 0.8817, 2.09, 0.305, 240, 223, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3732, d4qwgC_, 0.8817, 2.09, 0.305, 240, 223, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
3733, d4fzgQ_, 0.8817, 2.07, 0.305, 241, 223, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
3734, d3oevQ_, 0.8817, 2.09, 0.305, 241, 223, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
3735, d1rypR_, 0.8817, 2.06, 0.305, 241, 223, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
3736, d5le5C_, 0.8816, 1.93, 0.317, 236, 221, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
3737, d5bouQ_, 0.8816, 2.08, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
3738, d5bouC_, 0.8816, 2.08, 0.305, 240, 223, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
3739, d4qwgQ_, 0.8816, 2.09, 0.305, 240, 223, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
3740, d3mg8Q_, 0.8816, 2.09, 0.305, 241, 223, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
3741, d2gplQ_, 0.8816, 2.07, 0.305, 241, 223, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
3742, d2gplC_, 0.8816, 2.07, 0.305, 241, 223, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
3743, p4y6aQ_, 0.8815, 2.08, 0.305, 240, 223, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
3744, p4y6aC_, 0.8815, 2.08, 0.305, 240, 223, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
3745, d4r17Q_, 0.8815, 2.07, 0.305, 240, 223, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
3746, d4r17C_, 0.8815, 2.07, 0.305, 240, 223, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
3747, d4qw3Q_, 0.8815, 2.09, 0.305, 240, 223, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
3748, d4qw3C_, 0.8815, 2.09, 0.305, 240, 223, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
3749, d1yarD_, 0.8814, 1.62, 0.339, 221, 218, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
3750, p5vfsAA_, 0.8813, 1.71, 0.295, 232, 220, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3751, d5laiQ_, 0.8813, 2.08, 0.305, 240, 223, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3752, d5laiC_, 0.8813, 2.08, 0.305, 240, 223, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3753, d5l5wQ_, 0.8812, 2.08, 0.305, 240, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
3754, d5l5wC_, 0.8812, 2.08, 0.305, 240, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
3755, d4hrdQ_, 0.8812, 2.08, 0.305, 241, 223, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
3756, d4hrcQ_, 0.8812, 2.09, 0.305, 241, 223, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
3757, p4cr4C_, 0.8812, 2.06, 0.308, 245, 224, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
3758, p3jcpKA_, 0.8811, 1.78, 0.285, 250, 221, 
3759, p3jcpK_, 0.8811, 1.78, 0.285, 250, 221, 
3760, d1yarB_, 0.8811, 1.63, 0.339, 221, 218, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
3761, p6epdC_, 0.8810, 2.28, 0.339, 249, 227, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS1)
3762, p5vfsB_, 0.8810, 1.72, 0.295, 232, 220, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3763, p5mpcO_, 0.8810, 2.17, 0.215, 241, 228, 
3764, d3mg8F_, 0.8809, 2.21, 0.288, 237, 222, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
3765, d5l5zQ_, 0.8808, 2.09, 0.305, 240, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3766, d5l5zC_, 0.8808, 2.09, 0.305, 240, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3767, d5l5xQ_, 0.8808, 2.09, 0.305, 240, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3768, d5l5xC_, 0.8808, 2.09, 0.305, 240, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3769, d3mg7F_, 0.8808, 2.24, 0.287, 237, 223, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
3770, d3oeuQ_, 0.8807, 2.11, 0.305, 241, 223, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
3771, p5vfrK_, 0.8806, 1.85, 0.320, 228, 222, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3772, d5l64Q_, 0.8806, 2.09, 0.305, 240, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3773, d5l64C_, 0.8806, 2.09, 0.305, 240, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3774, d5l60Q_, 0.8806, 2.09, 0.305, 240, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3775, d5l60C_, 0.8806, 2.09, 0.305, 240, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3776, d5l5yQ_, 0.8806, 2.09, 0.305, 240, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3777, d5l5yC_, 0.8806, 2.09, 0.305, 240, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3778, p5wvkAA_, 0.8805, 1.03, 1.000, 210, 210, 
3779, p5vfqAA_, 0.8805, 1.73, 0.295, 232, 220, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3780, p5mpcT_, 0.8805, 1.26, 1.000, 213, 213, 
3781, d3oeuF_, 0.8805, 2.23, 0.287, 237, 223, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
3782, d1yarC_, 0.8805, 1.63, 0.339, 221, 218, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
3783, p5vfoK_, 0.8804, 1.77, 0.317, 228, 221, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3784, d5lttC_, 0.8804, 2.09, 0.305, 240, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
3785, d5lf7C_, 0.8804, 1.94, 0.317, 236, 221, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
3786, d5lf4C_, 0.8804, 1.95, 0.317, 236, 221, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
3787, d5lf3C_, 0.8804, 1.95, 0.317, 236, 221, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
3788, d5l62Q_, 0.8804, 2.09, 0.305, 240, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3789, d5l62C_, 0.8804, 2.09, 0.305, 240, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3790, d5l61Q_, 0.8804, 2.09, 0.305, 240, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3791, d5l61C_, 0.8804, 2.09, 0.305, 240, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3792, d1jd2C_, 0.8804, 2.08, 0.305, 241, 223, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
3793, p5vfok_, 0.8803, 1.88, 0.324, 228, 222, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3794, d5lttQ_, 0.8803, 2.09, 0.305, 240, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
3795, d5l63Q_, 0.8803, 2.09, 0.305, 240, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3796, d5l63C_, 0.8803, 2.09, 0.305, 240, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3797, d5l5uQ_, 0.8803, 2.09, 0.305, 240, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3798, d5l5uC_, 0.8803, 2.09, 0.305, 240, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3799, d5l5fQ_, 0.8803, 2.09, 0.305, 240, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3800, d5l5fC_, 0.8803, 2.09, 0.305, 240, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3801, d5l5eQ_, 0.8803, 2.09, 0.305, 240, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3802, d5l5eC_, 0.8803, 2.09, 0.305, 240, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3803, d5l5aQ_, 0.8803, 2.09, 0.305, 240, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
3804, d5l5aC_, 0.8803, 2.09, 0.305, 240, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
3805, d3wxrD_, 0.8803, 2.09, 0.305, 241, 223, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
3806, p3jcoKA_, 0.8803, 1.95, 0.288, 250, 222, 
3807, p3jcoK_, 0.8803, 1.95, 0.288, 250, 222, 
3808, d1jd2X_, 0.8803, 2.08, 0.305, 241, 223, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
3809, p5wviX_, 0.8802, 2.41, 0.288, 245, 229, 
3810, d5lf1C_, 0.8802, 1.96, 0.317, 236, 221, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
3811, p5leyC_, 0.8802, 1.95, 0.317, 236, 221, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
3812, d5l65Q_, 0.8802, 2.09, 0.305, 240, 223, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3813, d5l65C_, 0.8802, 2.09, 0.305, 240, 223, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3814, d5l5rQ_, 0.8802, 2.09, 0.305, 240, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
3815, d5l5rC_, 0.8802, 2.09, 0.305, 240, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
3816, d5l5bQ_, 0.8802, 2.08, 0.305, 240, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
3817, d5l5bC_, 0.8802, 2.08, 0.305, 240, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
3818, p6epeG_, 0.8801, 2.12, 0.263, 245, 224, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS2)
3819, p5mpcA_, 0.8801, 2.23, 0.203, 241, 227, 
3820, d5l5sQ_, 0.8801, 2.09, 0.305, 240, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
3821, d5l5sC_, 0.8801, 2.09, 0.305, 240, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
3822, p4v7oQ_, 0.8801, 1.57, 0.300, 232, 217, 
3823, d3l5qT_, 0.8801, 1.57, 0.300, 232, 217,  
3824, p5vfrh_, 0.8800, 1.74, 0.295, 232, 220, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3825, p5vfoh_, 0.8800, 1.74, 0.295, 232, 220, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3826, p5m32O_, 0.8800, 1.75, 0.291, 230, 220, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
3827, p5m32A_, 0.8800, 1.75, 0.291, 230, 220, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
3828, d5l6bQ_, 0.8800, 2.09, 0.305, 240, 223, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3829, d5l6bC_, 0.8800, 2.09, 0.305, 240, 223, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3830, d5l66Q_, 0.8800, 2.09, 0.305, 240, 223, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3831, d3oevF_, 0.8800, 2.25, 0.291, 237, 223, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
3832, d1yauE_, 0.8800, 1.69, 0.333, 222, 219, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
3833, d1vsyQ_, 0.8800, 1.57, 0.300, 232, 217,  
3834, p5vfuS_, 0.8799, 1.90, 0.294, 232, 221, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3835, p5vftH_, 0.8799, 1.90, 0.294, 232, 221, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3836, p5vfpZ_, 0.8799, 1.75, 0.295, 232, 220, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3837, p5vfpE_, 0.8799, 1.78, 0.317, 228, 221, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3838, d5l66C_, 0.8799, 2.09, 0.305, 240, 223, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3839, d5l5vQ_, 0.8799, 2.10, 0.305, 240, 223,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3840, d5l5vC_, 0.8799, 2.10, 0.305, 240, 223,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3841, d5l5qQ_, 0.8799, 2.10, 0.305, 240, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
3842, d5l5qC_, 0.8799, 2.10, 0.305, 240, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
3843, d5l5iQ_, 0.8799, 2.10, 0.305, 240, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
3844, d5l5iC_, 0.8799, 2.10, 0.305, 240, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
3845, d5l5hQ_, 0.8799, 2.09, 0.305, 240, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3846, d5l5hC_, 0.8799, 2.09, 0.305, 240, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3847, p4v7oKA_, 0.8799, 1.57, 0.300, 232, 217, 
3848, p4v7oC_, 0.8799, 1.57, 0.300, 232, 217, 
3849, d3l5qH_, 0.8799, 1.57, 0.300, 232, 217,  
3850, d1vsyC_, 0.8799, 1.57, 0.300, 232, 217,  
3851, d5l67Q_, 0.8798, 2.10, 0.305, 240, 223, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3852, d5l67C_, 0.8798, 2.10, 0.305, 240, 223, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3853, d3mg6F_, 0.8798, 2.26, 0.291, 237, 223, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
3854, d5l6cQ_, 0.8797, 2.10, 0.305, 240, 223, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3855, d5l6cC_, 0.8797, 2.10, 0.305, 240, 223, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3856, d5l6aQ_, 0.8797, 2.09, 0.305, 240, 223, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3857, d5l6aC_, 0.8797, 2.09, 0.305, 240, 223, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3858, d5l5tQ_, 0.8797, 2.10, 0.305, 240, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3859, d5l5tC_, 0.8797, 2.10, 0.305, 240, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3860, d5l5pQ_, 0.8797, 2.10, 0.305, 240, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3861, d5l5pC_, 0.8797, 2.10, 0.305, 240, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3862, d5l5dQ_, 0.8797, 2.10, 0.305, 240, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3863, d5l5dC_, 0.8797, 2.10, 0.305, 240, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3864, d1yarA_, 0.8797, 1.64, 0.339, 221, 218, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
3865, d5l5oQ_, 0.8796, 2.10, 0.305, 240, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3866, d5l5oC_, 0.8796, 2.10, 0.305, 240, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3867, d5l5jQ_, 0.8796, 2.10, 0.305, 240, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3868, d5l5jC_, 0.8796, 2.10, 0.305, 240, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3869, p5vfqE_, 0.8795, 1.87, 0.320, 228, 222, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3870, d5m2bQ_, 0.8795, 2.10, 0.305, 240, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
3871, d5m2bC_, 0.8795, 2.10, 0.305, 240, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
3872, d5l68Q_, 0.8795, 2.10, 0.305, 240, 223, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3873, d5l68C_, 0.8795, 2.10, 0.305, 240, 223, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3874, d3mg7Q_, 0.8795, 2.11, 0.305, 241, 223, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
3875, p5m32S_, 0.8794, 1.16, 0.536, 218, 211, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
3876, p5mp9b_, 0.8793, 1.79, 0.285, 250, 221, 26S PROTEASOME IN PRESENCE OF ATP (S1)
3877, p3unbQ_, 0.8793, 2.00, 0.324, 239, 222, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
3878, d3oevT_, 0.8793, 2.24, 0.293, 237, 222, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
3879, p4r3oR_, 0.8792, 2.00, 0.324, 231, 222, HUMAN CONSTITUTIVE 20S PROTEASOME
3880, p3unbC_, 0.8792, 2.00, 0.324, 239, 222, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
3881, p5lf6C_, 0.8791, 1.96, 0.317, 236, 221, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
3882, d5lexC_, 0.8791, 1.96, 0.317, 236, 221, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
3883, d5l69Q_, 0.8791, 2.10, 0.305, 240, 223, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3884, d5l69C_, 0.8791, 2.11, 0.305, 240, 223, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3885, p4r3oD_, 0.8791, 2.00, 0.324, 231, 222, HUMAN CONSTITUTIVE 20S PROTEASOME
3886, p3unbe_, 0.8791, 2.00, 0.324, 239, 222, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
3887, d3mg8T_, 0.8791, 2.29, 0.287, 237, 223, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
3888, p1fntD_, 0.8791, 2.11, 0.304, 239, 224, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3889, d3oeuT_, 0.8790, 2.28, 0.291, 237, 223, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
3890, p1fntR_, 0.8790, 2.11, 0.304, 239, 224, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3891, p3uneQ_, 0.8789, 2.00, 0.324, 239, 222, MOUSE CONSTITUTIVE 20S PROTEASOME
3892, p5vfpCA_, 0.8788, 1.90, 0.324, 228, 222, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3893, p5mpbG_, 0.8788, 2.44, 0.294, 243, 228, 
3894, p4cr4A_, 0.8788, 2.27, 0.227, 243, 229, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
3895, d3unfQ_, 0.8788, 2.01, 0.324, 238, 222, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
3896, d3unfC_, 0.8788, 2.01, 0.324, 238, 222, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
3897, p5vfqDA_, 0.8787, 1.90, 0.324, 228, 222, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3898, p5mp9B_, 0.8787, 1.81, 0.285, 250, 221, 26S PROTEASOME IN PRESENCE OF ATP (S1)
3899, p3unhQ_, 0.8787, 2.01, 0.324, 238, 222, MOUSE 20S IMMUNOPROTEASOME
3900, p3unhC_, 0.8787, 2.01, 0.324, 238, 222, MOUSE 20S IMMUNOPROTEASOME
3901, p5lf0C_, 0.8786, 1.97, 0.317, 236, 221, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
3902, p6epeA_, 0.8785, 2.19, 0.241, 246, 228, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS2)
3903, p5lezC_, 0.8785, 1.97, 0.317, 236, 221, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
3904, d3mg7T_, 0.8785, 2.26, 0.288, 237, 222, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
3905, d3mg6T_, 0.8785, 2.28, 0.287, 237, 223, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
3906, p5mpbU_, 0.8783, 2.32, 0.295, 243, 227, 
3907, p5vfrk_, 0.8782, 1.91, 0.324, 228, 222, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3908, p3unbs_, 0.8782, 2.02, 0.324, 239, 222, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
3909, p5wvkY_, 0.8781, 2.08, 0.305, 241, 223, 
3910, p5gjrV_, 0.8780, 2.02, 0.324, 231, 222, 
3911, p5gjrJA_, 0.8780, 2.03, 0.324, 231, 222, 
3912, p5t0iL_, 0.8778, 1.24, 0.533, 221, 212, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3913, p4r67t_, 0.8775, 2.03, 0.320, 232, 222, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
3914, p4r67f_, 0.8775, 2.03, 0.320, 232, 222, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
3915, p4r67D_, 0.8775, 2.03, 0.320, 232, 222, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
3916, p5vftK_, 0.8774, 1.91, 0.324, 228, 222, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3917, p6epeB_, 0.8773, 2.18, 0.290, 234, 224, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS2)
3918, p5t0cZA_, 0.8773, 1.94, 0.294, 232, 221, 
3919, p5t0cT_, 0.8773, 1.94, 0.294, 232, 221, 
3920, p4r67R_, 0.8772, 2.03, 0.320, 232, 222, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
3921, p3jcpMA_, 0.8772, 2.11, 0.305, 241, 223, 
3922, p3jcpM_, 0.8772, 2.11, 0.305, 241, 223, 
3923, p5mpcB_, 0.8771, 2.05, 0.279, 250, 226, 
3924, p6avoI_, 0.8769, 2.01, 0.320, 232, 222, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
3925, p5gjqE_, 0.8768, 2.06, 0.324, 231, 222, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
3926, p5mpbA_, 0.8767, 2.24, 0.215, 241, 228, 
3927, p6epfB_, 0.8766, 1.98, 0.294, 234, 221, GROUND STATE 26S PROTEASOME (GS1)
3928, p5vfuV_, 0.8766, 1.92, 0.324, 228, 222, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3929, p6avoN_, 0.8764, 2.02, 0.320, 232, 222, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
3930, p3uneC_, 0.8764, 2.02, 0.324, 239, 222, MOUSE CONSTITUTIVE 20S PROTEASOME
3931, p5vfuGA_, 0.8762, 1.93, 0.294, 232, 221, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3932, p5vfth_, 0.8762, 1.93, 0.294, 232, 221, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3933, p5fmgT_, 0.8762, 1.45, 0.360, 219, 214, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
3934, p5fmgF_, 0.8762, 1.45, 0.360, 219, 214, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
3935, p3unee_, 0.8762, 2.02, 0.324, 239, 222, MOUSE CONSTITUTIVE 20S PROTEASOME
3936, p5vftk_, 0.8761, 1.90, 0.324, 228, 222, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3937, p3jcoMA_, 0.8761, 2.11, 0.305, 241, 223, 
3938, p3jcoM_, 0.8761, 2.11, 0.305, 241, 223, 
3939, d1yarE_, 0.8761, 1.70, 0.339, 221, 218, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
3940, d5lexG_, 0.8760, 1.92, 0.249, 241, 221, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
3941, d3sdkF_, 0.8759, 2.24, 0.293, 236, 222, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
3942, p5t0gK_, 0.8758, 1.93, 0.324, 228, 222, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3943, d5lf3G_, 0.8758, 1.92, 0.249, 241, 221, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
3944, p5mpab_, 0.8757, 1.84, 0.285, 250, 221, 26S PROTEASOME IN PRESENCE OF ATP (S2)
3945, p5ln3G_, 0.8757, 2.30, 0.265, 242, 226, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
3946, d5lf7G_, 0.8755, 1.93, 0.249, 241, 221, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
3947, p5vy4Y_, 0.8754, 1.70, 0.339, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
3948, p5vy4W_, 0.8754, 1.70, 0.339, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
3949, p5vy4U_, 0.8754, 1.70, 0.339, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
3950, p5vy4S_, 0.8754, 1.70, 0.339, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
3951, p5vy4Q_, 0.8754, 1.70, 0.339, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
3952, p5vy4O_, 0.8754, 1.70, 0.339, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
3953, p5vy4M_, 0.8754, 1.70, 0.339, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
3954, p5vy4K_, 0.8754, 1.70, 0.339, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
3955, p5vy4I_, 0.8754, 1.70, 0.339, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
3956, p5vy4G_, 0.8754, 1.70, 0.339, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
3957, p5vy4E_, 0.8754, 1.70, 0.339, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
3958, p5vy4C_, 0.8754, 1.70, 0.339, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
3959, p5vy4AA_, 0.8754, 1.70, 0.339, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
3960, p5vy4A_, 0.8754, 1.70, 0.339, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
3961, p5vy40_, 0.8754, 1.70, 0.339, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
3962, p6bdfY_, 0.8753, 1.71, 0.339, 221, 218, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
3963, p6bdfW_, 0.8753, 1.71, 0.339, 221, 218, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
3964, p6bdfU_, 0.8753, 1.71, 0.339, 221, 218, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
3965, p6bdfS_, 0.8753, 1.71, 0.339, 221, 218, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
3966, p6bdfQ_, 0.8753, 1.71, 0.339, 221, 218, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
3967, p6bdfO_, 0.8753, 1.71, 0.339, 221, 218, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
3968, p6bdfM_, 0.8753, 1.71, 0.339, 221, 218, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
3969, p6bdfK_, 0.8753, 1.71, 0.339, 221, 218, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
3970, p6bdfI_, 0.8753, 1.71, 0.339, 221, 218, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
3971, p6bdfG_, 0.8753, 1.71, 0.339, 221, 218, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
3972, p6bdfE_, 0.8753, 1.71, 0.339, 221, 218, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
3973, p6bdfC_, 0.8753, 1.71, 0.339, 221, 218, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
3974, p6bdfA_, 0.8753, 1.71, 0.339, 221, 218, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
3975, p6bdf0_, 0.8753, 1.71, 0.339, 221, 218, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
3976, p5mpcG_, 0.8753, 2.45, 0.289, 243, 228, 
3977, p3unes_, 0.8753, 2.03, 0.324, 239, 222, MOUSE CONSTITUTIVE 20S PROTEASOME
3978, d3sdkT_, 0.8751, 2.27, 0.293, 236, 222, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
3979, p5m32P_, 0.8749, 2.22, 0.333, 244, 225, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
3980, d5lf1Q_, 0.8749, 2.02, 0.321, 238, 221, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
3981, d5lf1G_, 0.8749, 1.94, 0.249, 241, 221, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
3982, d5le5G_, 0.8748, 1.93, 0.249, 241, 221, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
3983, d5lf4G_, 0.8746, 1.94, 0.249, 241, 221, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
3984, p5vy3Y_, 0.8745, 1.72, 0.339, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
3985, p5vy3W_, 0.8745, 1.72, 0.339, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
3986, p5vy3U_, 0.8745, 1.72, 0.339, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
3987, p5vy3S_, 0.8745, 1.72, 0.339, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
3988, p5vy3Q_, 0.8745, 1.72, 0.339, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
3989, p5vy3O_, 0.8745, 1.72, 0.339, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
3990, p5vy3M_, 0.8745, 1.72, 0.339, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
3991, p5vy3K_, 0.8745, 1.72, 0.339, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
3992, p5vy3I_, 0.8745, 1.72, 0.339, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
3993, p5vy3G_, 0.8745, 1.72, 0.339, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
3994, p5vy3E_, 0.8745, 1.72, 0.339, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
3995, p5vy3C_, 0.8745, 1.72, 0.339, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
3996, p5vy3A_, 0.8745, 1.72, 0.339, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
3997, p5vy30_, 0.8745, 1.72, 0.339, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
3998, d5lf4Q_, 0.8745, 2.03, 0.321, 238, 221, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
3999, d3wxrU1, 0.8745, 2.10, 0.299, 236, 221, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
4000, d1pmaN_, 0.8745, 1.71, 0.330, 221, 218, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4001, p6epeC_, 0.8744, 2.28, 0.338, 249, 228, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS2)
4002, d3wxrR_, 0.8744, 2.20, 0.305, 241, 223, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
4003, p5vfuJA_, 0.8742, 1.94, 0.324, 228, 222, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4004, d1pmaO_, 0.8742, 1.72, 0.335, 221, 218, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4005, p5vfsC_, 0.8741, 2.24, 0.333, 250, 225, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4006, p5mp9d_, 0.8741, 2.16, 0.305, 240, 223, 26S PROTEASOME IN PRESENCE OF ATP (S1)
4007, p5lf0Q_, 0.8741, 2.03, 0.321, 238, 221, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
4008, d1pmaH_, 0.8740, 1.73, 0.335, 221, 218, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4009, d1pmaD_, 0.8740, 1.72, 0.330, 221, 218, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4010, p5leyQ_, 0.8739, 2.03, 0.321, 239, 221, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
4011, d3wxrG1, 0.8739, 2.09, 0.299, 236, 221, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
4012, d1pmaL_, 0.8739, 1.72, 0.330, 221, 218, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4013, d1pmaJ_, 0.8739, 1.72, 0.330, 221, 218, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4014, p5t0gH_, 0.8738, 1.82, 0.295, 233, 220, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4015, p5lf6Q_, 0.8738, 2.03, 0.321, 238, 221, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
4016, d3c91U1, 0.8738, 1.73, 0.330, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4017, d3c91T1, 0.8738, 1.73, 0.330, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4018, d3c91S1, 0.8738, 1.73, 0.330, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4019, d3c91R1, 0.8738, 1.73, 0.330, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4020, d3c91Q1, 0.8738, 1.73, 0.330, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4021, d3c91P1, 0.8738, 1.73, 0.330, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4022, d3c91O1, 0.8738, 1.73, 0.330, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4023, d3c91G1, 0.8738, 1.73, 0.330, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4024, d3c91F1, 0.8738, 1.73, 0.330, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4025, d3c91E1, 0.8738, 1.73, 0.330, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4026, d3c91D1, 0.8738, 1.73, 0.330, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4027, d3c91C1, 0.8738, 1.73, 0.330, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4028, d3c91B1, 0.8738, 1.73, 0.330, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4029, d3c91A1, 0.8738, 1.73, 0.330, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4030, d1pmaM_, 0.8738, 1.72, 0.330, 221, 218, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4031, d1pmaG_, 0.8738, 1.73, 0.335, 221, 218, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4032, d1pmaE_, 0.8738, 1.73, 0.330, 221, 218, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4033, d1pmaC_, 0.8738, 1.73, 0.330, 221, 218, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4034, d1pmaK_, 0.8737, 1.73, 0.330, 221, 218, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4035, p5m32G_, 0.8736, 2.05, 0.247, 233, 223, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
4036, d5lf7Q_, 0.8736, 2.03, 0.321, 238, 221, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
4037, d5lf3Q_, 0.8736, 2.04, 0.321, 238, 221, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
4038, d1pmaI_, 0.8736, 1.73, 0.330, 221, 218, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4039, d1pmaF_, 0.8736, 1.73, 0.330, 221, 218, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4040, d3c92U1, 0.8735, 1.73, 0.335, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4041, d3c92T1, 0.8735, 1.73, 0.335, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4042, d3c92S1, 0.8735, 1.73, 0.335, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4043, d3c92R1, 0.8735, 1.73, 0.335, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4044, d3c92Q1, 0.8735, 1.73, 0.335, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4045, d3c92P1, 0.8735, 1.73, 0.335, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4046, d3c92O1, 0.8735, 1.73, 0.335, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4047, d3c92G1, 0.8735, 1.73, 0.335, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4048, d3c92F1, 0.8735, 1.73, 0.335, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4049, d3c92E1, 0.8735, 1.73, 0.335, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4050, d3c92D1, 0.8735, 1.73, 0.335, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4051, d3c92C1, 0.8735, 1.73, 0.335, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4052, d3c92B1, 0.8735, 1.73, 0.335, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4053, d3c92A1, 0.8735, 1.73, 0.335, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4054, d1pmaA_, 0.8735, 1.73, 0.330, 221, 218, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4055, p5l4gD_, 0.8733, 2.10, 0.320, 231, 222, 
4056, p5m32C_, 0.8732, 2.11, 0.315, 234, 222, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
4057, p5l4gR_, 0.8731, 2.08, 0.320, 232, 222, 
4058, p5dsvC_, 0.8727, 1.76, 0.273, 234, 216, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
4059, p5vfsBA_, 0.8726, 2.25, 0.333, 240, 225, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4060, p5mpad_, 0.8720, 2.19, 0.305, 240, 223, 26S PROTEASOME IN PRESENCE OF ATP (S2)
4061, p5m32Q_, 0.8720, 2.11, 0.320, 235, 222, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
4062, p5t0iM_, 0.8719, 2.30, 0.267, 240, 225, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4063, d4cr2B_, 0.8718, 2.05, 0.284, 250, 222, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
4064, d3h4pA_, 0.8717, 1.80, 0.338, 232, 219, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4065, p5wvkW_, 0.8716, 1.87, 0.285, 250, 221, 
4066, p3h4pJ_, 0.8714, 1.81, 0.338, 232, 219, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4067, p5mpcE_, 0.8713, 1.95, 0.347, 242, 222, 
4068, d3h4pE_, 0.8713, 1.81, 0.338, 232, 219, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4069, p4cr4B_, 0.8712, 2.09, 0.279, 250, 222, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
4070, p5t0iH_, 0.8711, 1.86, 0.295, 233, 220, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4071, d3h4pC_, 0.8711, 1.81, 0.333, 232, 219, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4072, p5t0jI_, 0.8709, 2.31, 0.329, 250, 228, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4073, p5a5bA_, 0.8709, 2.26, 0.207, 243, 227, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
4074, p4cr3A_, 0.8709, 2.26, 0.207, 243, 227, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
4075, p5gjqk_, 0.8708, 2.14, 0.320, 231, 222, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
4076, p3h4pN_, 0.8708, 1.82, 0.338, 232, 219, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4077, d3h4pD_, 0.8706, 1.82, 0.338, 232, 219, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4078, p3h4pI_, 0.8705, 1.82, 0.338, 232, 219, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4079, p5wviBA_, 0.8704, 2.04, 0.341, 243, 223, 
4080, p3h4pL_, 0.8703, 1.82, 0.338, 232, 219, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4081, p3h4pH_, 0.8703, 1.82, 0.338, 232, 219, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4082, d1iruR_, 0.8703, 2.13, 0.320, 243, 222, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
4083, d1iruD_, 0.8703, 2.13, 0.320, 243, 222, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
4084, p5vfuT_, 0.8701, 2.26, 0.333, 250, 225, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4085, p5vftI_, 0.8701, 2.26, 0.333, 250, 225, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4086, d3h4pF_, 0.8696, 1.84, 0.338, 232, 219, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4087, p5t0cU_, 0.8694, 2.28, 0.333, 250, 225, 
4088, p5t0cAB_, 0.8694, 2.28, 0.333, 250, 225, 
4089, p3h4pM_, 0.8694, 1.84, 0.338, 232, 219, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4090, p5mpaB_, 0.8692, 1.93, 0.285, 250, 221, 26S PROTEASOME IN PRESENCE OF ATP (S2)
4091, p5ln3E_, 0.8692, 1.99, 0.324, 232, 222, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
4092, p5vfrJ_, 0.8689, 2.06, 0.306, 239, 222, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4093, d3h4pB_, 0.8688, 1.83, 0.333, 232, 219, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4094, p5wvkP_, 0.8686, 1.91, 0.285, 250, 221, 
4095, p5mp9D_, 0.8686, 2.22, 0.305, 240, 223, 26S PROTEASOME IN PRESENCE OF ATP (S1)
4096, d3h4pG_, 0.8684, 1.85, 0.338, 232, 219, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4097, p5t0hK_, 0.8681, 1.99, 0.324, 228, 222, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4098, p3h4pK_, 0.8679, 1.85, 0.338, 232, 219, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4099, p6gopA_, 0.8675, 1.68, 0.287, 230, 216, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
4100, p5vfqD_, 0.8673, 2.26, 0.320, 239, 225, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4101, p5mpbS_, 0.8672, 2.16, 0.341, 242, 223, 
4102, p5vfoJ_, 0.8669, 2.26, 0.320, 239, 225, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4103, p5t0iI_, 0.8665, 2.35, 0.332, 250, 226, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4104, p5mpcR_, 0.8661, 2.36, 0.310, 240, 226, 
4105, p5mpcS_, 0.8659, 2.04, 0.342, 242, 222, 
4106, p5a5bB_, 0.8658, 2.01, 0.290, 250, 221, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
4107, p4cr3B_, 0.8658, 2.01, 0.290, 250, 221, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
4108, p5a5bE_, 0.8657, 2.23, 0.345, 243, 223, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
4109, p4cr3E_, 0.8657, 2.23, 0.345, 243, 223, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
4110, p5wviDA_, 0.8655, 2.15, 0.284, 250, 222, 
4111, p5mpbB_, 0.8655, 2.02, 0.285, 250, 221, 
4112, p5wviCA_, 0.8654, 2.39, 0.310, 245, 226, 
4113, p5wviOA_, 0.8653, 2.15, 0.284, 250, 222, 
4114, p6epfC_, 0.8649, 2.52, 0.336, 249, 226, GROUND STATE 26S PROTEASOME (GS1)
4115, p5mpaD_, 0.8647, 2.28, 0.305, 240, 223, 26S PROTEASOME IN PRESENCE OF ATP (S2)
4116, d5lexU_, 0.8647, 1.94, 0.257, 235, 218, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
4117, p6epdB_, 0.8644, 2.22, 0.276, 234, 221, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS1)
4118, p5vfuHA_, 0.8644, 2.34, 0.333, 240, 225, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4119, p5vfti_, 0.8644, 2.34, 0.333, 240, 225, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4120, d5lf7U_, 0.8643, 1.94, 0.257, 235, 218, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
4121, p5wvkR_, 0.8641, 2.32, 0.305, 241, 223, 
4122, d5lf3U_, 0.8641, 1.94, 0.257, 235, 218, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
4123, p5a0qS_, 0.8640, 1.49, 0.325, 215, 212, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4124, p5a0qE_, 0.8640, 1.49, 0.325, 215, 212, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4125, p5t0gI_, 0.8639, 2.32, 0.333, 250, 225, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4126, p5cghA_, 0.8635, 1.69, 0.288, 229, 215, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
4127, p5cggA_, 0.8635, 1.68, 0.288, 229, 215, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
4128, d5lf1U_, 0.8634, 1.95, 0.257, 235, 218, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
4129, p5cgiA_, 0.8634, 1.69, 0.288, 229, 215, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
4130, p4ya9A_, 0.8634, 1.69, 0.288, 229, 215, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
4131, p4y8sA_, 0.8634, 1.69, 0.288, 229, 215, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
4132, p4ya7A_, 0.8633, 1.69, 0.288, 229, 215, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
4133, p4ya2A_, 0.8633, 1.69, 0.288, 229, 215, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
4134, p4y9zA_, 0.8633, 1.69, 0.288, 229, 215, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
4135, p4y75A_, 0.8633, 1.69, 0.288, 229, 215, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
4136, p4qbyA_, 0.8633, 1.69, 0.288, 229, 215, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
4137, p4y77A_, 0.8632, 1.69, 0.288, 229, 215, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
4138, p5lf6U_, 0.8630, 1.95, 0.257, 235, 218, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
4139, p4y8lA_, 0.8630, 1.69, 0.288, 229, 215, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
4140, p4y8jA_, 0.8629, 1.70, 0.288, 229, 215, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
4141, p4y8iA_, 0.8629, 1.70, 0.288, 229, 215, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
4142, p4y70A_, 0.8629, 1.69, 0.288, 229, 215, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
4143, d5lf4U_, 0.8628, 1.96, 0.257, 235, 218, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
4144, p4y8tA_, 0.8628, 1.70, 0.288, 229, 215, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
4145, p4y7yA_, 0.8628, 1.70, 0.288, 229, 215, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
4146, p4y7wA_, 0.8628, 1.70, 0.288, 229, 215, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
4147, p4y8oA_, 0.8627, 1.70, 0.288, 229, 215, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
4148, p4y8hA_, 0.8627, 1.70, 0.288, 229, 215, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
4149, p4y8gA_, 0.8627, 1.70, 0.288, 229, 215, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
4150, p4y6vA_, 0.8627, 1.70, 0.288, 229, 215, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
4151, p4y8uA_, 0.8625, 1.70, 0.288, 229, 215, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
4152, p4y69A_, 0.8625, 1.70, 0.288, 229, 215, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
4153, p5mpbP_, 0.8624, 2.03, 0.285, 250, 221, 
4154, p4ya5A_, 0.8624, 1.70, 0.288, 229, 215, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
4155, p4y8nA_, 0.8624, 1.70, 0.288, 229, 215, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
4156, p4y84A_, 0.8624, 1.70, 0.288, 229, 215, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
4157, p5fghA_, 0.8622, 1.71, 0.288, 229, 215, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
4158, p5t0iK_, 0.8618, 2.19, 0.323, 228, 223, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4159, p4ya3A_, 0.8618, 1.71, 0.288, 229, 215, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
4160, p4ya0A_, 0.8618, 1.71, 0.288, 229, 215, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
4161, p5vfsD_, 0.8617, 2.21, 0.320, 239, 222, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4162, p5t0cV_, 0.8609, 2.21, 0.320, 239, 222, 
4163, p5t0cBB_, 0.8609, 2.21, 0.320, 239, 222, 
4164, p5t0hI_, 0.8602, 2.46, 0.332, 250, 226, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4165, p4y8pA_, 0.8597, 1.68, 0.285, 228, 214, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
4166, p4y8kA_, 0.8596, 1.68, 0.285, 228, 214, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
4167, p3un4A_, 0.8595, 1.69, 0.285, 228, 214, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
4168, p4gk7A_, 0.8593, 1.69, 0.285, 228, 214, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
4169, p4y7xA_, 0.8591, 1.69, 0.285, 228, 214, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
4170, p5vfsCA_, 0.8590, 2.25, 0.320, 239, 222, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4171, p4y8qA_, 0.8590, 1.69, 0.285, 228, 214, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
4172, p4y82A_, 0.8590, 1.69, 0.285, 228, 214, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
4173, p4y80A_, 0.8589, 1.70, 0.285, 228, 214, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
4174, p4y74A_, 0.8589, 1.69, 0.285, 228, 214, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
4175, p4y81A_, 0.8588, 1.70, 0.285, 228, 214, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
4176, p5ln3B_, 0.8587, 2.18, 0.294, 234, 221, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
4177, p4y6zA_, 0.8587, 1.70, 0.285, 228, 214, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
4178, p4y6aA_, 0.8586, 1.70, 0.285, 228, 214, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
4179, p5vfuU_, 0.8585, 2.24, 0.320, 239, 222, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4180, p5vftJ_, 0.8585, 2.24, 0.320, 239, 222, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4181, p4y78A_, 0.8585, 1.70, 0.285, 228, 214, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
4182, p5a5bD_, 0.8582, 2.26, 0.306, 242, 222, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
4183, p4cr3D_, 0.8582, 2.26, 0.306, 242, 222, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
4184, d4cr2D_, 0.8581, 2.29, 0.306, 242, 222, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
4185, p5t0hH_, 0.8575, 2.05, 0.291, 232, 220, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4186, p6epcC_, 0.8571, 2.47, 0.338, 249, 225, GROUND STATE 26S PROTEASOME (GS2)
4187, d5le5U_, 0.8571, 1.82, 0.256, 232, 215, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
4188, d5lexQ_, 0.8564, 2.01, 0.324, 233, 216, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
4189, p5lezQ_, 0.8563, 2.01, 0.324, 234, 216, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
4190, d5le5Q_, 0.8561, 2.09, 0.318, 233, 217, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
4191, p5ln3F_, 0.8556, 1.53, 0.531, 212, 211, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
4192, p6epdG_, 0.8554, 2.69, 0.262, 245, 225, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS1)
4193, p5t0gJ_, 0.8544, 2.28, 0.315, 239, 222, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4194, p4cr4D_, 0.8543, 2.38, 0.305, 242, 223, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
4195, p5vfoj_, 0.8527, 2.34, 0.315, 239, 222, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4196, p5mpbD_, 0.8522, 2.29, 0.300, 240, 220, 
4197, p5fmgS_, 0.8516, 1.79, 0.332, 217, 214, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4198, p5fmgE_, 0.8516, 1.79, 0.332, 217, 214, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4199, p6epcB_, 0.8506, 2.39, 0.286, 234, 220, GROUND STATE 26S PROTEASOME (GS2)
4200, p5vfuIA_, 0.8504, 2.34, 0.320, 239, 222, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4201, p5vftj_, 0.8504, 2.34, 0.320, 239, 222, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4202, p5vfqCA_, 0.8504, 2.38, 0.315, 239, 222, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4203, p5m32B_, 0.8502, 2.07, 0.333, 234, 216, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
4204, p5vfpBA_, 0.8500, 2.36, 0.315, 239, 222, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4205, p5vfrj_, 0.8491, 2.40, 0.315, 239, 222, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4206, p6epfD_, 0.8482, 2.27, 0.326, 246, 221, GROUND STATE 26S PROTEASOME (GS1)
4207, p6epcE_, 0.8459, 2.40, 0.314, 233, 223, GROUND STATE 26S PROTEASOME (GS2)
4208, p6epfE_, 0.8453, 2.36, 0.306, 233, 222, GROUND STATE 26S PROTEASOME (GS1)
4209, p6epeE_, 0.8453, 2.27, 0.314, 233, 220, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS2)
4210, p5fmgO_, 0.8450, 1.81, 0.274, 219, 212, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4211, p5fmgA_, 0.8450, 1.81, 0.274, 219, 212, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4212, p5t0hJ_, 0.8435, 2.39, 0.324, 239, 222, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4213, d4g4sD_, 0.8433, 1.88, 0.318, 220, 211, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
4214, p5mpbR_, 0.8424, 2.59, 0.305, 240, 223, 
4215, p5wviI_, 0.8417, 2.33, 0.297, 231, 219, 
4216, p5fmgQ_, 0.8411, 1.84, 0.338, 220, 210, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4217, p5fmgC_, 0.8411, 1.84, 0.338, 220, 210, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4218, p6epdE_, 0.8373, 2.57, 0.311, 233, 222, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS1)
4219, p5a0qP_, 0.8373, 1.93, 0.295, 214, 210, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4220, p5a0qB_, 0.8373, 1.93, 0.295, 214, 210, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4221, p5wviAA_, 0.8357, 2.32, 0.294, 231, 218, 
4222, p4v7oP_, 0.8353, 1.74, 0.273, 231, 209, 
4223, d3l5qS_, 0.8353, 1.74, 0.273, 231, 209,  
4224, p4v7oXA_, 0.8351, 1.74, 0.273, 231, 209, 
4225, p4v7oB_, 0.8351, 1.74, 0.273, 231, 209, 
4226, d3l5qG_, 0.8351, 1.74, 0.273, 231, 209,  
4227, d1vsyP_, 0.8351, 1.74, 0.273, 231, 209,  
4228, p4v7oJA_, 0.8350, 1.74, 0.273, 231, 209, 
4229, d1vsyB_, 0.8350, 1.74, 0.273, 231, 209,  
4230, p5gjrGA_, 0.8349, 1.86, 0.224, 221, 210, 
4231, p5a5bC_, 0.8342, 1.84, 0.290, 226, 210, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
4232, p4cr3C_, 0.8342, 1.84, 0.290, 226, 210, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
4233, p5gjrS_, 0.8341, 1.87, 0.224, 221, 210, 
4234, p4v7oR_, 0.8337, 2.09, 0.297, 227, 212, 
4235, p4v7oLA_, 0.8337, 2.09, 0.297, 227, 212, 
4236, p4v7oD_, 0.8337, 2.09, 0.297, 227, 212, 
4237, d3l5qU_, 0.8337, 2.09, 0.297, 227, 212,  
4238, d3l5qI_, 0.8337, 2.09, 0.297, 227, 212,  
4239, d1vsyD_, 0.8337, 2.09, 0.297, 227, 212,  
4240, p5gjqB_, 0.8336, 1.89, 0.224, 221, 210, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
4241, p4v7oZA_, 0.8336, 2.09, 0.297, 227, 212, 
4242, d1vsyR_, 0.8336, 2.09, 0.297, 227, 212,  
4243, p5a0qU_, 0.8332, 1.65, 0.273, 209, 205, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4244, p5a0qG_, 0.8332, 1.65, 0.273, 209, 205, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4245, p5gjqh_, 0.8330, 1.88, 0.224, 221, 210, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
4246, p3unhU_, 0.8329, 1.89, 0.224, 220, 210, MOUSE 20S IMMUNOPROTEASOME
4247, p3unhG_, 0.8329, 1.89, 0.224, 220, 210, MOUSE 20S IMMUNOPROTEASOME
4248, p5fmgU_, 0.8328, 2.01, 0.203, 219, 212, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4249, p5fmgG_, 0.8328, 2.01, 0.203, 219, 212, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4250, p5l4gO_, 0.8320, 1.87, 0.224, 221, 210, 
4251, p5mpaA_, 0.8309, 1.96, 0.199, 224, 211, 26S PROTEASOME IN PRESENCE OF ATP (S2)
4252, p5fmgP_, 0.8309, 1.90, 0.303, 212, 208, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4253, p5fmgB_, 0.8309, 1.90, 0.303, 212, 208, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4254, p4v7oE_, 0.8309, 1.73, 0.324, 227, 207, 
4255, p4v7oAB_, 0.8309, 1.73, 0.324, 227, 207, 
4256, p4v7oMA_, 0.8308, 1.73, 0.324, 227, 207, 
4257, p4v7oS_, 0.8307, 1.73, 0.324, 227, 207, 
4258, p5l4gA_, 0.8300, 1.90, 0.224, 221, 210, 
4259, p6epcD_, 0.8294, 2.63, 0.321, 246, 221, GROUND STATE 26S PROTEASOME (GS2)
4260, p5ln3D_, 0.8288, 2.51, 0.305, 232, 220, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
4261, p5wvkX_, 0.8280, 1.90, 0.286, 225, 210, 
4262, p5t0jH_, 0.8258, 2.81, 0.284, 232, 225, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4263, p5wvkQ_, 0.8226, 1.99, 0.290, 225, 210, 
4264, p5mpbE_, 0.8225, 1.98, 0.325, 228, 209, 
4265, p5vfrG_, 0.8211, 2.05, 0.224, 220, 210, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4266, p5a0qT_, 0.8210, 0.96, 0.554, 195, 195, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4267, p5vfoG_, 0.8208, 2.04, 0.224, 220, 210, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4268, p5m32U_, 0.8208, 1.98, 0.230, 218, 209, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
4269, p5a0qF_, 0.8205, 0.97, 0.554, 195, 195, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4270, p5vfog_, 0.8203, 2.05, 0.224, 220, 210, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4271, p5vfqA_, 0.8202, 2.05, 0.224, 220, 210, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4272, p5vfoi_, 0.8202, 2.12, 0.318, 232, 211, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4273, p6avoR_, 0.8200, 1.82, 0.228, 217, 206, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
4274, p6avoK_, 0.8200, 1.82, 0.228, 217, 206, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
4275, p5vfpAA_, 0.8199, 2.11, 0.318, 232, 211, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4276, p5vfsZ_, 0.8197, 2.06, 0.224, 220, 210, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4277, p5mpbO_, 0.8196, 2.16, 0.203, 225, 212, 
4278, p5vfpA_, 0.8195, 2.06, 0.224, 220, 210, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4279, p5vfqBA_, 0.8194, 2.12, 0.318, 232, 211, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4280, p5t0cYA_, 0.8193, 2.08, 0.224, 220, 210, 
4281, p5t0cS_, 0.8193, 2.08, 0.224, 220, 210, 
4282, p5a0qR_, 0.8191, 2.03, 0.327, 214, 208, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4283, p5a0qD_, 0.8191, 2.03, 0.327, 214, 208, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4284, p5vfsA_, 0.8190, 2.07, 0.224, 220, 210, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4285, p5vfri_, 0.8190, 2.12, 0.318, 232, 211, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4286, p5vfpY_, 0.8188, 2.07, 0.224, 220, 210, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4287, p5vfrg_, 0.8187, 2.06, 0.224, 220, 210, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4288, p5vfqZ_, 0.8187, 2.07, 0.224, 220, 210, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4289, p5vfuR_, 0.8171, 2.11, 0.224, 220, 210, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4290, p5vftG_, 0.8171, 2.11, 0.224, 220, 210, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4291, p5t0jG_, 0.8159, 2.03, 0.224, 220, 210, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4292, p5t0gG_, 0.8146, 2.14, 0.224, 220, 210, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4293, p5fmgR_, 0.8145, 1.73, 0.320, 215, 203, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4294, p5fmgD_, 0.8145, 1.73, 0.320, 215, 203, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4295, p5vfuFA_, 0.8139, 2.15, 0.224, 220, 210, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4296, p5vftg_, 0.8139, 2.15, 0.224, 220, 210, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4297, p5wviY_, 0.8119, 2.20, 0.204, 225, 211, 
4298, p5lf0G_, 0.8119, 1.84, 0.230, 218, 204, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
4299, p5leyG_, 0.8115, 1.84, 0.230, 218, 204, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
4300, p5lezG_, 0.8109, 1.85, 0.230, 218, 204, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
4301, p5lf6G_, 0.8101, 1.86, 0.230, 218, 204, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
4302, p5t0jK_, 0.8098, 1.95, 0.301, 212, 206, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4303, p5t0iG_, 0.8089, 2.20, 0.224, 220, 210, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4304, d3mkaF_, 0.8070, 2.32, 0.152, 221, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4305, d3mi0F_, 0.8057, 2.33, 0.152, 220, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4306, p5mpcD_, 0.8052, 2.26, 0.297, 224, 209, 
4307, d3mkaA_, 0.8051, 2.42, 0.151, 222, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4308, d5thoS_, 0.8047, 2.31, 0.152, 221, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4309, d5trsA_, 0.8035, 2.23, 0.153, 219, 209, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4310, p5t0hG_, 0.8035, 2.26, 0.224, 220, 210, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4311, d3h6iQ_, 0.8026, 2.23, 0.153, 218, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4312, d5trgP_, 0.8025, 2.21, 0.154, 219, 208, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4313, d3mkaK_, 0.8023, 2.41, 0.147, 221, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4314, d5ts0G_, 0.8021, 2.26, 0.153, 220, 209, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4315, d3mkaQ_, 0.8020, 2.44, 0.147, 222, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4316, d3mkaU_, 0.8016, 2.45, 0.152, 221, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4317, p6epfA_, 0.8014, 2.25, 0.230, 222, 209, GROUND STATE 26S PROTEASOME (GS1)
4318, d5trsD_, 0.8013, 2.23, 0.154, 218, 208, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4319, p5ln3C_, 0.8012, 2.34, 0.318, 225, 211, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
4320, p5wviD_, 0.8010, 2.12, 0.179, 222, 207, 
4321, d5thoG_, 0.8009, 2.23, 0.154, 218, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4322, d3mkaY_, 0.8008, 2.44, 0.152, 224, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4323, d5tryA_, 0.8004, 2.23, 0.154, 218, 208, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4324, d5trgA_, 0.8004, 2.23, 0.154, 218, 208, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4325, d5thoO_, 0.8004, 2.24, 0.154, 218, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4326, d5trrA_, 0.8003, 2.22, 0.154, 218, 208, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4327, p5lf0U_, 0.8003, 1.85, 0.239, 212, 201, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
4328, d5trsP_, 0.8001, 2.25, 0.154, 219, 208, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4329, d5ts0P_, 0.8000, 2.26, 0.154, 218, 208, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4330, p2fhgW_, 0.7999, 2.23, 0.144, 220, 208, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4331, d5tryS_, 0.7998, 2.25, 0.154, 219, 208, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4332, d5tryP_, 0.7998, 2.22, 0.155, 217, 207, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4333, p5leyU_, 0.7998, 1.86, 0.239, 212, 201, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
4334, p2fhgQ_, 0.7998, 2.23, 0.144, 220, 208, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4335, p5wviNA_, 0.7997, 2.09, 0.277, 222, 206, 
4336, p2fhgU_, 0.7997, 2.23, 0.144, 220, 208, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4337, p2fhgI_, 0.7997, 2.23, 0.144, 220, 208, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4338, p2fhgD_, 0.7997, 2.23, 0.144, 220, 208, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4339, p2fhgB_, 0.7997, 2.23, 0.144, 220, 208, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4340, d5thoA_, 0.7996, 2.23, 0.154, 218, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4341, d3h6iF_, 0.7996, 2.23, 0.154, 217, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4342, p2fhgS_, 0.7996, 2.23, 0.144, 220, 208, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4343, p2fhgM_, 0.7996, 2.23, 0.144, 220, 208, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4344, p2fhgA_, 0.7996, 2.23, 0.144, 220, 208, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4345, p2fhg1_, 0.7996, 2.23, 0.144, 220, 208, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4346, p2fhgO_, 0.7995, 2.23, 0.144, 220, 208, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4347, p2fhgK_, 0.7995, 2.23, 0.144, 220, 208, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4348, d5trrP_, 0.7994, 2.27, 0.154, 219, 208, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4349, p5lezU_, 0.7992, 1.87, 0.239, 212, 201, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
4350, d3mkaD_, 0.7992, 2.33, 0.153, 222, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4351, d2fhhW_, 0.7992, 2.24, 0.144, 220, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4352, d2fhhD_, 0.7992, 2.24, 0.144, 220, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4353, d2fhhU_, 0.7991, 2.24, 0.144, 220, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4354, d2fhhO_, 0.7991, 2.24, 0.144, 220, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4355, d2fhhM_, 0.7991, 2.24, 0.144, 220, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4356, d2fhhI_, 0.7991, 2.24, 0.144, 220, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4357, d2fhhY_, 0.7990, 2.24, 0.144, 220, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4358, d2fhhS_, 0.7990, 2.24, 0.144, 220, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4359, d2fhhF_, 0.7990, 2.24, 0.144, 220, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4360, d2fhhQ_, 0.7989, 2.24, 0.144, 220, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4361, d2fhhA_, 0.7989, 2.24, 0.144, 220, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4362, d2fhhK_, 0.7988, 2.24, 0.144, 220, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4363, d2fhhB_, 0.7988, 2.24, 0.144, 220, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4364, d2fhh1_, 0.7987, 2.25, 0.144, 220, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4365, d5trgO_, 0.7986, 2.26, 0.154, 218, 208, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4366, p6epdA_, 0.7984, 2.33, 0.219, 223, 210, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS1)
4367, d3mkaB_, 0.7984, 2.42, 0.148, 220, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4368, p6epcA_, 0.7983, 2.15, 0.209, 219, 206, GROUND STATE 26S PROTEASOME (GS2)
4369, p5lzpD_, 0.7983, 2.24, 0.154, 217, 208, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4370, d5ts0A_, 0.7982, 2.25, 0.154, 218, 208, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4371, p5wviF_, 0.7981, 2.42, 0.269, 223, 208, 
4372, p5wviH_, 0.7977, 1.73, 0.340, 214, 200, 
4373, d5ts0E_, 0.7977, 2.27, 0.154, 218, 208, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4374, d3mfeB_, 0.7976, 2.15, 0.150, 216, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4375, d3mka1_, 0.7975, 2.35, 0.153, 219, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4376, d5trrT_, 0.7974, 2.22, 0.155, 217, 207, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4377, d5thoE_, 0.7974, 2.27, 0.154, 218, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4378, d3h6fQ_, 0.7974, 2.24, 0.154, 217, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4379, d2h6jB1, 0.7974, 2.18, 0.135, 219, 207, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4380, d5thoT_, 0.7973, 2.22, 0.155, 217, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4381, d3mkaM_, 0.7973, 2.35, 0.153, 224, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4382, d3mfeI_, 0.7970, 2.21, 0.155, 217, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4383, d3mkaI_, 0.7969, 2.30, 0.144, 217, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4384, d2h6jF1, 0.7969, 2.21, 0.135, 219, 207, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4385, d5trgS_, 0.7967, 2.24, 0.155, 218, 207, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4386, d3h6iK_, 0.7965, 2.26, 0.154, 217, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4387, d2h6jA1, 0.7965, 2.19, 0.135, 219, 207, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4388, p6epdD_, 0.7964, 2.93, 0.324, 246, 222, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS1)
4389, d5trgG_, 0.7964, 2.19, 0.150, 216, 206, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4390, d2h6jG1, 0.7964, 2.22, 0.135, 219, 207, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4391, d2h6jE1, 0.7964, 2.19, 0.135, 219, 207, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4392, d2h6jC1, 0.7964, 2.19, 0.135, 219, 207, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4393, d5thoR_, 0.7963, 2.25, 0.155, 217, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4394, d5trrO_, 0.7962, 2.23, 0.145, 217, 207, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4395, d5trgE_, 0.7962, 2.29, 0.154, 218, 208, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4396, d3mkaS_, 0.7962, 2.31, 0.149, 219, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4397, d3h6iW_, 0.7962, 2.29, 0.154, 217, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4398, d5ts0T_, 0.7961, 2.24, 0.155, 218, 207, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4399, d5ts0R_, 0.7961, 2.26, 0.155, 217, 207, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4400, d2h6jD1, 0.7961, 2.19, 0.135, 219, 207, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4401, d5tryE_, 0.7960, 2.25, 0.155, 217, 207, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4402, d5thoP_, 0.7960, 2.26, 0.155, 217, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4403, d5ts0U_, 0.7959, 2.23, 0.155, 217, 207, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4404, d5tryR_, 0.7959, 2.25, 0.155, 217, 207, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4405, d5trsE_, 0.7959, 2.24, 0.155, 217, 207, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4406, d5trrE_, 0.7958, 2.24, 0.155, 217, 207, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4407, d5thoD_, 0.7958, 2.25, 0.155, 216, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4408, d3h6iA_, 0.7958, 2.23, 0.155, 216, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4409, d5trsT_, 0.7957, 2.24, 0.155, 217, 207, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4410, d5tryF_, 0.7956, 2.24, 0.155, 218, 207, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4411, d3mkaO_, 0.7956, 2.35, 0.149, 218, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4412, d3mi0Y_, 0.7955, 2.23, 0.155, 216, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4413, d3mi0K_, 0.7955, 2.24, 0.155, 216, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4414, d5ts0D_, 0.7954, 2.25, 0.155, 217, 207, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4415, d5trsC_, 0.7954, 2.26, 0.155, 218, 207, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4416, d5trgU_, 0.7954, 2.20, 0.155, 216, 206, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4417, d5thoF_, 0.7954, 2.25, 0.155, 217, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4418, d5trrS_, 0.7953, 2.26, 0.155, 218, 207, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4419, d3h6fF_, 0.7952, 2.22, 0.155, 216, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4420, d5trsS_, 0.7951, 2.26, 0.155, 218, 207, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4421, d5trgT_, 0.7951, 2.25, 0.155, 217, 207, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4422, d3mfeK_, 0.7951, 2.19, 0.155, 216, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4423, d5ts0C_, 0.7950, 2.22, 0.155, 217, 206, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4424, d3h6fW_, 0.7950, 2.29, 0.154, 217, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4425, d5trsF_, 0.7948, 2.26, 0.155, 216, 207, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4426, d5trsR_, 0.7946, 2.27, 0.155, 216, 207, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4427, d3mkaW_, 0.7946, 2.30, 0.150, 221, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4428, d5tryD_, 0.7945, 2.27, 0.155, 217, 207, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4429, d5trsO_, 0.7945, 2.26, 0.145, 217, 207, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4430, d5thoC_, 0.7945, 2.22, 0.155, 217, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4431, p5a0qO_, 0.7944, 1.33, 0.269, 195, 193, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4432, p5a0qA_, 0.7944, 1.33, 0.269, 195, 193, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4433, d3h6iU_, 0.7944, 2.20, 0.150, 215, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4434, d5tryQ_, 0.7943, 2.27, 0.155, 218, 207, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4435, d5trrC_, 0.7943, 2.21, 0.155, 217, 206, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4436, d5ts0Q_, 0.7941, 2.27, 0.155, 218, 207, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4437, d5trsU_, 0.7941, 2.22, 0.155, 216, 206, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4438, d5trrU_, 0.7939, 2.21, 0.155, 216, 206, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4439, d5trrD_, 0.7939, 2.22, 0.155, 216, 206, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4440, d3mi0O_, 0.7939, 2.31, 0.155, 216, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4441, d3mi0I_, 0.7939, 2.30, 0.155, 216, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4442, d5ts0O_, 0.7937, 2.24, 0.155, 216, 206, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4443, d5ts0F_, 0.7936, 2.21, 0.150, 215, 206, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4444, d5tryC_, 0.7936, 2.20, 0.155, 216, 206, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4445, d3hfaB_, 0.7936, 2.15, 0.156, 214, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4446, d5trgF_, 0.7934, 2.22, 0.155, 215, 206, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4447, d3h6iI_, 0.7934, 2.20, 0.155, 215, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4448, d1q5qG_, 0.7934, 2.29, 0.135, 219, 207, THE RHODOCOCCUS 20S PROTEASOME
4449, d1q5qF_, 0.7934, 2.29, 0.135, 219, 207, THE RHODOCOCCUS 20S PROTEASOME
4450, d1q5qE_, 0.7934, 2.29, 0.135, 219, 207, THE RHODOCOCCUS 20S PROTEASOME
4451, d1q5qD_, 0.7934, 2.29, 0.135, 219, 207, THE RHODOCOCCUS 20S PROTEASOME
4452, d1q5qC_, 0.7934, 2.29, 0.135, 219, 207, THE RHODOCOCCUS 20S PROTEASOME
4453, d1q5qA_, 0.7934, 2.29, 0.135, 219, 207, THE RHODOCOCCUS 20S PROTEASOME
4454, d5ts0S_, 0.7933, 2.29, 0.155, 218, 207, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4455, d3mi0U_, 0.7933, 2.32, 0.150, 216, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4456, d1q5qB_, 0.7933, 2.29, 0.135, 219, 207, THE RHODOCOCCUS 20S PROTEASOME
4457, d3h6i1_, 0.7932, 2.21, 0.155, 215, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4458, d5trgD_, 0.7931, 2.23, 0.146, 223, 206, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4459, d1q5rG_, 0.7931, 2.26, 0.135, 219, 207, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4460, d1q5rF_, 0.7931, 2.26, 0.135, 219, 207, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4461, d1q5rE_, 0.7931, 2.26, 0.135, 219, 207, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4462, d1q5rD_, 0.7931, 2.26, 0.135, 219, 207, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4463, d1q5rC_, 0.7931, 2.26, 0.135, 219, 207, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4464, d1q5rB_, 0.7931, 2.26, 0.135, 219, 207, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4465, d1q5rA_, 0.7931, 2.26, 0.135, 219, 207, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4466, d5tryU_, 0.7929, 2.23, 0.155, 216, 206, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4467, d5thoU_, 0.7929, 2.23, 0.155, 216, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4468, d3h6iO_, 0.7927, 2.22, 0.150, 215, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4469, d3h6iM_, 0.7927, 2.29, 0.150, 216, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4470, d5tryT_, 0.7926, 2.23, 0.155, 216, 206, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4471, d5trgB_, 0.7926, 2.18, 0.156, 215, 205, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4472, d3krdY_, 0.7926, 2.22, 0.150, 216, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4473, d3krdI_, 0.7926, 2.23, 0.150, 215, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4474, d3krd1_, 0.7924, 2.23, 0.150, 215, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4475, d5trrG_, 0.7923, 2.23, 0.150, 216, 206, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4476, d3mi0M_, 0.7923, 2.31, 0.155, 216, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4477, d3mi01_, 0.7923, 2.24, 0.155, 215, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4478, d3h6f1_, 0.7922, 2.21, 0.155, 215, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4479, d3h6fA_, 0.7921, 2.21, 0.155, 215, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4480, d5trrR_, 0.7920, 2.24, 0.155, 215, 206, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4481, d5ts0B_, 0.7918, 2.20, 0.156, 216, 205, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4482, d5trsG_, 0.7917, 2.24, 0.146, 216, 206, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4483, d3h6fK_, 0.7917, 2.22, 0.155, 215, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4484, d5trrB_, 0.7914, 2.19, 0.156, 215, 205, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4485, p5lzpH_, 0.7914, 2.23, 0.155, 215, 206, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4486, d3mi0Q_, 0.7914, 2.24, 0.150, 215, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4487, d5tryG_, 0.7913, 2.25, 0.150, 216, 206, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4488, d3mi0S_, 0.7913, 2.24, 0.150, 216, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4489, d5trgR_, 0.7912, 2.25, 0.155, 215, 206, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4490, p5lzp4_, 0.7911, 2.25, 0.155, 215, 206, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4491, d3hfaQ_, 0.7911, 2.20, 0.156, 214, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4492, d5trgC_, 0.7910, 2.26, 0.155, 216, 206, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4493, p5lzp2_, 0.7910, 2.25, 0.155, 215, 206, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4494, d3h6iS_, 0.7910, 2.24, 0.150, 215, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4495, d3h6fO_, 0.7910, 2.24, 0.150, 215, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4496, p5lzpS_, 0.7909, 2.24, 0.155, 215, 206, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4497, p5lzp6_, 0.7908, 2.25, 0.155, 215, 206, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4498, p5lzp0_, 0.7908, 2.26, 0.155, 215, 206, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4499, d3krdF_, 0.7908, 2.24, 0.150, 216, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4500, d3hfaS_, 0.7908, 2.21, 0.156, 214, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4501, d5trrF_, 0.7907, 2.24, 0.150, 215, 206, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4502, d3mi0A_, 0.7907, 2.24, 0.150, 215, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4503, d3hfaA_, 0.7907, 2.20, 0.156, 214, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4504, p5lzp8_, 0.7906, 2.26, 0.155, 215, 206, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4505, d3krdW_, 0.7906, 2.24, 0.150, 215, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4506, d3hfaK_, 0.7906, 2.20, 0.156, 214, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4507, p5lzpY_, 0.7905, 2.26, 0.155, 215, 206, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4508, d3hfaW_, 0.7905, 2.20, 0.156, 214, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4509, p5lzpW_, 0.7904, 2.26, 0.155, 215, 206, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4510, d3hfaM_, 0.7904, 2.21, 0.156, 214, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4511, d3h6fS_, 0.7904, 2.25, 0.150, 215, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4512, d5tryO_, 0.7903, 2.27, 0.146, 216, 206, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4513, d3hfaI_, 0.7903, 2.21, 0.156, 214, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4514, d5thoB_, 0.7902, 2.21, 0.156, 215, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4515, d3mfeS_, 0.7902, 2.20, 0.151, 215, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4516, d3hfaF_, 0.7902, 2.21, 0.156, 214, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4517, d5trgQ_, 0.7900, 2.23, 0.156, 217, 205, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4518, d3hfaO_, 0.7900, 2.21, 0.156, 214, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4519, d3hfa1_, 0.7900, 2.23, 0.156, 214, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4520, d5trsB_, 0.7899, 2.21, 0.156, 216, 205, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4521, d5tryB_, 0.7898, 2.22, 0.156, 215, 205, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4522, d3krdO_, 0.7898, 2.23, 0.151, 214, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4523, d3hfaY_, 0.7898, 2.23, 0.156, 214, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4524, p5lzpJ_, 0.7897, 2.27, 0.155, 215, 206, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4525, d3mfeA_, 0.7895, 2.21, 0.151, 214, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4526, d3krdK_, 0.7895, 2.27, 0.150, 215, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4527, d3mfeY_, 0.7892, 2.17, 0.147, 213, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4528, d3hfaU_, 0.7891, 2.23, 0.156, 214, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4529, d3mi0W_, 0.7890, 2.44, 0.150, 216, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4530, d3h6fI_, 0.7884, 2.21, 0.156, 214, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4531, p5vfpD_, 0.7882, 2.25, 0.298, 219, 205, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4532, d3h6iB_, 0.7882, 2.23, 0.151, 214, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4533, d3krdA_, 0.7879, 2.24, 0.151, 214, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4534, d3krdQ_, 0.7876, 2.24, 0.151, 214, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4535, p5ln3A_, 0.7875, 2.28, 0.213, 219, 207, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
4536, d3mi0D_, 0.7875, 2.25, 0.151, 214, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4537, d3h6fD_, 0.7874, 2.23, 0.151, 214, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4538, d3krdS_, 0.7872, 2.25, 0.151, 215, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4539, d5trrQ_, 0.7871, 2.26, 0.156, 215, 205, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4540, p5lzpM_, 0.7870, 2.24, 0.151, 214, 205, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4541, d3h6fB_, 0.7869, 2.25, 0.151, 214, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4542, d3h6fM_, 0.7868, 2.32, 0.150, 215, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4543, p5lzpB_, 0.7865, 2.25, 0.151, 214, 205, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4544, d3krdU_, 0.7865, 2.26, 0.151, 214, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4545, d5thoQ_, 0.7864, 2.27, 0.156, 216, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4546, d3hfaD_, 0.7864, 2.21, 0.152, 213, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4547, d3h6fU_, 0.7864, 2.25, 0.151, 214, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4548, d5trsQ_, 0.7862, 2.28, 0.156, 216, 205, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4549, p5lzpQ_, 0.7862, 2.25, 0.151, 214, 205, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4550, d3mfeQ_, 0.7860, 2.20, 0.152, 213, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4551, d3mfe1_, 0.7860, 2.19, 0.147, 213, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4552, d3krdM_, 0.7859, 2.27, 0.151, 214, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4553, d3mfeD_, 0.7857, 2.22, 0.152, 213, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4554, d3h6iD_, 0.7855, 2.20, 0.152, 213, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4555, d3mi0B_, 0.7848, 2.23, 0.147, 213, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4556, p5t0jJ_, 0.7846, 2.37, 0.312, 222, 208, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4557, d3krdB_, 0.7844, 2.24, 0.147, 213, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4558, p6bgoI_, 0.7843, 2.32, 0.155, 215, 206, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4559, p6bgoH_, 0.7843, 2.32, 0.155, 215, 206, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4560, p6bgoG_, 0.7843, 2.32, 0.155, 215, 206, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4561, p6bgoF_, 0.7843, 2.32, 0.155, 215, 206, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4562, p6bgoE_, 0.7843, 2.32, 0.155, 215, 206, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4563, p6bgoD_, 0.7843, 2.32, 0.155, 215, 206, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4564, p6bgoC_, 0.7843, 2.32, 0.155, 215, 206, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4565, p6bglO_, 0.7843, 2.32, 0.155, 215, 206, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4566, p6bglN_, 0.7843, 2.32, 0.155, 215, 206, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4567, p6bglM_, 0.7843, 2.32, 0.155, 215, 206, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4568, p6bglL_, 0.7843, 2.32, 0.155, 215, 206, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4569, p6bglK_, 0.7843, 2.32, 0.155, 215, 206, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4570, p6bglJ_, 0.7843, 2.32, 0.155, 215, 206, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4571, p6bglI_, 0.7843, 2.32, 0.155, 215, 206, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4572, p6bglH_, 0.7843, 2.32, 0.155, 215, 206, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4573, p6bglG_, 0.7843, 2.32, 0.155, 215, 206, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4574, p6bglF_, 0.7843, 2.32, 0.155, 215, 206, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4575, p6bglE_, 0.7843, 2.32, 0.155, 215, 206, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4576, p6bglD_, 0.7843, 2.32, 0.155, 215, 206, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4577, p6bglC_, 0.7843, 2.32, 0.155, 215, 206, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4578, p6bglA_, 0.7843, 2.32, 0.155, 215, 206, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4579, d3mfeO_, 0.7836, 2.24, 0.152, 214, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4580, p6epeD_, 0.7833, 2.51, 0.306, 229, 209, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS2)
4581, d3h6iY_, 0.7832, 2.23, 0.152, 213, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4582, d3h6fY_, 0.7831, 2.24, 0.152, 213, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4583, d3krdD_, 0.7823, 2.30, 0.152, 213, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4584, d3mfeU_, 0.7816, 2.22, 0.153, 212, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4585, p3hf9s_, 0.7816, 2.16, 0.149, 211, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4586, d3hf9B_, 0.7811, 2.16, 0.149, 211, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4587, p3hf9f_, 0.7808, 2.17, 0.149, 211, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4588, p3hf9y_, 0.7805, 2.16, 0.149, 211, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4589, p3hf9b_, 0.7803, 2.17, 0.149, 211, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4590, p3hf9k_, 0.7802, 2.17, 0.149, 211, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4591, p3hf9d_, 0.7802, 2.16, 0.149, 211, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4592, d3hf9A_, 0.7799, 2.18, 0.149, 211, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4593, d3hf9I_, 0.7797, 2.18, 0.149, 212, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4594, d3hf9K_, 0.7796, 2.20, 0.149, 211, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4595, d3hf91_, 0.7796, 2.17, 0.149, 211, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4596, d3hf9U_, 0.7795, 2.18, 0.149, 211, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4597, p3hf9i_, 0.7795, 2.18, 0.149, 211, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4598, p3hf9u_, 0.7793, 2.18, 0.149, 211, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4599, d3hf9S_, 0.7792, 2.18, 0.149, 211, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4600, p3hf9a_, 0.7792, 2.18, 0.149, 211, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4601, d3hf9Q_, 0.7787, 2.20, 0.149, 211, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4602, d3hf9O_, 0.7785, 2.18, 0.149, 211, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4603, p3hf9w_, 0.7783, 2.18, 0.149, 211, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4604, p3hf9q_, 0.7781, 2.19, 0.149, 211, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4605, p3hf9o_, 0.7775, 2.19, 0.149, 211, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4606, d3hf93_, 0.7766, 2.16, 0.149, 210, 201, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4607, d3hf9Y_, 0.7750, 2.18, 0.149, 210, 201, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4608, d3hf9D_, 0.7748, 2.20, 0.149, 210, 201, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4609, d3mfeW_, 0.7744, 2.12, 0.150, 209, 200, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4610, p3hf9m_, 0.7692, 2.16, 0.151, 208, 199, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4611, p5t0iJ_, 0.7644, 2.53, 0.304, 222, 207, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4612, p2fhgF_, 0.7636, 2.11, 0.147, 209, 197, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4613, p2fhgY_, 0.7635, 2.11, 0.147, 209, 197, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4614, p6bgoN_, 0.7613, 2.18, 0.162, 207, 198, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4615, p6bgoM_, 0.7613, 2.18, 0.162, 207, 198, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4616, p6bgoL_, 0.7613, 2.18, 0.162, 207, 198, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4617, p6bgoK_, 0.7613, 2.18, 0.162, 207, 198, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4618, p6bgoJ_, 0.7613, 2.18, 0.162, 207, 198, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4619, p6bgoA_, 0.7613, 2.18, 0.162, 207, 198, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4620, d3hf9M_, 0.7610, 2.08, 0.153, 205, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4621, p6bgoO_, 0.7577, 2.18, 0.162, 206, 197, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4622, p5vy3Z_, 0.7444, 2.41, 0.224, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4623, p5vy3X_, 0.7444, 2.41, 0.224, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4624, p5vy3V_, 0.7444, 2.41, 0.224, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4625, p5vy3T_, 0.7444, 2.41, 0.224, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4626, p5vy3R_, 0.7444, 2.41, 0.224, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4627, p5vy3P_, 0.7444, 2.41, 0.224, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4628, p5vy3N_, 0.7444, 2.41, 0.224, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4629, p5vy3J_, 0.7444, 2.41, 0.224, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4630, p5vy3H_, 0.7444, 2.41, 0.224, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4631, p5vy31_, 0.7444, 2.41, 0.224, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4632, p5vy3L_, 0.7443, 2.41, 0.224, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4633, p5vy3F_, 0.7443, 2.41, 0.224, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4634, p5vy3D_, 0.7443, 2.41, 0.224, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4635, p5vy3B_, 0.7443, 2.41, 0.224, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4636, p5vy4Z_, 0.7441, 2.40, 0.224, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4637, p5vy4X_, 0.7441, 2.40, 0.224, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4638, p5vy4V_, 0.7441, 2.40, 0.224, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4639, p5vy4T_, 0.7441, 2.40, 0.224, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4640, p5vy4R_, 0.7441, 2.40, 0.224, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4641, p5vy4P_, 0.7441, 2.40, 0.224, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4642, p5vy4N_, 0.7441, 2.40, 0.224, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4643, p5vy4L_, 0.7441, 2.40, 0.224, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4644, p5vy4J_, 0.7441, 2.40, 0.224, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4645, p5vy4H_, 0.7441, 2.40, 0.224, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4646, p5vy4F_, 0.7441, 2.40, 0.224, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4647, p5vy4D_, 0.7441, 2.40, 0.224, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4648, p5vy4BA_, 0.7441, 2.40, 0.224, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4649, p5vy4B_, 0.7441, 2.40, 0.224, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4650, p5vy41_, 0.7441, 2.40, 0.224, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4651, p6bdfZ_, 0.7438, 2.42, 0.224, 201, 192, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4652, p6bdfX_, 0.7438, 2.42, 0.224, 201, 192, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4653, p6bdfV_, 0.7438, 2.42, 0.224, 201, 192, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4654, p6bdfT_, 0.7438, 2.42, 0.224, 201, 192, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4655, p6bdfR_, 0.7438, 2.42, 0.224, 201, 192, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4656, p6bdfP_, 0.7438, 2.42, 0.224, 201, 192, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4657, p6bdfN_, 0.7438, 2.42, 0.224, 201, 192, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4658, p6bdfL_, 0.7438, 2.42, 0.224, 201, 192, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4659, p6bdfJ_, 0.7438, 2.42, 0.224, 201, 192, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4660, p6bdfH_, 0.7438, 2.42, 0.224, 201, 192, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4661, p6bdfF_, 0.7438, 2.42, 0.224, 201, 192, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4662, p6bdfD_, 0.7438, 2.42, 0.224, 201, 192, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4663, p6bdfB_, 0.7438, 2.42, 0.224, 201, 192, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4664, p6bdf1_, 0.7438, 2.42, 0.224, 201, 192, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4665, d1yauM_, 0.7432, 2.36, 0.225, 203, 191, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4666, d1yarM_, 0.7430, 2.37, 0.225, 203, 191, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4667, d1ya7M_, 0.7427, 2.37, 0.225, 203, 191, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
4668, p3j9iZ_, 0.7423, 2.38, 0.225, 203, 191, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4669, p3j9iY_, 0.7423, 2.38, 0.225, 203, 191, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4670, p3j9iX_, 0.7423, 2.38, 0.225, 203, 191, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4671, p3j9iW_, 0.7423, 2.38, 0.225, 203, 191, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4672, p3j9iV_, 0.7423, 2.38, 0.225, 203, 191, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4673, p3j9iN_, 0.7423, 2.38, 0.225, 203, 191, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4674, p3j9iM_, 0.7423, 2.38, 0.225, 203, 191, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4675, p3j9iL_, 0.7423, 2.38, 0.225, 203, 191, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4676, p3j9iK_, 0.7423, 2.38, 0.225, 203, 191, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4677, p3j9iJ_, 0.7423, 2.38, 0.225, 203, 191, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4678, p3j9iI_, 0.7423, 2.38, 0.225, 203, 191, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4679, p3j9iH_, 0.7423, 2.38, 0.225, 203, 191, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4680, p3j9i2_, 0.7423, 2.38, 0.225, 203, 191, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4681, p3j9i1_, 0.7423, 2.38, 0.225, 203, 191, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4682, d3jseM_, 0.7416, 2.39, 0.225, 203, 191, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4683, d3c92X1, 0.7415, 2.39, 0.225, 203, 191, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4684, d3c92J1, 0.7415, 2.39, 0.225, 203, 191, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4685, d3c91X1, 0.7415, 2.39, 0.225, 203, 191, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4686, d3c91J1, 0.7415, 2.39, 0.225, 203, 191, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4687, d1pmaQ_, 0.7415, 2.39, 0.225, 203, 191, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4688, p5gjqu_, 0.7414, 2.84, 0.156, 207, 199, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
4689, d3jrmM_, 0.7414, 2.40, 0.225, 203, 191, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4690, d1pmaX_, 0.7414, 2.39, 0.225, 203, 191, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4691, d1pmaP_, 0.7414, 2.39, 0.225, 203, 191, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4692, p3h4pf_, 0.7413, 2.33, 0.246, 202, 191, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4693, d3c92W1, 0.7413, 2.39, 0.225, 203, 191, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4694, d3c92I1, 0.7413, 2.39, 0.225, 203, 191, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4695, d3c91W1, 0.7413, 2.39, 0.225, 203, 191, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4696, d3c91I1, 0.7413, 2.39, 0.225, 203, 191, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4697, d1pmaZ_, 0.7413, 2.40, 0.225, 203, 191, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4698, d1pmaU_, 0.7413, 2.39, 0.225, 203, 191, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4699, d3c92N1, 0.7412, 2.39, 0.225, 203, 191, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4700, d3c9221, 0.7412, 2.39, 0.225, 203, 191, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4701, d3c91N1, 0.7412, 2.39, 0.225, 203, 191, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4702, d3c9121, 0.7412, 2.39, 0.225, 203, 191, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4703, d3c92Z1, 0.7411, 2.39, 0.225, 203, 191, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4704, d3c92M1, 0.7411, 2.39, 0.225, 203, 191, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4705, d3c92L1, 0.7411, 2.39, 0.225, 203, 191, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4706, d3c9211, 0.7411, 2.39, 0.225, 203, 191, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4707, d3c91Z1, 0.7411, 2.39, 0.225, 203, 191, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4708, d3c91M1, 0.7411, 2.39, 0.225, 203, 191, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4709, d3c91L1, 0.7411, 2.39, 0.225, 203, 191, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4710, d3c9111, 0.7411, 2.39, 0.225, 203, 191, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4711, d1yauJ_, 0.7411, 2.39, 0.225, 203, 191, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4712, d1pmaT_, 0.7411, 2.39, 0.225, 203, 191, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4713, d1pmaS_, 0.7411, 2.39, 0.225, 203, 191, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4714, d1pma2_, 0.7411, 2.39, 0.225, 203, 191, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4715, d1pma1_, 0.7411, 2.39, 0.225, 203, 191, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4716, d3jseK_, 0.7410, 2.39, 0.225, 203, 191, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4717, d3jrmK_, 0.7410, 2.40, 0.225, 203, 191, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4718, d3jrmJ_, 0.7410, 2.40, 0.225, 203, 191, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4719, d3jrmI_, 0.7410, 2.40, 0.225, 203, 191, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4720, d3jrmH_, 0.7410, 2.40, 0.225, 203, 191, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4721, d1ya7J_, 0.7410, 2.40, 0.225, 203, 191, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
4722, d1pmaY_, 0.7410, 2.39, 0.225, 203, 191, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4723, d1pmaV_, 0.7410, 2.40, 0.225, 203, 191, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4724, d3jseL_, 0.7409, 2.40, 0.225, 203, 191, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4725, d3jseJ_, 0.7409, 2.40, 0.225, 203, 191, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4726, d3jseI_, 0.7409, 2.40, 0.225, 203, 191, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4727, d3jrmN_, 0.7409, 2.41, 0.225, 203, 191, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4728, d3jrmL_, 0.7409, 2.40, 0.225, 203, 191, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4729, p3jtlM_, 0.7408, 2.40, 0.225, 203, 191, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4730, d3jseN_, 0.7408, 2.40, 0.225, 203, 191, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4731, d3jseH_, 0.7408, 2.40, 0.225, 203, 191, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4732, d1ya7I_, 0.7408, 2.40, 0.225, 203, 191, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
4733, p3jtlI_, 0.7407, 2.40, 0.225, 203, 191, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4734, d3c92Y1, 0.7407, 2.40, 0.225, 203, 191, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4735, d3c92V1, 0.7407, 2.40, 0.225, 203, 191, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4736, d3c92K1, 0.7407, 2.40, 0.225, 203, 191, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4737, d3c92H1, 0.7407, 2.40, 0.225, 203, 191, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4738, d3c91Y1, 0.7407, 2.40, 0.225, 203, 191, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4739, d3c91V1, 0.7407, 2.40, 0.225, 203, 191, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4740, d3c91K1, 0.7407, 2.40, 0.225, 203, 191, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4741, d3c91H1, 0.7407, 2.40, 0.225, 203, 191, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4742, d1yarK_, 0.7407, 2.40, 0.225, 203, 191, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4743, d1ya7L_, 0.7407, 2.40, 0.225, 203, 191, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
4744, d1ya7K_, 0.7407, 2.40, 0.225, 203, 191, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
4745, d1pmaR_, 0.7407, 2.40, 0.225, 203, 191, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4746, d1pmaB_, 0.7407, 2.40, 0.225, 203, 191, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4747, p3jtlK_, 0.7406, 2.40, 0.225, 203, 191, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4748, d3h4pk_, 0.7406, 2.33, 0.246, 202, 191, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4749, d1yarJ_, 0.7406, 2.40, 0.225, 203, 191, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4750, d1ya7N_, 0.7406, 2.41, 0.225, 203, 191, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
4751, d1ya7H_, 0.7406, 2.40, 0.225, 203, 191, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
4752, p3jtlN_, 0.7405, 2.41, 0.225, 203, 191, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4753, p3jtlL_, 0.7405, 2.40, 0.225, 203, 191, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4754, p3jtlJ_, 0.7405, 2.40, 0.225, 203, 191, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4755, p3jtlH_, 0.7405, 2.40, 0.225, 203, 191, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4756, d3h4pl_, 0.7405, 2.33, 0.246, 202, 191, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4757, d1yarL_, 0.7404, 2.40, 0.225, 203, 191, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4758, d1pmaW_, 0.7404, 2.41, 0.225, 203, 191, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4759, d1yauK_, 0.7403, 2.40, 0.225, 203, 191, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4760, d1yauH_, 0.7403, 2.40, 0.225, 203, 191, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4761, d1yarI_, 0.7402, 2.40, 0.225, 203, 191, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4762, d1yauI_, 0.7401, 2.40, 0.225, 203, 191, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4763, d1yarH_, 0.7401, 2.41, 0.225, 203, 191, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4764, d3h4pn_, 0.7400, 2.35, 0.251, 202, 191, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4765, p3h4pa_, 0.7400, 2.34, 0.246, 202, 191, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4766, d1yauN_, 0.7400, 2.42, 0.225, 203, 191, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4767, d1yarN_, 0.7400, 2.43, 0.225, 203, 191, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4768, p3h4pd_, 0.7399, 2.35, 0.246, 202, 191, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4769, d1yauL_, 0.7399, 2.41, 0.225, 203, 191, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4770, d3h4pi_, 0.7398, 2.35, 0.246, 202, 191, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4771, p3h4pg_, 0.7398, 2.33, 0.246, 202, 191, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4772, p3h4pc_, 0.7398, 2.35, 0.251, 202, 191, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4773, d3h4ph_, 0.7397, 2.35, 0.246, 202, 191, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4774, d3h4pm_, 0.7396, 2.35, 0.246, 202, 191, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4775, p3h4pe_, 0.7396, 2.36, 0.246, 202, 191, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4776, d3h4pj_, 0.7392, 2.29, 0.247, 202, 190, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4777, p3h4pb_, 0.7391, 2.35, 0.246, 202, 191, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4778, p5l4gK_, 0.7384, 2.85, 0.156, 207, 199, 
4779, p5gjqg_, 0.7382, 2.88, 0.156, 206, 199, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
4780, p5gjrTA_, 0.7376, 2.89, 0.156, 207, 199, 
4781, p5gjrFA_, 0.7374, 2.89, 0.156, 206, 199, 
4782, p5l4gY_, 0.7372, 2.89, 0.156, 207, 199, 
4783, p3ipmK_, 0.7367, 2.47, 0.225, 203, 191, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4784, p3ipmJ_, 0.7367, 2.47, 0.225, 203, 191, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4785, p3ipmM_, 0.7366, 2.47, 0.225, 203, 191, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4786, p3ipmL_, 0.7366, 2.47, 0.225, 203, 191, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4787, p3ipmI_, 0.7366, 2.47, 0.225, 203, 191, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4788, p3ipmH_, 0.7366, 2.47, 0.225, 203, 191, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4789, p3ipmN_, 0.7365, 2.47, 0.225, 203, 191, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4790, d1j2qJ_, 0.7363, 2.50, 0.276, 202, 192, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
4791, d1j2qH_, 0.7363, 2.50, 0.276, 202, 192, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
4792, d1j2qK_, 0.7362, 2.50, 0.276, 202, 192, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
4793, p5m32a_, 0.7359, 2.88, 0.157, 206, 198, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
4794, p6avoW_, 0.7358, 2.89, 0.156, 206, 199, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
4795, p6avoa_, 0.7358, 2.89, 0.156, 206, 199, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
4796, p5m32M_, 0.7356, 2.89, 0.157, 206, 198, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
4797, d1j2qN_, 0.7351, 2.46, 0.277, 202, 191, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
4798, p5vfoT_, 0.7349, 2.82, 0.157, 205, 198, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4799, d1j2qL_, 0.7349, 2.46, 0.277, 202, 191, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
4800, d1j2qM_, 0.7348, 2.46, 0.277, 202, 191, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
4801, d1j2qI_, 0.7348, 2.47, 0.277, 202, 191, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
4802, p5vfot_, 0.7345, 2.83, 0.157, 205, 198, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4803, d5fgiH_, 0.7344, 3.06, 0.207, 234, 198, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4804, p2z5cF_, 0.7344, 1.31, 0.298, 189, 178, CRYSTAL STRUCTURE OF A NOVEL CHAPERONE COMPLEX FOR YEAST 20S PROTEASOME ASSEMBLY
4805, p2z5cC_, 0.7344, 1.31, 0.298, 189, 178, CRYSTAL STRUCTURE OF A NOVEL CHAPERONE COMPLEX FOR YEAST 20S PROTEASOME ASSEMBLY
4806, d2h6jK1, 0.7342, 2.90, 0.177, 225, 198, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4807, p5vfsMA_, 0.7341, 2.86, 0.157, 205, 198, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4808, d5fgiV_, 0.7341, 3.08, 0.207, 234, 198, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4809, d2h6jN1, 0.7341, 2.90, 0.177, 225, 198, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4810, d2h6jM1, 0.7340, 2.90, 0.177, 225, 198, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4811, d2h6jH1, 0.7340, 2.90, 0.177, 225, 198, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4812, p5vfpLA_, 0.7339, 2.84, 0.157, 205, 198, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4813, d2h6jJ1, 0.7339, 2.91, 0.182, 225, 198, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4814, p5vfrT_, 0.7338, 2.84, 0.157, 205, 198, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4815, d2h6jI1, 0.7338, 2.90, 0.177, 225, 198, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4816, p5vfpN_, 0.7337, 2.74, 0.168, 205, 197, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4817, p3unea_, 0.7336, 2.92, 0.156, 206, 199, MOUSE CONSTITUTIVE 20S PROTEASOME
4818, d4r3oN_, 0.7335, 2.93, 0.156, 217, 199, HUMAN CONSTITUTIVE 20S PROTEASOME
4819, d4r3o2_, 0.7335, 2.93, 0.156, 217, 199, HUMAN CONSTITUTIVE 20S PROTEASOME
4820, d2h6jL1, 0.7335, 2.91, 0.177, 225, 198, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4821, p5t0cLB_, 0.7333, 2.75, 0.157, 205, 197, 
4822, p5t0cFA_, 0.7333, 2.75, 0.157, 205, 197, 
4823, p3uneo_, 0.7333, 2.92, 0.156, 206, 199, MOUSE CONSTITUTIVE 20S PROTEASOME
4824, p5vfqMA_, 0.7330, 2.85, 0.157, 205, 198, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4825, p3uneM_, 0.7330, 2.92, 0.156, 206, 199, MOUSE CONSTITUTIVE 20S PROTEASOME
4826, p5t0hT_, 0.7329, 2.83, 0.162, 205, 198, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4827, p5lf7a_, 0.7329, 2.94, 0.156, 206, 199, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
4828, p5lf3a_, 0.7329, 2.94, 0.156, 206, 199, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
4829, d5lf7M_, 0.7327, 3.05, 0.165, 216, 200, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
4830, d5lexM_, 0.7327, 3.06, 0.165, 216, 200, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
4831, p3une3_, 0.7327, 2.93, 0.156, 206, 199, MOUSE CONSTITUTIVE 20S PROTEASOME
4832, d5lf4M_, 0.7326, 3.05, 0.165, 216, 200, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
4833, p5lf4a_, 0.7326, 2.94, 0.156, 206, 199, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
4834, p5vfrt_, 0.7325, 2.85, 0.157, 205, 198, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4835, d4r67N_, 0.7325, 2.94, 0.156, 217, 199, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
4836, d4r672_, 0.7325, 2.94, 0.156, 217, 199, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
4837, p3unhM_, 0.7325, 3.06, 0.165, 206, 200, MOUSE 20S IMMUNOPROTEASOME
4838, p3unha_, 0.7325, 3.06, 0.165, 206, 200, MOUSE 20S IMMUNOPROTEASOME
4839, p3unfa_, 0.7325, 3.06, 0.165, 206, 200, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
4840, p5vfsN_, 0.7324, 2.76, 0.157, 205, 197, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4841, p5leya_, 0.7324, 2.94, 0.156, 206, 199, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
4842, d5fg9H_, 0.7324, 2.55, 0.208, 230, 192, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
4843, p4r67p_, 0.7324, 2.94, 0.156, 207, 199, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
4844, p4r67b_, 0.7324, 2.94, 0.156, 207, 199, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
4845, p5lf0a_, 0.7323, 2.95, 0.156, 206, 199, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
4846, p5lexa_, 0.7323, 2.95, 0.156, 206, 199, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
4847, p5le5a_, 0.7323, 2.95, 0.156, 206, 199, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
4848, d5fg9V_, 0.7323, 2.55, 0.208, 230, 192, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
4849, d3unfM_, 0.7323, 3.06, 0.165, 216, 200, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
4850, p5vfqN_, 0.7322, 2.76, 0.157, 205, 197, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4851, p5lf1a_, 0.7322, 2.95, 0.156, 206, 199, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
4852, d5le5M_, 0.7322, 3.06, 0.165, 216, 200, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
4853, p3unba_, 0.7322, 2.95, 0.156, 206, 199, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
4854, p5t0jT_, 0.7321, 2.71, 0.168, 205, 197, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4855, d5lf3M_, 0.7321, 3.06, 0.165, 216, 200, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
4856, d3unb3_, 0.7320, 2.95, 0.156, 216, 199, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
4857, p5vfuEA_, 0.7319, 2.78, 0.157, 205, 197, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4858, p5vftT_, 0.7319, 2.78, 0.157, 205, 197, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4859, p5lf6a_, 0.7319, 2.95, 0.156, 206, 199, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
4860, p5lf0M_, 0.7319, 2.95, 0.156, 206, 199, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
4861, d5lf1M_, 0.7317, 2.95, 0.156, 216, 199, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
4862, p5lezM_, 0.7317, 2.96, 0.156, 206, 199, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
4863, p5leza_, 0.7317, 2.96, 0.156, 206, 199, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
4864, p5leyM_, 0.7316, 2.95, 0.156, 206, 199, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
4865, d3unbM_, 0.7316, 2.95, 0.156, 216, 199, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
4866, p5vfuSA_, 0.7313, 2.78, 0.157, 205, 197, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4867, p5vftt_, 0.7313, 2.78, 0.157, 205, 197, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4868, p5lf6M_, 0.7313, 2.96, 0.156, 206, 199, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
4869, p5t0iT_, 0.7312, 2.75, 0.157, 205, 197, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4870, d5fgeY_, 0.7312, 3.10, 0.173, 218, 197, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4871, p3unbo_, 0.7312, 2.95, 0.156, 206, 199, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
4872, d1iruN_, 0.7309, 2.96, 0.151, 217, 199, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
4873, d1iru2_, 0.7309, 2.96, 0.151, 217, 199, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
4874, d5fgdY_, 0.7305, 2.97, 0.173, 216, 196, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4875, d5fgeK_, 0.7300, 2.99, 0.173, 218, 196, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4876, p5t0gT_, 0.7299, 2.79, 0.157, 205, 197, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4877, d1q5rN_, 0.7295, 2.82, 0.173, 251, 197, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4878, d1q5rM_, 0.7295, 2.82, 0.173, 251, 197, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4879, d1q5rH_, 0.7295, 2.82, 0.173, 251, 197, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4880, d1q5rL_, 0.7294, 2.82, 0.173, 251, 197, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4881, d1q5rK_, 0.7294, 2.82, 0.173, 251, 197, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4882, d1q5rJ_, 0.7294, 2.82, 0.173, 251, 197, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4883, d1q5rI_, 0.7294, 2.82, 0.173, 251, 197, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4884, d5fgdK_, 0.7288, 2.90, 0.174, 215, 195, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4885, d5cz7Y_, 0.7287, 3.04, 0.168, 217, 196, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
4886, d5cz7K_, 0.7287, 3.05, 0.168, 217, 196, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
4887, p5vfoO_, 0.7285, 2.43, 0.201, 193, 189, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4888, d3bdmX_, 0.7282, 2.47, 0.208, 198, 192, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
4889, d3bdmJ_, 0.7282, 2.47, 0.208, 198, 192, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
4890, d3gpjX_, 0.7280, 2.48, 0.208, 198, 192, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
4891, d3gpjJ_, 0.7280, 2.48, 0.208, 198, 192, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
4892, d3d29X_, 0.7280, 2.50, 0.208, 198, 192, PROTEASOME INHIBITION BY FELLUTAMIDE B
4893, d3d29J_, 0.7280, 2.49, 0.208, 198, 192, PROTEASOME INHIBITION BY FELLUTAMIDE B
4894, d5ts0K_, 0.7278, 2.50, 0.166, 223, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4895, d3mkaN_, 0.7276, 2.93, 0.167, 252, 198, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4896, d3mkaG_, 0.7275, 2.82, 0.168, 251, 197, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4897, p5vfpI_, 0.7273, 2.44, 0.201, 193, 189, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4898, d3mkaV_, 0.7270, 2.83, 0.168, 249, 197, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4899, p5vfoo_, 0.7269, 2.44, 0.201, 193, 189, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4900, d5trgK_, 0.7269, 2.50, 0.166, 223, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4901, d5fgfK_, 0.7269, 2.88, 0.170, 214, 194, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
4902, d3mkaJ_, 0.7269, 2.83, 0.168, 252, 197, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4903, d5fg7V_, 0.7268, 2.83, 0.212, 228, 193, YEAST 20S PROTEASOME BETA2-T1A MUTANT
4904, d3okjX_, 0.7268, 2.51, 0.208, 198, 192, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
4905, d3okjJ_, 0.7268, 2.51, 0.208, 198, 192, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
4906, d2zcyX_, 0.7268, 2.50, 0.208, 198, 192, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
4907, d5trsK_, 0.7267, 2.52, 0.166, 223, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4908, d5fgfY_, 0.7267, 2.88, 0.170, 214, 194, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
4909, d4jsqX_, 0.7267, 2.51, 0.208, 198, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
4910, d4jsqJ_, 0.7267, 2.51, 0.208, 198, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
4911, d4inuX_, 0.7267, 2.51, 0.208, 198, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
4912, d2zcyJ_, 0.7267, 2.50, 0.208, 198, 192, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
4913, p5vfqHA_, 0.7266, 2.44, 0.201, 193, 189, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4914, d5trgL_, 0.7266, 2.51, 0.166, 223, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4915, d4inuJ_, 0.7265, 2.51, 0.208, 198, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
4916, d4hrcX_, 0.7265, 2.50, 0.208, 198, 192, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
4917, d3nzwX_, 0.7265, 2.51, 0.208, 198, 192, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
4918, d1g65X_, 0.7265, 2.52, 0.208, 198, 192, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
4919, d4intJ_, 0.7264, 2.52, 0.208, 198, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
4920, d3nzwJ_, 0.7264, 2.51, 0.208, 198, 192, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
4921, p5vfro_, 0.7261, 2.44, 0.201, 193, 189, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4922, d4jsuX_, 0.7261, 2.51, 0.208, 198, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
4923, d4jsuJ_, 0.7261, 2.51, 0.208, 198, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
4924, d4intX_, 0.7261, 2.52, 0.208, 198, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
4925, d4inrX_, 0.7261, 2.51, 0.208, 198, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
4926, d3nzxX_, 0.7261, 2.51, 0.208, 198, 192, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
4927, d3nzxJ_, 0.7261, 2.51, 0.208, 198, 192, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
4928, d3mkaP_, 0.7261, 2.83, 0.168, 250, 197, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4929, p5vfrO_, 0.7260, 2.47, 0.201, 193, 189, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4930, d4ltcX_, 0.7260, 2.52, 0.208, 198, 192, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
4931, d4inrJ_, 0.7260, 2.51, 0.208, 198, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
4932, d3mkaL_, 0.7260, 2.84, 0.168, 251, 197, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4933, p5vfqI_, 0.7259, 2.46, 0.201, 193, 189, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4934, p5vfpGA_, 0.7259, 2.45, 0.201, 193, 189, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4935, d5fg7H_, 0.7259, 2.71, 0.208, 228, 192, YEAST 20S PROTEASOME BETA2-T1A MUTANT
4936, d4hrdJ_, 0.7259, 2.51, 0.208, 198, 192, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
4937, d5l5rY_, 0.7258, 2.81, 0.156, 211, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
4938, d5l5rK_, 0.7258, 2.81, 0.156, 211, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
4939, p3un4J_, 0.7258, 2.51, 0.208, 198, 192, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
4940, p5a5b2_, 0.7257, 2.47, 0.206, 197, 189, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
4941, d4hrdX_, 0.7257, 2.51, 0.208, 198, 192, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
4942, p4cr32_, 0.7257, 2.47, 0.206, 197, 189, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
4943, p3un4X_, 0.7257, 2.52, 0.208, 198, 192, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
4944, d3mkaH_, 0.7257, 2.85, 0.168, 249, 197, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4945, d5thoL_, 0.7256, 2.51, 0.166, 223, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4946, d5m2bY_, 0.7256, 2.83, 0.156, 211, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
4947, d5m2bK_, 0.7256, 2.82, 0.156, 211, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
4948, p4gk7J_, 0.7256, 2.51, 0.208, 198, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
4949, d1g65J_, 0.7256, 2.52, 0.208, 198, 192, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
4950, d5tryK_, 0.7255, 2.53, 0.166, 223, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4951, d5trrL_, 0.7255, 2.51, 0.166, 223, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4952, d5trrI_, 0.7255, 2.52, 0.166, 222, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4953, d5trgI_, 0.7255, 2.52, 0.166, 222, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4954, d4hrcJ_, 0.7255, 2.51, 0.208, 198, 192, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
4955, p4gk7X_, 0.7255, 2.52, 0.208, 198, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
4956, d3sdiX_, 0.7255, 2.53, 0.208, 198, 192, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
4957, d3dy3X_, 0.7255, 2.51, 0.208, 198, 192, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
4958, d3dy3J_, 0.7255, 2.51, 0.208, 198, 192, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
4959, d5l5bY_, 0.7254, 2.81, 0.156, 211, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
4960, d4jt0X_, 0.7254, 2.52, 0.208, 198, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
4961, d4jt0J_, 0.7254, 2.52, 0.208, 198, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
4962, d3mkaT_, 0.7254, 2.84, 0.168, 250, 197, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4963, d5trsY_, 0.7253, 2.52, 0.166, 223, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4964, d5trrK_, 0.7253, 2.52, 0.166, 223, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4965, d5l5bK_, 0.7253, 2.81, 0.156, 211, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
4966, d3sdiJ_, 0.7253, 2.52, 0.208, 198, 192, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
4967, d3mkaC_, 0.7253, 2.84, 0.168, 250, 197, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4968, d3dy4X_, 0.7253, 2.51, 0.208, 198, 192, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
4969, d3dy4J_, 0.7253, 2.51, 0.208, 198, 192, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
4970, d2fakX_, 0.7253, 2.52, 0.208, 198, 192, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
4971, d2fakJ_, 0.7253, 2.52, 0.208, 198, 192, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
4972, d5trgY_, 0.7252, 2.52, 0.166, 223, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4973, d5trgV_, 0.7252, 2.53, 0.166, 223, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4974, d3mka2_, 0.7252, 2.85, 0.168, 246, 197, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4975, d3gptX_, 0.7252, 2.52, 0.208, 198, 192, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
4976, d2f16X_, 0.7252, 2.52, 0.208, 198, 192, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
4977, d2f16J_, 0.7252, 2.52, 0.208, 198, 192, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
4978, d5trsL_, 0.7251, 2.52, 0.166, 223, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4979, d5trrV_, 0.7251, 2.53, 0.166, 223, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4980, d5thoK_, 0.7251, 2.53, 0.166, 223, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4981, d4r3oI_, 0.7251, 2.49, 0.202, 220, 188, HUMAN CONSTITUTIVE 20S PROTEASOME
4982, d4fzgX_, 0.7251, 2.52, 0.208, 198, 192, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
4983, d4fzgJ_, 0.7251, 2.52, 0.208, 198, 192, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
4984, d3gptJ_, 0.7251, 2.52, 0.208, 198, 192, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
4985, d5trsN_, 0.7250, 2.53, 0.166, 223, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4986, d5trgX_, 0.7250, 2.53, 0.166, 222, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4987, p5mpcN_, 0.7250, 3.09, 0.164, 218, 201, 
4988, p5gjqp_, 0.7250, 2.48, 0.202, 193, 188, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
4989, d4r3oW_, 0.7250, 2.49, 0.202, 220, 188, HUMAN CONSTITUTIVE 20S PROTEASOME
4990, d3mkaR_, 0.7250, 2.73, 0.168, 246, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4991, d3mg8J_, 0.7250, 2.52, 0.208, 198, 192, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
4992, p5trga_, 0.7249, 2.53, 0.166, 223, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4993, d5l5eY_, 0.7249, 2.82, 0.156, 211, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
4994, d5l5eK_, 0.7249, 2.82, 0.156, 211, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
4995, d3nzjX_, 0.7249, 2.53, 0.208, 198, 192, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
4996, d3nzjJ_, 0.7249, 2.53, 0.208, 198, 192, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
4997, d3mg0X_, 0.7249, 2.52, 0.208, 198, 192, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
4998, d3mg0J_, 0.7249, 2.52, 0.208, 198, 192, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
4999, d5trrY_, 0.7248, 2.52, 0.166, 223, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
5000, d5trrW_, 0.7248, 2.52, 0.166, 223, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
